metronidazole has been researched along with tetracycline in 729 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 88 (12.07) | 18.7374 |
| 1990's | 230 (31.55) | 18.2507 |
| 2000's | 200 (27.43) | 29.6817 |
| 2010's | 160 (21.95) | 24.3611 |
| 2020's | 51 (7.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abedi, JK; Carcanague, D; Jones, J; Joubran, C; Kühler, TC; Shue, YK; Uria-Nickelsen, M; Wuonola, MA | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Angelini, P; Curini, M; Epifano, F; Genovese, S; Menghini, L; Pagiotti, R | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cheng, WC; Hsu, TL; Liou, JM; Tseng, YY; Wong, CH; Wu, MS | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lindhe, J; Listgarten, MA; Parodi, R | 1 |
| Fitzgerald, JF; Grosfeld, JL; Jessee, WF; Ryan, JM | 1 |
| Dornbusch, K; Nord, CE; Olsson, B | 1 |
| Dahlbäck, A; Dornbusch, K; Nord, CE | 1 |
| Adams, EB; MacLeod, IN | 1 |
| Waldvogel, FA | 1 |
| Gustafsson, BE; Norin, KE | 1 |
| Gill, F; Miller, LH; Neva, FA | 1 |
| Fossati, C | 1 |
| Tyler, CW | 1 |
| Dornbusch, K; Holmberg, K; Nord, CE | 1 |
| Ridley, DS; Tomkins, AM; Wright, SG | 1 |
| Frank, S; Hofstetter, A; Schmiedt, E; Weissenbacher, ER | 1 |
| Finegold, SM | 1 |
| Katz, M | 1 |
| Roser, H | 1 |
| Guida, G; Minucci, D; Rabasso, A | 1 |
| Dempster, R; Donaldson, M; Garcia, L; Heyneman, D | 1 |
| Busch, DF; Finegold, SM; Sutter, VL | 1 |
| Bishop, P; Wade, WG | 1 |
| Avanessian, AB; Lomeli, SL; Nachnani, S; Newman, MG; Scuteri, A | 1 |
| Khatiblou, FA | 2 |
| Cheng, A; Chung, SC; Hosking, SW; Leung, JW; Li, AK; Ling, TK; Yung, MY | 1 |
| Jaskiewicz, K; Lastovica, A; Le Roux, E; Louw, JA; Lucke, W; Marks, IN; Winter, T; Zak, J | 1 |
| Andrews, P; Borody, TJ; Brandl, S; George, LL; Jankiewicz, E; Ostapowicz, N | 1 |
| Bell, GD; Burridge, SM; Gant, PW; Harrison, G; Jones, PH; Pallecaros, A; Powell, K; Trowell, JE | 1 |
| Laine, L | 1 |
| Ashkenazi, M; Donly, KJ | 1 |
| Barten, G; Gerber, B; Splitt, G; Wilken, H; Zacharias, K | 1 |
| Beattie, S; Keane, C; O'Morain, C; Patchett, S | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Saeed, ZA | 1 |
| Andrews, P; Borody, TJ; Brandl, S; Devine, M; George, LL; Lenne, J; Moore-Jones, D; Walton, M | 1 |
| Addy, M; Moran, J; Morgan, JR; Newcombe, R; Wade, WG | 1 |
| Börsch, G; Labenz, J | 1 |
| Alpert, LC; Evans, DG; Evans, DJ; Genta, RM; Graham, DY; Klein, PD; Lew, GM; Malaty, HM | 1 |
| de Uzeda, M; Feitosa, AC; Fonseca, ME; Novaes, AB | 1 |
| Gattereau, D; Knoefel, F; Morisset, ME; Morisset, R; Rousseau, S | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM | 1 |
| Baldan, N; Freeman, E | 1 |
| Andrews, P; Borody, TJ; Brandl, S; Devine, M; George, LL; Moore-Jones, D; Walton, M | 1 |
| Keku, J; Lichtman, SN; Sartor, RB; Schwab, JH | 1 |
| Elechi, EN; Etawo, SU | 1 |
| Hirsh, DC; Jang, SS | 1 |
| Bellone, F; Pecorari, D | 1 |
| Davey, MR; van Iddekinge, B | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM; Opekun, A | 1 |
| Deasy, MJ | 1 |
| Wade, WG | 1 |
| Collins, AE; Deasy, PB; MacCarthy, DJ; Russell, RJ | 1 |
| Borody, EG; Borody, TJ; Brandl, S; Cole, P; George, LL; Hyland, L; Lenne, J; Morgan, A; Noonan, S | 1 |
| Lacroix, JM; Mayrand, D | 1 |
| Duerden, BI; Geary, I; Jones, BM; Lee, ME | 1 |
| Laine, BM; Maier, KA; Mitten, JE; Stevens, DL | 1 |
| Maier, KA; Mitten, JE; Stevens, DL | 1 |
| Carle, G; Davidson, AI; Miller, SS; Reid, TM; Thomson, SR | 1 |
| Mangels, JI | 1 |
| Fadillah, A; Sidabutar, P; Soedin, K; Syukran, OK | 1 |
| Christiansen, JV; Hjorth, N; Schmidt, H; Veien, NK | 1 |
| D'Angelo, G; Golub, LM; Greenwald, RA; McNamara, TF; Ramamurthy, NS | 1 |
| Addy, M; Hassan, H; Moran, J; Newcombe, R; Wade, W | 1 |
| Bremmelgaard, A; Jansen, JE | 1 |
| Nasir, MA | 1 |
| Scher, KS | 1 |
| Addy, M; Wade, WG | 1 |
| Feingold, DS; Wagner, RF | 1 |
| Burchell, HJ; Cronjé, HS; de Wet, JI | 1 |
| Barr, GD; Jewell, DP; Shepherd, HA | 1 |
| Pankey, GA; Valainis, GT | 1 |
| Addy, M; Hassan, H; Langeroudi, M | 1 |
| Higgins, TJ; Hunter, N; Knox, KW | 1 |
| Opferkuch, W | 1 |
| Hanmer, D | 1 |
| Lassen, E | 1 |
| Leigh, DA | 1 |
| Steinitz, H | 1 |
| Knudsen, EA | 1 |
| Jarumilinta, R; Kradolfer, F; Sackmann, W | 1 |
| Hermans, PE; Wilkowske, CJ | 1 |
| Freeman, WA; McFadzean, JA; Whelan, JP | 1 |
| Hartley, PS; Leary, PM; Watson, CE | 1 |
| Powell, SJ; Rubidge, CJ; Scragg, JN | 1 |
| Farqharson, M | 1 |
| Hammer, B; Reutter, FW | 1 |
| Longerbeam, JK; Reeves, CD; Tetz, EM | 1 |
| Geddes, AM | 1 |
| Onifade, A; Osoba, AO | 1 |
| Woodcock, KR | 1 |
| Bell, DR | 2 |
| Prakash, A; Prandit, PN; Sharma, LK | 1 |
| Lerner, PI | 1 |
| Moxey, PC; Robles, E; Schimmel, EM; Trier, JS | 1 |
| Penza, J; Rankin, JS | 1 |
| Finegold, SM; Nastro, LJ | 1 |
| Kröger, E; Lohmeyer, H | 1 |
| Thompson, JW; Walton, JG | 1 |
| De Carneri, I | 1 |
| Kümmel, G | 1 |
| Luger, A | 1 |
| Wolfe, MS | 1 |
| Belsheim, MR; Champion, M; Sullivan, SN; Troster, M | 1 |
| Nielsen, PG | 1 |
| Deodhare, SG; Pujari, BD | 1 |
| Malamy, MH; Tally, FP | 1 |
| Dhawan, BN; Mukherjee, KC; Raghubir, R; Singh, D; Srimal, RC; Suri, YV | 1 |
| Dextraze, L; Mayrand, D; Mouton, C | 1 |
| Hamp, SE; Johansson, LA; Lundström, A | 1 |
| Addy, M; Langeroudi, M | 1 |
| Chan, EC; Quee, TC; Roussou, T | 1 |
| Felman, YM; Nikitas, JA | 1 |
| Addy, M; Coventry, JF; Handley, R; Newman, HN; Rawle, L | 1 |
| Anver, MR; Battles, JK; Blumenauer, LL; Gonda, MA; Gorelick, PL; Haines, DC; Russell, RJ; Ward, JM | 1 |
| Flynn, MJ; Li, G; Slots, J | 1 |
| Andrews, P; Bae, H; Borody, TJ; Brandl, S; Fracchia, G; Shortis, NP | 1 |
| Alvarez Baleriola, I; Boixeda, D; de Rafael, L; Gisbert, JP; Martín de Argila, C; Vila, T | 1 |
| Alvarez Baleriola, I; Bermejo, F; Boixeda, D; de Rafael, L; García Plaza, A; Gisbert, JP; Martín de Argila, C | 1 |
| Becker, T; Börsch, G; Köhl, H; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 2 |
| Dettmer, A; Domschke, W; Fenner, T; Gregor, M; Hesse, P; Holtmann, G; Miederer, SE; Schentke, KU; Schütz, E; van Husen, N | 1 |
| Schepp, W | 1 |
| Wilson, WH | 1 |
| Iwamoto, Y; Miyake, Y; Okuda, K; Suginaka, H; Tsuruda, K | 1 |
| Folwaczny, C | 1 |
| Foltz, CJ; Fox, JG; Shames, B; Yan, L | 2 |
| Hogan, DJ | 1 |
| de Boer, WA; Tytgat, GN | 2 |
| Fennerty, MB | 2 |
| Beattie, S; Gilvarry, J; Hamilton, H; Keane, CT; O'Morain, CA; Sweeney, EC; Xia, HX | 1 |
| Dehbashi, N; Etaati, H; Fattahi, M; Javan, A; Massarrat, S; Saberi-Firoozi, M; Zare, S | 1 |
| Cheng, AF; Chung, SC; Leung, VK; Li, AK; Ling, TK; Suen, R; Sung, JJ | 1 |
| Keane, CT; Marshall, DG; O'Morain, CA; Smyth, CJ; Windle, HJ; Xia, HX | 1 |
| Axon, AT; Clarke, AM; Dixon, MF; Jackson, P; Lynch, DA; Mapstone, NP; Morrison, L; Quirke, P; Sobala, GM | 1 |
| Dassiou, M; Maraki, S; Margioris, AN; Samonis, G; Toloudis, P; Tselentis, Y | 1 |
| Bhutta, AS; Cunnane, K; Feeley, KM; Kanduru, C; Meehan, JM; O'Connor, HJ | 1 |
| Hahm, JS; Kim, HJ; Park, KN | 1 |
| Bermejo, F; Boixeda, D; de Rafael, L; García Plaza, A; Gisbert, JP; Martín de Argila, C | 1 |
| Cohen, MH | 1 |
| Murty, VL; Piotrowski, J; Slomiany, A; Slomiany, BL | 1 |
| Klotz, O; Treiber, G | 1 |
| Cheng, AF; Chung, SC; Leung, VK; Li, AK; Li, MK; Ling, TK; Ng, EK; Sung, JJ; Yung, MY | 1 |
| Van den Bossche, L | 1 |
| Kamel, E; Legrand, R | 1 |
| de Boer, WA; Driessen, WM | 2 |
| Marsh, BT | 1 |
| Archimandritis, A; Balatsos, V; Delis, V; Kastanas, K; Mentis, A; Scandalis, N | 1 |
| Harris, A; Misiewicz, JJ | 2 |
| de Boer, W; Driessen, W; Jansz, A; Tytgat, G | 1 |
| Chen, CY; Chen, LT; Jan, CM; Lin, SR; Liu, CS; Perng, DS; Wang, WM | 2 |
| Buttigieg, RJ; Iseli, A; Iser, JH | 1 |
| Cheng, AF; Chung, SC; Hosking, SW; Li, AK; Ling, TK; Sung, JJ; Yung, MY | 2 |
| Dhillon, AP; Fraser, AG; Pounder, RE; Sankey, EA; Sim, R | 1 |
| Bertrams, J; Börsch, G; Labenz, J; Rühl, GH | 1 |
| de Boer, WA; Driessen, WM; Potters, VP; Tytgat, GN | 1 |
| Dare, FO; Fadiran, OA; Jeje, EA; Nwosu, SO; Oyero, TO | 1 |
| Dent, J; Eyre-Brook, IA; Lobo, AJ; McNulty, CA; Uff, JS; Wilkinson, SP | 1 |
| Graham, DY; Peura, DA | 1 |
| Chan, FT; Diaz-Mitoma, F; Guan, MX; Mackenzie, AM | 1 |
| Reilly, TG; Walt, RP | 1 |
| Arber, N; Gilat, T; Gorea, A; Hallak, A; Moshkowitz, M; Peled, Y; Santo, M; Tiomny, E | 1 |
| De Korte, H; Moolenaar, W; Oom, JA; Runhaar, EA; Thijs, JC; Van Zwet, AA | 1 |
| Brazer, SR; Maniatis, AG | 1 |
| Genta, RM; Go, MF; Graham, DY; Lew, GM; Rehfeld, JF | 1 |
| Beattie, S; Collins, R; Hamilton, H; McCarthy, CJ; O'Morain, C | 1 |
| Feik, D; Rams, TE; Slots, J | 1 |
| Alaluusua, S; Asikainen, S; Jousimies-Somer, H; Pajukanta, R; Saarela, M | 1 |
| Hammar, CH; Jaspersen, D | 1 |
| Flynn, MJ; Slots, J | 1 |
| Andrews, P; Borody, TJ; Brandl, S; Ferch, N; Hyland, L; Jankiewicz, E | 1 |
| Oey, HB; Thijs, JC; Van Zwet, AA | 1 |
| Graham, DY; Hepps, KS; Lew, GM; Ramirez, FC; Saeed, ZA | 1 |
| Börsch, G; Gyenes, E; Labenz, J; Rühl, GH | 2 |
| Andrews, P; Borody, TJ; Carroll, M; Ferch, N; Jankiewicz, E | 1 |
| Calam, J; Moss, SF | 1 |
| Cutler, AF; Schubert, TT | 2 |
| Axon, AT | 1 |
| Kanayama, S; Matsuzawa, Y; Nakanishi, T; Shinomura, Y | 1 |
| Genta, RM; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Ramirez, FC | 1 |
| Asikainen, S; Saxén, L | 1 |
| Jaskiewicz, K; Louw, JA; Marks, IN | 1 |
| Allardyce, RA; Bagshaw, PF; Munster, DJ; Phillips, K | 1 |
| Hatzis, A; Mantzaris, GJ; Petraki, K; Spiliades, C; Tamvakologos, G; Triadaphyllou, G | 1 |
| De Graaff, J; Namavar, F; Pavicić, MJ; van Winkelhoff, AJ; Verboom, T | 1 |
| Moolenaar, W; ten Bokkel Huinink, J; Thijs, JC; van Zwet, AA; Wolfhagen, MJ | 1 |
| Boixeda, D; Gisbert, JP; Hernández Ranz, F; Martín de Argila, C | 1 |
| Majka, J; Piotrowski, J; Slomiany, A; Slomiany, BL | 1 |
| Walsh, TF | 1 |
| Avila-Campos, MJ; Carvalho, MA; Zelante, F | 1 |
| Foyle, DM; Needleman, IG; Pandya, NV; Smith, SR | 1 |
| Fennerty, MB; Vakil, N | 1 |
| Davis, S | 1 |
| Cheng, AF; Chung, SC; Lau, JY; Leung, VK; Li, AK; Ling, TK; Suen, R; Sung, JJ | 1 |
| Alvarez Baleriola, I; Boixeda, D; de Rafael, L; García Plaza, A; García, M; Gisbert, JP; Martín de Argila, C | 1 |
| Alván, G; Blomgren, K | 1 |
| Boixeda, D; Cantón, R; de Rafael, L; Gisbert, JP; Martín de Argila, C; Redondo, C; Vila, T | 1 |
| Bermejo, F; Boixeda, D; de Rafael, L; Gisbert, JP; Martín de Argila, C; Redondo, C | 1 |
| Cohen, RO; Colodner, R; Keness, J; Ziv, G | 1 |
| Ali, MR; Chua, LE; Fraser, AG; Hollis, B; Little, SV; Moore, L | 1 |
| de Boer, WA; Driessen, WM; Jansz, AR; Tytgat, GN | 1 |
| Jaup, BH; Norrby, A | 1 |
| de Boer, WA; Ouwehand, ME; Schade, RW; Schneeberger, PM; Tytgat, GN; van Etten, RJ | 1 |
| Avsar, E; Gültekin, O; Kalayci, C; Kiziltas, S; Lawrence, R; Tözün, N; Ulusoy, NB | 1 |
| Griffiths, AE; Halliday, D; Jacyna, MR; Phull, PS | 1 |
| De Boer, WA; Driessen, WM; Tytgat, GN | 1 |
| Batema, RP; Ford, LL; Petschow, BW | 1 |
| Dammann, HG | 1 |
| De Boer, WA; Driessen, WM; Geuskens, LM; Lai, JY | 1 |
| Kinane, DF; Pourtaghi, N; Radvar, M | 1 |
| Kinane, DF; Mooney, J; Pourtaghi, N; Radvar, M | 1 |
| Koh, IH; Silva, RM | 1 |
| Bollen, CM; Quirynen, M | 1 |
| Gimeno, L; Gomollón, F; Marzo, J; Pérez-Caballero, MC; Valdepérez, J; Yus, C | 1 |
| Carmichael, JM; Patchin, GM; Wieland, KA | 1 |
| Freston, JW; Murphy, K; Taylor, JL; Zagari, M | 1 |
| Alvarez Baleriola, I; Boixeda, D; Gisbert, JP; Jiménez, I; Pajares, JM; Pérez García, JI; Redondo, C | 1 |
| Bruno, M; Grosso, S; Peyre, S; Rizzi, R; Sategna-Guidetti, C | 1 |
| Asahara, M; Chiba, T; Fujimori, T; Fukuda, H; Kawanami, C; Kinoshita, Y; Matsumoto, S; Matsushima, Y; Waki, S | 1 |
| Scott, BB; Vautier, G | 1 |
| de Boer, WA; Ouwehand, ME; Schade, RW; Schneeberger, PM; Tytgat, GN; van Etten, RJ; van Unnik, AJ | 1 |
| Seifrit, B | 1 |
| Choi, CH; Chung, EC; Kung, NN; Kwok, SP; Li, TH; Lim, BH; Ma, HC; Ng, PW; Sung, JJ; Wong, KC; Yuen, NW | 1 |
| Agrawal, BK; Dayal, VM; Kamal, J; Kumar, P; Shahi, SK | 1 |
| Adams, RM | 1 |
| Becker, T; Börsch, G; Labenz, J; Peitz, U; Siehoff, S; Tillenburg, B | 1 |
| Kinane, DF; Radvar, M | 2 |
| Damianos, AJ; McGarrity, TJ | 1 |
| Beattie, S; Buckley, MJ; Gilvarry, J; Hamilton, H; O'Morain, CA | 1 |
| Angeletti, S; Annibale, B; Bordi, C; Delle Fave, G; Malagnino, F; Mancino, C; Marignani, M | 1 |
| Ortiz, JA; Palacín, C; Sacristán, A; Tarragó, C | 1 |
| Kim, MJ; Michener, R; Triadafilopoulos, G | 1 |
| Myers, D | 1 |
| Alarcon, T; Domingo, D; López-Brea, M; Sanchez, I | 1 |
| Chan, CS; Chan, FK; Chung, SC; Lee, YT; Leung, VK; Li, EK; Sung, JJ; To, KF; Woo, J; Yung, MY | 1 |
| El-Zaatari, F; Engstrand, L; Genta, RM; Graham, D; Scheynius, A | 1 |
| Attili, AF; Diana, F; Pugliano, F; Rinaldi, V; Valente, C; Zullo, A | 1 |
| el-Zimaity, HM; Graham, DP; Graham, DY; Hoffman, J; Osato, M | 1 |
| Eaton, KA; Kramer, LW; Wack, RF | 1 |
| Malfertheiner, P; Mégraud, F | 1 |
| Moayyedi, P | 1 |
| de Boer, WA; Driessen, WM; Lai, JY; Schneeberger, PM; van de Wouw, BA; van Etten, RJ | 1 |
| Keller, JJ; Rauws, EA; Tytgat, GN; van der Hulst, RW | 1 |
| Cheng, AF; Chung, SS; Ling, TK; Sung, JJ; Yiu, PY | 1 |
| Emami, S; Estrada, R; Laine, L; Trujillo, M | 1 |
| Carrazco, J; Checkley, W; Cordero, L; Gilman, RH; Leon-Barua, R; McDonald, J; Ramirez-Ramos, A; Recavarren-Arce, S; Salazar, G; Valdez, Y; Watanabe, J | 1 |
| Bell, JM; Grayson, ML; Lambert, JR; Midolo, PD; Turnidge, JD | 1 |
| Bolin, TD; Engelman, JL; Korman, MG; Pianko, S | 1 |
| Chan, FK; Cheng, AF; Chung, SC; Lau, JY; Lee, YT; Leung, VK; Leung, WK; Ling, TK; Ng, EK; Suen, R; Sung, JJ | 1 |
| Metz, DC | 1 |
| Dankert, J; Homan, A; Roorda, P; Tytgat, GN; van der Ende, A; van der Hulst, RW | 1 |
| Collins, BJ; Coombs, GW; Forbes, GM; McCullough, CA; Robins, PD | 1 |
| de Boer, WA; Schneeberger, PM; van Etten, RJ | 1 |
| Cohen, PR | 1 |
| Dudhani, RV; Jariwala, U; Jayachandran, P; Somayaji, BV; Vidyalakshmi, K | 1 |
| Ducóns, JA; Fuentes, J; García, S; Gimeno, L; Gomollón, F; Montoro, M; Vera, J | 1 |
| Calvet Calvo, X | 1 |
| Cummins, AG; Grove, DI; Koutsouridis, G | 1 |
| Aly, R; Baker, MO; Bayles, C; Coleman, E; Czernielewski, JM; Dahl, MV; Herndon, JH; Katz, HI; Krueger, GG; Millikan, LE; Odom, RB; Parker, F; Patrignelli, R; Reusser, B; Tuley, MR; Weidner, M; Wolf, JE | 1 |
| van Winkelhoff, AJ; Winkel, EG | 1 |
| de Boer, SY; Siem, TH | 1 |
| Fitzgerald, JF; Troncone, R | 1 |
| de Boer, WA; Haeck, PW; Mulder, CJ; Otten, MH | 1 |
| Fendrick, AM; Jeffries, MA; Scheiman, JM | 1 |
| Ihm, P; Koch, HK; Massarrat, S | 1 |
| Coremans, A; de Boer, WA; Schneeberger, PM; van Etten, RJ | 1 |
| Gilman, RH; Gutierrez, V; León, C; Valdez, Y; Velapatiño, B | 1 |
| Böe, OE; Bruun, G; Lie, T | 1 |
| Bolin, TD; Engelman, JL; Korman, MG; Nicholson, FB | 1 |
| Killoy, WJ | 1 |
| Kashifard, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Siavoshi, F | 1 |
| Coudron, PE; Stratton, CW | 1 |
| Bellin, EY; Fletcher, DD; Shuter, J; Simone, VJ | 1 |
| Dickson, A; El-Nujumi, A; El-Omar, E; Hilditch, T; Kelman, A; Knill-Jones, R; McColl, K; Murray, L; Penny, C; Wirz, A | 1 |
| Aronna, G; Caruso, F; De Rosa, A; Margarucci, S; Rosso, F | 1 |
| Chan, FK; Chan, HL; Chung, SC; Lai, AC; Lau, JY; Lee, YT; Leung, WK; Ng, EK; Suen, R; Sung, JJ; Wu, JC | 1 |
| Eshraghi, J; Fassihi, R; Yang, L | 1 |
| Wilkin, JK | 1 |
| Enwonwu, CO; Falkler, WA; Idigbe, EO | 1 |
| Chua, AB; Cutler, A; Ding, RP; Goh, KL; Kandasami, P; Mazlam, MZ; Raj, SM | 1 |
| Harasawa, S; Kouda, K; Kurumada, T; Miwa, T; Shirai, T; Tada, U; Takagi, A; Wada, T; Watanabe, S | 1 |
| Choi, CH; Kung, NN; Lai, WM; Lam, KN; Leung, EM; Li, TH; Lui, YH; Ng, PW; Sung, JJ; Yuen, NW | 1 |
| Fennerty, MB; Kelly, C; Knigge, K; Peterson, WL | 1 |
| Marshall, JB | 1 |
| Addy, M; Moran, J; Newcombe, R; Wade, W | 1 |
| Clyne, M; Drumm, B; Goggin, N; Imrie, C; Rowland, M; Walsh, D | 1 |
| Jousimies-Somer, H; Kanervo, A; Könönen, E; Salminen, K | 1 |
| Hirschowitz, BI; Mönkemüller, KE | 1 |
| Debets-Ossenkopp, YJ; Herscheid, AJ; Kuipers, EJ; Kusters, JG; Pot, RG; Vandenbroucke-Grauls, CM | 1 |
| Magnusson, I | 1 |
| Are, BM; Atzei, A; Carta, M; Cugia, L; Dore, MP; Graham, DY; Maida, A; Manca, A; Massarelli, G; Mura, I; Piana, A; Realdi, G | 1 |
| Kleinfelder, JW; Lange, DE; Müller, RF | 1 |
| Dhali, GK; Garg, PK; Sharma, MP | 1 |
| Barone, A; Ciaglia, RN; Ramaglia, L; Sbordone, L | 1 |
| de Boer, WA | 1 |
| Dashti, M; Massarrat, S; Pahlewanzadeh, MR; Roghani, HS | 1 |
| Charbit, Y; Fosse, TB; Hannoun, LR; Hitzig, C; Madinier, IM | 1 |
| Zwimpfer, J | 1 |
| Bazzoli, F; Berretti, D; De Luca, L; Fossi, S; Nicolini, G; Pozzato, P; Zagari, M | 1 |
| de Boer, WA; de Grauw, WJ; Lai, JY | 1 |
| Carpio, D; Gisbert, JL; Gisbert, JP; Grávalos, RG; Marcos, S; Pajares, JM | 1 |
| Canning, A; Egan, C; Farraye, FA; Kemp, JA; Lee, M; Tataronis, G | 1 |
| Alonso García, I; García Pérez, A; Giménez Samper, M; Valverde de La Osa, J | 1 |
| De Boer, WA; Jansen, JB; Schneeberger, PM; Van De Wouw, BA; Van Etten, RJ; Van Oijen, AH | 1 |
| Anderson, SY; El-Zimaity, HM; Graham, DY; Hoffman, J; Opekun, AR; Osato, MS | 1 |
| Gurer, I; Hilmioglu, F; Ozyilkan, E; Sare, M; Taskin, V | 1 |
| Brullet, E; Calvet, X; Campo, R; Comet, R; García, N; Titó, L | 1 |
| de Boer, WA; Nouhan, N; Plaisier, AP; Quint, WG; Schneeberger, PM; van Doorn, LJ | 1 |
| de Boer, WA; Schneeberger, PM; Tytgat, GN; van Etten, RJ | 1 |
| Bisson, S; Bojarski, C; Epple, HJ; Fromm, M; Kirstein, FW; Riecken, EO; Schulzke, JD | 1 |
| Boyanova, L; Katzarov, N; Koumanova, R; Mitov, I; Spassova, Z; Stancheva, I | 1 |
| Balta, A; Bouzakis, H; Broutet, N; Kralios, N; Michopoulos, S; Tsibouris, P; Vougadiotis, J | 1 |
| Anderson, SY; El-Zimaity, HM; Graham, DY; Hoffman, J; Kwon, DH; Opekun, AR; Osato, MS | 1 |
| Antczak-Bouckoms, AA; Weinstein, MC | 1 |
| Liu, JX; Shi, XD; Wang, HT; Wu, H | 1 |
| Vdovenko, AA; Williams, JE | 1 |
| Boyea, N; Danziger, LH; Hackleman, JM; Neuhauser, MM; Pendland, SL; Prause, JL | 1 |
| Barrera, F; Fuentes, J; Garuz, R; Gomollón, F; Malo, J; Simón, MA; Tirado, M; Valdepérez, J | 1 |
| Piqué, JM | 1 |
| El-Zaatari, FA; Graham, DY; Kato, M; Kim, JJ; Kwon, DH; Lee, M; Osato, MS; Yamaoka, Y | 1 |
| Cooper, R; Miskovitz, P; Nagler, J | 1 |
| Lam, SK; Wang, WH; Wong, BC | 1 |
| Mégraud, F | 1 |
| Baena Díez, JM; García Lareo, M; López Mompó, C; Rams Rams, F; Rosario Hernández Ibáñez, M; Teruel Gila, J | 1 |
| Dahlén, G; Molander, A; Reit, C; Samuelsson, W | 1 |
| Andriulli, A; Bergoli, ML; Caruso, N; Clemente, R; Festa, V; Perri, F; Quitadamo, M; Villani, MR | 1 |
| El-Zaatari, FA; Graham, DY; Kim, JG; Kim, JJ; Kwon, DH; Lee, M; Osato, MS; Reddy, R | 1 |
| Chan, FK; Chan, HL; Chung, SC; Hui, Y; Lai, MS; Lau, JY; Lee, YT; Leung, VK; Leung, WK; Suen, BY; Sung, JJ; Wu, JC | 1 |
| Cattabriga, M; Pedrazzoli, V; Wilson, TG | 1 |
| Al-Quorain, AA; Al-Qurashi, AR; El-Morsy, F | 1 |
| El-Zimaity, HM; Graham, DY; Hoffman, J; Kwon, DH; Osato, MS; Saeed, MA | 1 |
| Silver, AH; Silver, DS; Silver, EA | 1 |
| Bravo, JC; Bravo, LE; Casabon, AL; Collazos, T; Correa, P; Fischbach, LA; Ramirez, H; Realpe, JL; Ruiz, B; Schmidt, BA | 1 |
| Brullet, E; Calvet, X; Campo, R; Garcia, N; Gené, E; Sanfeliu, I | 1 |
| Kuipers, EJ; Kusters, JG | 1 |
| Bateson, MC | 1 |
| Hojo, M; Miwa, H; Nagahara, A; Sato, N | 1 |
| Conejo Gonzalo, C; Hergueta Delgado, P; Herrerías Gutiérrez, JM; Rojas Feria, M; Romero Castro, R; Suárez Barrenechea, AI | 1 |
| Bayerdörffer, E; Graham, DY; Miehlke, S | 1 |
| Ananthakrishnan, N; Badrinath, S; Kate, V | 1 |
| Cutler, RH; Freedman, AL; Mellado, JR; Salkin, LM; Schneider, DB; Stein, MD | 1 |
| Fedorov, AV; Sazhin, VP | 1 |
| Feldman, SR; Fleischer, AB; Gupta, AK; Hollar, CB | 1 |
| Archambault, A; Bailey, R; Dallaire, C; Desrochers, S; Dumont, A; Fallone, CA; Farley, A; Hunt, R; Lahaie, R; Marcon, N; Nguyen, B; Oravec, M; Ponich, T; Spénard, J; Van Zanten, SV; Whitsitt, P | 1 |
| Webster, GF | 1 |
| Fan, X; Hu, G; Liu, L; Yakoob, J; Zhang, Z | 1 |
| Alarcón, T; Baquero, M; Carbó, J; García-Samaniego, J; Iñiguez, A; López-Brea, M; Toro, C | 1 |
| Kinane, DF | 1 |
| Kleibeuker, JH; Thijs, JC; van der Wouden, EJ; van Zwet, AA | 1 |
| Cortesi, R; Esposito, E; Luca, G; Nastruzzi, C | 1 |
| Brou, E; Coulibaly, NT; Kamagate, A; Kone, D; Sixou, M | 1 |
| Asgari, AA; Dariani, NE; Malekzadeh, R; Massarrat, S; Sotoudehmanesh, R; Vahedi, H | 1 |
| Araj, GF; Barada, KA; Chedid, M; Mourad, FH; Sharara, AI | 1 |
| Artikis, V; Georgopoulos, SD; Karatapanis, S; Ladas, SD; Mentis, A; Raptis, SA; Spiliadi, C; Triantafyllou, K | 1 |
| Fallah, MS; Mansour-Ghanaei, F; Shafaghi, A | 1 |
| Grove, DI; Koutsouridis, G | 1 |
| Amsler, KM; Foster, LA; Merrill, JJ; Modzelewski, TC; Quispe, JD; Sizemore, CF; Slee, AM; Stevenson, DA | 1 |
| Takahashi, S; Tanaka, A | 1 |
| Ohkusa, T; Sato, N | 1 |
| Isomoto, H; Kohno, S | 1 |
| Cuchí Burgos, E; Forné Bardera, M; Garau Alemany, J; Lite Lite, J; Quintana Riera, S | 1 |
| Dore, MP; Graham, DY; Manca, A; Marras, L; Mele, R; Nieddu, S; Realdi, G | 1 |
| Bachor, J; Dinari, G; Fishman, M; Gal, E; Geler, A; Niv, Y; Passaro, DJ; Samra, Z; Shmuely, H; Yahav, J | 1 |
| Andreu, V; Bory, F; Calvet, X; Ducons, J; Guardiola, J; Guirao, R; Tito, L | 1 |
| Domareva, I; Ganskaya, Z; Isakov, V; Koudryavtseva, L; Maev, I | 1 |
| Amat, C; Ancelin-Malbreil, E; Becquart, JP; Faulques, B; Michault, A; Picot, S; Sapin, G; Simac, C | 1 |
| Bermejo, F; Boixeda, D; Defarges, V; García-Plaza, A; Hernández-Ranz, F; López-Sanromán, A; Martín-De-Argila, C; Milicua, JM | 1 |
| Buckley, M; Gilvarry, J; McNamara, D; O'Morain, C | 1 |
| Lang, NP; Mombelli, A; Rutar, A; Schmid, B | 1 |
| Karpinia, K; Walker, C | 1 |
| Alanís-Aguilar, O; Bosques-Padilla, FJ; Garza-González, E; Maldonado-Garza, HJ; Pérez-Pérez, GI; Tijerina-Menchaca, R | 1 |
| Abdelshehid, G; Goodson, JM; Niederman, R | 1 |
| Amberiadis, P; Archavlis, E; Chiotakakou, E; Christoforidis, P; Kourtessas, D; Mantzaris, GJ; Petraki, K; Triantafyllou, G | 1 |
| Douglass, CW; Hung, HC | 1 |
| Farup, PG; Høie, O; Lange, OJ; Tholfsen, J; Torp, R; Wetternus, S | 1 |
| Borody, T; Dallaire, C; De Boer, WA; Fallone, CA; Farley, A; Mégraud, F; O'Morain, C; Piotrowski, J; Schuman, R; Spénard, J; Tytgat, G | 1 |
| Celińska-Cedro, D; Dzierzanowska, D; Dzierzanowska-Fangrat, K; Jóźwiak, P; Madaliński, K; Rozynek, E | 1 |
| Buchmann, R; Lange, DE; Müller, RF; Van Dyke, TE | 1 |
| El-Zimaity, H; Hunt, R; Laine, L; Nguyen, B; Osato, M; Spénard, J | 1 |
| Kather, EJ; Marks, SL | 1 |
| Azagra, R; Calvet, X; Gené, E; Gisbert, JP | 1 |
| Brooke, CJ; Hampson, DJ; Riley, TV | 1 |
| Fischbach, L; Nash, C; Veldhuyzen van Zanten, S | 1 |
| Hardikar, W; Midolo, PD; Rerksuppaphol, S; Ward, P | 1 |
| Dore, MP; Graham, DY | 1 |
| Correa, P; Feldman, M; Fischbach, LA; Fontham, E; Goodman, KJ; Jain, R; Priest, E | 1 |
| Bästlein, E; Bayerdörffer, E; Haferland, C; Jacobs, E; Kirsch, C; Lehn, N; Miehlke, S; Neumeyer, M; Papke, J; Schneider-Brachert, W; Stolte, M; Vieth, M | 1 |
| de Boer, SY; de Boer, WA; Siem, H; v d Meeberg, PC | 1 |
| SENECA, H | 1 |
| FULPIUS, B; HAUSSER, E; ROSNER, P | 1 |
| Grenier, D; Mayrand, D; Roy, E | 1 |
| Ayyagari, A; Bhasin, D; Das, BK; Dharmalingam, S; Habibullah, CM; Khan, AA; Naik, SR; Rajasambandam, P; Ramathilagam, B; Rao, UA; Ray, P; Sharma, MP; Thyagarajan, SP | 1 |
| Farup, PG | 1 |
| Hanes, PJ; Purvis, JP | 1 |
| Gunsolley, JC; Haffajee, AD; Socransky, SS | 1 |
| Boyacioglu, S; Cosar, AM; Gumurdulu, Y; Gur, G; Gursoy, M; Kayaselcuk, F; Ozer, B; Ozsahin, K; Serin, E; Yilmaz, U | 1 |
| Mombelli, A; Samaranayake, LP | 1 |
| Cuomo, A; De Simone, T; Del Vecchio Blanco, C; Iovene, MR; Marmo, R; Montella, F; Mucherino, C; Nardone, G; Romano, M; Tufano, MA | 1 |
| Gilbert, P; Ledder, RG; McBain, AJ; Sreenivasan, P | 1 |
| Aumais, C; Lefebvre, M; Massicotte, J; Spénard, J; Tremblay, C | 1 |
| Fraser, A | 1 |
| Bonito, AJ; Evensen, C; Jackman, A; Lohr, KN; Lux, L; Sutton, S; Whitener, L | 1 |
| de Boer, WA; Kuipers, EJ; Kusters, JG | 1 |
| Abudayyeh, S; Belson, G; Dore, MP; El-Zimaity, HM; Graham, DY; Osato, MS | 1 |
| Wollner, T | 1 |
| Altintaş, E; Aydin, O; Camdeviren, H; Sezgin, O; Ulu, O | 1 |
| Calvet, X; Gené, E; Güell, M; Montserrat, A; Vergara, M | 1 |
| Choi, JH; Choung, RS; Chun, HJ; Han, WS; Hyun, JH; Jeen, YT; Jung, SW; Keum, B; Kim, CD; Kim, YS; Lee, HS; Lee, SW; Park, SC; Ryu, HS; Um, SH | 1 |
| de Boer, WA; Jansen, JB; Janssen, MJ; Laheij, RJ | 1 |
| Lundgren, T; Renvert, S | 1 |
| Bax, DA; de Jong, A; Gerrits, MM; Kuipers, EJ; Kusters, JG; Thijs, JC; van der Wouden, EJ; van Vliet, AH; van Zwet, AA | 1 |
| García, F; Lang, L | 1 |
| Dickason, J; Fischbach, LA; van Zanten, S | 1 |
| Fassihi, R; Wu, Y | 1 |
| Belson, G; Carlson, MR; El-Zimaity, HM; Graham, DY; Opekun, AR | 1 |
| Bory, F; Calvet, X; Ducons, J; Guardiola, J; Marko, D; Tito, L | 1 |
| Amini, M; Khedmat, H; Yari, F | 1 |
| Wolf, JE | 1 |
| Graber, MA; van Zuuren, EJ | 1 |
| Benno, Y; Hayashi, H; Hirai, S; Hojo, M; Kobayashi, O; Miwa, H; Nomura, T; Ogihara, T; Ohkusa, T; Okayasu, I; Sakamoto, M; Sato, N; Takei, Y; Terai, T; Yoshida, T | 1 |
| Filik, L; Köksal, AS; Odemiş, B; Ozden, A; Parlak, E; Sahin, B; Saşmaz, N; Ulker, A; Yolcu, OF | 1 |
| Aponte-Rivera, E; Fernández-Carbia, A; Marxuach-Cuétara, AM; Ríos-Bedoya, CF; Rodríguez-Orengo, JF; Rodríguez-Torres, M; Salgado-Mercado, R | 1 |
| Calvet, X; Carpio, D; Fuentes, J; Gisbert, JP; Guardiola, J; Olivares, D; Tito, L; Tomas, A | 1 |
| Lengyel, G; Zsolt, T | 1 |
| Thurmayr, R; Weber, K | 1 |
| Berg, DE; Bhattacharya, SK; Chattopadhyay, S; Chowdhury, A; Datta, S; De, R; Hembram, J; Mukhopadhyay, AK; Nair, GB; Patra, R; Ramamurthy, T | 1 |
| Roberts, FA; Wang, IC | 1 |
| Bonito, AJ; Lohr, KN; Lux, L | 1 |
| Cheon, JH; Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, DH; Lee, JH; Park, MJ; Song, IS | 1 |
| Budzyńska, A; Celińska-Cedro, D; Dzierzanowska, D; Dzierzanowska-Fangrat, K; Jarosz, M; Jóźwiak, P; Nowak, J; Pawłowska, J; Prosiecki, R; Romańczuk, W; Rozynek, E; Szadkowski, A | 1 |
| Roebuck, HL | 1 |
| Aumais, C; Brunet, JS; Grace, M; Lefebvre, M; Massicotte, J; Spénard, J; Tremblay, C | 1 |
| Borody, TJ | 1 |
| Hirai, S; Hojo, M; Kobayashi, O; Miwa, H; Nomura, T; Ogihara, T; Ohkusa, T; Okayasu, I; Sato, N; Takei, Y; Terai, T | 1 |
| Fukuda, Y; Sakagami, T | 1 |
| Berini-Aytés, L; Brescó-Salinas, M; Costa-Riu, N; Gay-Escoda, C | 1 |
| Chan, AO; Chan, CK; Chu, KM; Fung, FM; Gu, Q; Lai, KC; Tong, TS; Wong, BC; Wong, WM; Yee, YK | 1 |
| Cheon, JH; Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, DH; Song, IS | 1 |
| Delitala, G; Dore, MP; Maragkoudakis, E; Pironti, A; Realdi, G; Tadeu, V; Tedde, R | 1 |
| Benito, LM; Bermejo, F; Bory, F; Castro-Fernández, M; Cosme, A; Ducons, J; Fernández-Bermejo, M; Gisbert, JP; Lamas, E; López-Rivas, L; Olivares, D; Pabón, M; Pérez-Aisa, A | 1 |
| Deguchi, R; Kobayashi, I; Kobayashi, K; Kurumada, T; Masui, A; Matsushima, M; Mine, T; Muraoka, H; Shirai, T; Suzuki, T; Takagi, A; Watanabe, K; Watanabe, S | 1 |
| Butorov, IV; Butorov, SI; Maksimov, VV; Osoianu, IuP | 1 |
| Chey, WD; Kim, HM; Saad, RJ; Schoenfeld, P | 1 |
| Castro-Fernández, M; Cosme, A; Gisbert, JP; Gómez, B; Herrerías, JM; Luna, M; Monés, J; Olivares, D; Pajares, JM; Sánchez-Pobre, P | 1 |
| Amayo, EO; Kariuki, S; Lwai-Lume, L; Ogutu, EO | 1 |
| Schulz, H | 1 |
| Alarcón, T; Díaz-Reganon, J; Domingo, D; López-Brea, M | 1 |
| Quandalle, P; Tran, TT | 1 |
| Altintaş, E; Sezgin, O; Tataroğlu, C; Uçbilek, E | 1 |
| Cheon, JH; Jung, HC; Kim, JM; Kim, JS; Kim, N; Kim, SG; Lee, DH; Song, IS | 1 |
| Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P | 1 |
| Chen, A; Hsu, PI; Lai, KH; Lo, GH; Tsay, FW; Tseng, HH; Wang, WM; Wu, CJ; Wu, DC; Wu, IC; Wu, JY | 1 |
| Crosbie, O; Dempsey, C; Hooton, C; Keohane, J; Lucey, B; O'Mahony, S | 1 |
| Doratotaj, D; Fallahi, GH; Khatami, GR; Mirnaseri, MM; Safari, F; Siavoshi, F | 1 |
| Alizadeh, M; Arj, A; Bagheri-Lankarani, K; Bahri-Najafi, R; Dehbashi, N; Emami, MH; Esmaeili, A; Fattahi, MR; Geramizadeh, B; Kaviani, MJ; Saberfiroozi, MM; Taghavi, AR | 1 |
| Berg, DE; Bruce, MG; Bruden, DL; Hennessy, TW; Hurlburt, DA; Martinez, P; McMahon, BJ; Morris, J; Parkinson, AJ; Parks, D; Peters, H; Reasonover, A; Sacco, F; Swenson, M | 1 |
| Aduse-Opoku, J; Brazier, JS; Pumbwe, L; Wareham, DW; Wexler, HM | 1 |
| Cheng, CC; Hu, CT; Lin, CY; Lin, NT; Su, SC; Tseng, YH; Wu, CC | 1 |
| Kadayifçi, A | 1 |
| Cáceres, D; Defilippi, C; Garrido, L; Madrid, AM; Toledo, H; Vallejos, C | 1 |
| Aslan, M; Bagci, S; Erdil, A; Gunhan, O; Ozel, AM; Uygun, A; Yesilova, Z; Yildiz, O | 1 |
| Demirci, H; Ersoy, O; Ersoy, R; Tatlican, S; Yayar, O | 1 |
| Cabrera, E; Castro, M; Fernández, N; Méndez, I; Moreno, JL; Navarro-Jarabo, JM; Perea-Milla, E; Ramírez, LM; Rivas-Ruiz, F; Rivera, R; Sousa, FL; Ubiña, E; Vera, F | 1 |
| Balkrishnan, R; Conde, JF; Feldman, SR; Fleischer, AB; Yelverton, CB | 1 |
| Mahachai, V; Thong-Ngam, D | 1 |
| Sedlacek, MJ; Walker, C | 1 |
| Bagci, S; Ilgan, S; Kadayifci, A; Safali, M; Uygun, A | 1 |
| Gisbert, JL; Gisbert, JP; Jimenez-Alonso, I; Marcos, S; Moreno-Otero, R; Pajares, JM | 1 |
| Jung, HC; Kang, JM; Kim, JS; Kim, N; Kim, YR; Lee, DH; Park, YS; Song, IS | 1 |
| Altintaş, E; Nayir, E; Sezgin, O; Uçbilek, E | 1 |
| Davey, K; Gilbert, A; Hussein, I; Ranka, M | 1 |
| Chen, J; Hu, HJ; Huang, XL; Li, ZY; Yan, WH; Yu, JD | 1 |
| Chan, FK; Lee, CC; Lee, VW; Ling, TK | 1 |
| Akoachere, JF; Luma, HN; MacMillan, M; Malange Takang, AE; Malongue, A; Ndip, LM; Ndip, RN; Ojongokpoko, JE; Weaver, LT | 1 |
| Ilgan, S; Kadayifci, A; Karaeren, N; Safali, M; Uygun, A; Yesilova, Z | 1 |
| Baker, DE | 1 |
| Eide, GE; Hanevik, K; Hausken, T; Langeland, N; Mørch, K | 1 |
| Ching, SS; Jenkinson, LR; Sabanathan, S | 1 |
| Egan, BJ; O'Connor, HJ; O'Morain, CA | 1 |
| Vakil, N | 1 |
| Liu, ZQ; Yang, PC; Zheng, PY | 1 |
| Benno, Y; Kudo, T; Nishikawa, J; Sakata, S; Sugiyama, T | 1 |
| Lorentzen, HF; Madsen, JT; Paulsen, E | 1 |
| Chang, LL; Chen, A; Hsu, PI; Hu, HM; Jan, CM; Kuo, CH; Kuo, FC; Li, CJ; Tsai, PY; Wang, SW; Wang, WM; Weng, BC; Wu, DC; Wu, IC; Yu, FJ | 1 |
| Gao, W; Li, J; Tian, Y; Wang, WH; Zhang, XP | 1 |
| Bago, J; Bago, P; Bakula, V; Marusić, M; Pevec, B; Tomić, M | 1 |
| Arigbabu, AO; Coker, AO; Oyedeji, KS; Smith, SI | 1 |
| Ghisolfi, M; Lops, D; Romeo, E; Storelli, S | 1 |
| Balkarli, A; Baştürk, A; Cerçi, S; Senol, A; Songür, Y | 1 |
| Agudo, S; Alarcón, T; Cibrelus, L; López-Brea, M; Martínez, MJ; Urruzuno, P | 1 |
| Alvarez, A; Corredor, LF; Moncayo, JI; Reinosa, E; Santacoloma, M; Santacruz, JJ | 1 |
| O'Connor, HJ; O'Morain, CA; Qasim, A; Saleem, A | 1 |
| Dixit, VK; Gulati, AK; Jain, AK; Maurya, P; Mishra, S; Nath, G; Rao, G; Singh, V | 1 |
| Chey, WD; Higgins, PD; Luther, J; Moayyedi, P; Schoenfeld, PS; Vakil, N | 1 |
| Blackwood, RS; Christe, KL; Lerche, NW; Spinner, A; Tarara, RP | 1 |
| Cervigón, I; Palomo, A; Torres-Iglesias, LM | 1 |
| Choe, YH; Chung, IS; Kim, HS; Kim, JI; Kim, JJ; Kim, N | 1 |
| Classen, M; Liu, W; Ma, J; Pan, K; Winawer, S; You, W; Zauber, A; Zhang, L; Zhao, H; Zhou, T | 1 |
| Berk, T; Scheinfeld, N | 1 |
| Levy, I; Samra, Z; Shmuely, H; Yahav, J; Zevit, N | 1 |
| Chiba, T; Kato, K; Mabe, K; Mizokami, Y; Murakami, K; Ohkusa, T; Okayasu, I; Sato, N; Sugiyama, T; Tajiri, H; Takeuchi, Y; Terao, S; Watanabe, S; Yamato, S; Yanaka, A; Yokoyama, T | 1 |
| Hwang, JH; Hwang, TJ; Jeong, SH; Jung, HC; Kim, JW; Kim, N; Lee, BH; Lee, DH; Lee, SH; Park, YS; Song, IS | 1 |
| Hibi, T; Nishizawa, T; Suzuki, H | 1 |
| Cetinkaya, ZA; Coşgun, S; Düzgün, S; Güzelbulut, F; Kurdaş, OO; Sezikli, M | 1 |
| Demir, M; Göktürk, S; Oztürk, NA; Serin, E; Yilmaz, U | 1 |
| Feliciano, O; Fernández, H; Gala, A; Gutiérrez, O; Guzmán, D; Kobayashi, N; Llanes, R; Llop, A; Nagashima, S; Soria, C; Valdés, L; Wada, A | 1 |
| Clarke, AM; Green, E; Mkwetshana, N; Naidoo, N; Ndip, LM; Ndip, RN; Okeleye, BI; Tanih, NF | 1 |
| Latifi-Navid, S; Massarrat, S; Saniee, P; Sheykholeslami, A; Siavoshi, F | 1 |
| Ishii, Y; Kato, K; Moriyama, M; Nemoto, N; Ohkusa, T; Sugitani, M; Uehara, T | 1 |
| Ataseven, H; Demir, M; Gen, R | 1 |
| Hall, CS; Reichenberg, J | 1 |
| Chen, WJ; Lu, H; Sun, QJ; Xiao, SD; Zheng, Q | 1 |
| Bahar, K; Çinar, K; Özden, A; Seven, G; Yakut, M | 1 |
| Mobarez, AM; Taghvaei, T; Talebi Bezmin Abadi, A; Wolfram, L | 1 |
| Smith, PT | 1 |
| Kilic, ZM; Nadir, I; Ozin, Y; Sezgin, O; Yonem, O | 1 |
| Hirano, T; Kato, K; Ohkusa, T; Tamura, I; Terao, S; Yamashiro, K | 1 |
| Kelsberg, G; May, D; Safranek, S | 1 |
| Kim, N; Lee, BH | 1 |
| Bazzoli, F; Celiñski, K; Delchier, JC; Giguère, M; Malfertheiner, P; Mégraud, F; Rivière, M | 1 |
| Albayrak, B; Altuntas, Y; Bayraktar, B; Bugdaci, MS; Sokmen, M; Toksoy, B; Zuhur, SS | 1 |
| Bytzer, P; Dahlerup, JF; Eriksen, JR; Jarbøl, DE; Rosenstock, S; Wildt, S | 1 |
| Chen, A; Hsu, PI; Kuo, CH; Lai, KH; Tsay, FW; Tseng, HH; Wang, SW; Wu, DC | 1 |
| Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS | 1 |
| Gisbert, JP | 1 |
| Choi, KD; Chung, JW; Jung, HY; Kim, JH; Lee, GH; Lee, JH; Oh, TH; Song, HJ; Yun, SC | 1 |
| Cuccu, M; Dore, MP; Farina, V; Graham, DY; Mameli, L; Massarelli, G | 1 |
| Benoliel, J; Cabral, J; Lemos, PS; Lopes, AI; Oleastro, M; Paixão, E; Ramalho, PM; Santos, A | 1 |
| Choi, KD; Chung, JW; Jeong, JY; Jung, HY; Jung, JH; Kim, JH; Lee, GH; Lee, SM; Song, HJ | 1 |
| Cozzani, E; Drago, F; Gallo, R; Paolino, S; Parodi, A | 2 |
| Choi, JH; Hyun, JJ; Jung, SW; Kim, JH; Kim, SY; Koo, JS; Kwon, BS; Lee, SK; Lee, SW; Park, JY; Yim, HJ | 1 |
| Chuah, SK; Hsu, PI; Tsay, FW; Wu, DC | 1 |
| Kolber, MR; Korownyk, C | 1 |
| Emer, O; Kadayifci, A; Kantarcioglu, M; Kara, M; Kilciler, G; Ozcan, A; Uygun, A | 1 |
| Başer, O; Emer, O; Kadayifci, A; Kantarcioğlu, M; Kılcıler, G; Ozcan, A; Polat, Z; Uygun, A | 1 |
| Wang, Z; Wu, S | 1 |
| Bogren, A; Goodson, JM; Haffajee, AD; Hasturk, H; Kent, R; Lindhe, J; Socransky, SS; Teles, R; Van Dyke, T; Wennstrom, J | 1 |
| Boyanova, L; Gergova, G; Mateev, G; Mitev, A; Mitov, I | 1 |
| Cardenas, VM; Dominguez, DC; Graham, DY; Reddy, RK; Salazar, CO; Snyder, LK | 1 |
| Coffin, SE; Feng, R; Haynes, K; Kronman, MP; Zaoutis, TE | 1 |
| Li, Y; Lu, J; Pang, Y; Wang, C | 1 |
| Andersen, LP; Berg, D; Jonaitis, L; Jørgensen, M; Kadusevicius, E; Kiudelis, G; Kupcinskas, J; Kupcinskas, L; Miciuleviciene, J; Rasmussen, L; Tamosiunas, V; Urbonaviciene, N | 1 |
| Adegbola, RA; Antonio, M; Berg, DE; Corrah, T; Galano, JJ; Sancho, J; Secka, O; Tapgun, M; Thomas, JE; Thomas, V; Walton, R | 1 |
| Breurec, S; Burucoa, C; Dia, D; Mbengue, M; Onambele, M; Raymond, J; Seck, A | 1 |
| da Silva Patricio, FR; Godoy, AP; Kawakami, E; Ogata, SK | 1 |
| Amin, M; Anwar, F; Mehmood, T; Naz, F; Saari, N | 1 |
| Boyanova, L; Evstatiev, I; Gergova, G; Ilieva, J; Mitov, I; Nikolov, R | 1 |
| Bogren, A; Goodson, JM; Haffajee, AD; Hasturk, H; Lindhe, J; Socransky, SS; Teles, R; van Dyke, T; Wang, X; Wennstrom, JL | 1 |
| Benzer, E; Bilir, G; Gokcan, H; Onal, IK; Oztas, E | 1 |
| Ecker, T; Krieger, T; Leandro, G; Malfertheiner, P; Venerito, M | 1 |
| Almasi, V; Moradimoghadam, F; Zendedel, A; Zivarifar, H | 1 |
| Jang, JY; Jung, HK; Kim, CG; Kim, SG; Lee, H; Lee, HL; Lee, YC; Shin, ES; Shin, WG | 1 |
| Jo, HJ; Kim, MS; Kim, N; Kim, SE; Lee, DH; Park, YS; Shin, CM | 1 |
| Algaba, A; Antón, R; Barrio, J; Bermejo, F; Castro-Fernández, M; Cosme, A; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Barcenas, M; Harb, Y; Marín, AC; McNicholl, AG; Modolell, I; Molina-Infante, J; Perez-Aisa, A; Rodrigo, L; Sacristán, B | 1 |
| Davis, SA; Feldman, SR | 1 |
| Atasoy, P; Güliter, S; Kalkan, IH; Sapmaz, F | 1 |
| But, DY; Hsu, AS; Hung, IF; Lam, FY; Leung, WK; Liu, KS; Seto, WK; Tong, T; Wong, SY | 1 |
| Arakawa, H; Kajihara, M; Kajiura, T; Koido, S; Mitobe, J; Odahara, S; Ohkusa, T; Saito, K; Shinozaki, J; Suzuki, M; Tajiri, H; Takakura, K; Tsukinaga, S; Uchiyama, K; Yukawa, T | 1 |
| Chiba, T; Ishii, Y; Kato, K; Murakami, K; Ohkusa, T; Soma, M; Tajiri, H; Terao, S; Uehara, T; Yanaka, A | 1 |
| Ding, L; Huang, NY; Li, WB; Liu, B; Wen, AD; Wu, Y | 1 |
| Brodsky, D; Glyatman, T; Nasser, O; On, A; Paritsky, M; Peretz, A; Segal, S | 1 |
| Delchier, JC; Malfertheiner, P; Thieroff-Ekerdt, R | 1 |
| Fakharian, T; Ghanei, H; Hosseini, SM; Nazemian, F; Sharifipoor, F; Zivarifar, HR | 1 |
| Jo, HJ; Kim, N; Lee, DH; Lee, ST; Lim, JH; Park, YS; Shin, CM; Song, IS | 1 |
| Aisa, AP; Barrio, J; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Gisbert, JL; Gisbert, JP; Marcos, S; Marín, AC; McNicholl, AG; Modolell, I; Molina-Infante, J; Rodrigo, L | 1 |
| Cho, Y; Chung, KH; Hwang, JH; Jeong, SH; Jin, E; Kim, JW; Kim, N; Lee, DH; Seo, JY; Shin, CM | 1 |
| Dlugosz, J; Dzierzanowska, D; Dzierzanowska-Fangrat, K; Gosciniak, G; Iwanczak, B; Iwanczak, F; Laszewicz, W; Rozynek, M | 1 |
| Acosta, A; Araya, N; Gamboa, F; García, DA; Ledergerber, R; Velosa, J | 1 |
| Abangah, G; Asadollahi, K; Hafezi Ahmadi, MR; Moradkhani, A; Rahmani, A | 1 |
| Carter, B; Charland, L; Fedorowicz, Z; van der Linden, MM; van Zuuren, EJ | 1 |
| Akkan, T; Aktaş, B; Atbaşı, ST; Başyiğit, S; Nazlıgül, Y; Şimşek, G; Uzman, M; Yılmaz, B; Yüksel, O | 1 |
| Jang, EY; Lee, JY; Moon, JH; Shim, KS | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Lee, JY; Lin, JT; Liou, JM; Liou, TC; Luo, JC; Sheu, BS; Tseng, CH; Wang, HP; Wu, CY; Wu, JY; Wu, MS; Yang, TH | 1 |
| Azodo, CC; Ojehanon, PI | 1 |
| Bajbouj, M; Classen, M; Gerhard, M; Guan, WX; Li, M; Liu, RY; Liu, WD; Ma, JL; Pan, KF; Quante, M; Schmid, R; Suchanek, S; Ulm, K; Vieth, M; Wang, JX; Wang, LH; You, WC; Zhang, L; Zhang, LF; Zhang, Y; Zhou, T | 1 |
| Altun, B; Ozturk, K | 1 |
| Bair, MJ; Hsu, PI; Hsu, WH; Hu, CT; Hu, HM; Jheng, GH; Kuo, CH; Kuo, FC; Liu, CJ; Shih, HY; Wu, DC; Wu, IC; Wu, MC | 1 |
| Atasoy, P; Demirci, H; Guliter, S; Kalkan, IH; Sapmaz, F; Suslu, I | 1 |
| Hwang, JJ; Kim, N; Lee, AR; Lee, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Graham, DY; Lee, SY | 1 |
| Choi, YJ; Kim, N; Kwon, YH; Lee, DH; Lee, JW; Lee, JY; Nam, RH; Suh, JH; Yoon, K | 1 |
| Boyanova, L; Evstatiev, I; Gergova, G; Mitov, I; Yaneva, P | 1 |
| Chiang, YS; Chien, CC; Chiou, SS; Chou, YP; Chuah, SK; Hu, ML; Hu, TH; Kuo, CH; Kuo, CM; Kuo, YH; Lee, CH; Liang, CM; Lu, LS; Tai, WC; Wu, IT; Yang, SC; Yen, YH | 1 |
| Al Kaabi, S; Babu, R; Chandra, P; Derbala, M; Doiphode, S; John, A; Sharma, M; Yacoub, R | 1 |
| Cataldi, V; Cellini, L; Ciccaglione, AF; Di Bartolomeo, S; Di Campli, E; Di Giulio, M; Grossi, L; Marzio, L; Nostro, A | 1 |
| Aslan, M; Basyigit, S; Kefeli, A; Kefeli, TT; Tanas, O; Yeniova, AO | 1 |
| Niv, Y | 1 |
| Amiot, A; Bastuji-Garin, S; Deforges, L; Delchier, JC; Le Thuaut, A; Muller, N | 1 |
| Bibbò, S; Dore, MP; Loria, MF; Pes, GM; Rocchi, C; Soro, S | 1 |
| Chiba, N; Fallone, CA; Fischbach, L; Gisbert, JP; Hunt, RH; Jones, NL; Leontiadis, GI; Marshall, JK; Moayyedi, P; Render, C; van Zanten, SV | 1 |
| Asai, Y; Baibergenova, A; Barankin, B; Cochrane, CL; Humphrey, S; Lynde, CW; Marcoux, D; Poulin, Y; Rivers, JK; Sapijaszko, M; Sibbald, RG; Tan, J; Toole, J; Ulmer, M; Zip, C | 1 |
| Fallone, CA; Shaikh, T | 1 |
| Chen, Q; Fu, Q; Liang, X; Liu, W; Lu, H; Xiao, S; Zhang, W | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chen, YN; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Hu, WH; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Sheu, BS; Shun, CT; Tseng, CH; Wu, JY; Wu, MS; Yang, TH | 1 |
| Miftahussurur, M; Sharma, RP; Shrestha, PK; Subsomwong, P; Yamaoka, Y | 1 |
| Fagoonee, S; Graham, DY; Pellicano, R | 1 |
| Baldassarre, G; Boscariolo, L; De Bastiani, R; De Polo, M; Di Mario, F; Elisei, W; Ferronato, A; Franceschi, M; Grillo, S; Landi, S; Picchio, M; Tursi, A; Zamparella, M | 1 |
| Jung, K; Kim, HK; Kim, JH; Kim, SE; Lee, YD; Moon, W; Park, MI; Park, SJ | 1 |
| Chang, WL; Chen, WY; Cheng, HC; Lin, CH; Lu, CC; Ou, HY; Sheu, BS; Wu, CT; Yang, HB; Yang, YJ | 1 |
| Attaran, B; Falsafi, T; Ghorbanmehr, N | 1 |
| Hu, Y; Lu, NH; Zhu, Y | 1 |
| Colak, Y; Doganay, L; Ozdil, K; Ozturk, O; Tuncer, I; Ulasoglu, C; Yilmaz Enc, F | 1 |
| Adedayo, O; Adeoye-Isijola, MO; Coopoosamy, RM; Okon, V; Olajuyigbe, OO | 1 |
| Argüelles Arias, F; Castro Laria, L; Castro Márquez, C; Caunedo Álvarez, Á; Gómez Rodríguez, BJ; Romero Gómez, M | 1 |
| Bundrick, JB; Edson, RS; Litin, SC | 1 |
| Alarcón, T; Alba, C; Blanco, A | 1 |
| Chowers, Y; Geffen, Y; Khoury, J; Saadi, T; Shaul, R; Sholy, H | 1 |
| Ang, TL; Aung, MM; Chakravuth, O; Chotivitayatarakorn, P; Fock, KM; Goh, KL; Graham, D; Harnsomburana, P; Kositchaiwat, C; Lee, YC; Leelakusolvong, S; Leow, A; Mahachai, V; Mairiang, P; Maneerattanaporn, M; Mya, SM; Pisespongsa, P; Pittayanon, R; Rani, A; Rasachak, B; Rojborwonwitaya, J; Sansak, I; Sollano, JD; Sugano, K; Syam, AF; Treeprasertsuk, S; Trong Quach, D; Vannarath, S; Vilaichone, RK; Wiwattanachang, O; Yamaoka, Y | 1 |
| Das, R; El-Omar, EM; Goh, KL; Kuo, YT; Leow, AHR; Lin, JT; Liou, JM; Lu, H; Tu, YK; Wu, JY; Wu, MS; Yamaoka, Y | 1 |
| Chen, WC; Cheng, JS; Hsu, PI; Kao, SS; Lin, KH; Sun, WC; Tsai, KW; Tsay, FW; Wang, HM; Wu, DC; Yu, HC | 1 |
| Costa, S; Gonçalves, R; Soares, JB | 1 |
| Alvaro, D; Bellesia, A; Brambilla, G; Bresci, G; D'Angelo, A; De Francesco, V; Di Ciaula, A; Eramo, A; Londoni, C; Manta, R; Portincasa, P; Ridola, L; Sacco, R; Scaccianoce, G; Tanzilli, A; Vassallo, R; Zullo, A | 1 |
| Economopoulos, KP; Mylonas, KS; Stefanopoulos, A; Theochari, NA | 1 |
| Azrad, M; Brodsky, D; Isakovich, N; On, A; Pastukh, N; Peretz, A | 1 |
| de la Morena-Madrigal, E; Galera Rodenas, AB; Pérez-Arellano, E; Rodriguez-Garcia, MI | 1 |
| Göktaş, Z; Kahramanoğlu Aksoy, E; Nazlıgül, Y; Pirinçci Sapmaz, F; Uzman, M | 1 |
| de Boer, MGJ; Ruiter, R; Veenendaal, RA; Visser, LG; Wunderink, HF | 1 |
| Fiorini, G; Gatta, L; Pavoni, M; Saracino, IM; Vaira, D; Zullo, A | 1 |
| Li, L; Li, Y; Liu, J; Lu, W; Wang, Z; Wu, H; Zhong, Q | 1 |
| Chen, Y; Du, Y; Li, Y; Liu, D; Lv, N; Pan, X; Wang, H; Wang, J; Wu, K; Xie, Y; Xu, J; Zeng, Z; Zhang, G | 1 |
| Allegretta, L; Baldassarre, G; Brandimarte, G; Cassieri, C; De Bastiani, R; Di Mario, F; Elisei, W; Ferronato, A; Franceschi, M; Licci, C; Miraglia, C; Penna, A; Picchio, M; Pranzo, G; Rizzo, GL; Savarino, E; Scida, S; Tursi, A | 1 |
| Bernardy, J; Faldyna, M; Krejčí, J; Krutova, M; Matejkova, J; Nyc, O; Tkadlec, J; Zouharova, M | 1 |
| Baghbanian, M; Mirvakili, M; Salmanroghani, H; Salmanroghani, R; Sanati, G; Yazdian, P | 1 |
| An, Z; Bie, M; Huang, H; Tang, C; Wan, L; Wang, B; Zhou, Y | 1 |
| Chen, CL; Hsu, PI; Kao, JY; Kao, SS; Pan, CY; Peng, NJ; Tsai, KW; Tsai, TJ; Tsay, FW; Wang, HM; Wu, DC | 1 |
| Bazzoli, F; Conigliaro, R; Eusebi, LH; Farinati, F; Grande, G; Gravina, AG; Ierardi, E; Maconi, G; Panarese, A; Romano, M; Romiti, A; Savarino, E; Stasi, E; Zagari, RM | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chen, CC; Chen, MJ; Chen, PY; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Lee, JY; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Wu, MS; Yang, TH | 1 |
| Agudo-Fernández, S; González Blanco, A | 1 |
| Malekzadeh, R; Saniee, P; Siavoshi, F | 1 |
| Alimov, A; Dekhnich, N; Ivanchik, N; Kirsov, P; Kozlov, R; Pandav, K; Steshits, A | 1 |
| Baik, GH; Bang, CS; Choi, JH; Hong, JT; Kang, HS; Kim, DJ; Lee, JJ; Lim, H; Shin, SP; Shin, WG; Soh, JS; Suk, KT; Yang, YJ | 1 |
| Kim, JM; Kim, N; Lee, DH; Lee, JW; Lee, SM; Nam, RH; Soo In, C | 1 |
| Gisbert, JP; McNicholl, AG; Nyssen, OP | 1 |
| Chen, PX; Fu, JL; Gu, XX; Jiang, HX; Yang, L; Zhang, LJ | 1 |
| De Francesco, V | 1 |
| Fallone, CA; Malfertheiner, P; Moss, SF | 1 |
| Alghamdi, SA; Alsharif, KF; Eed, EM; Hawash, YA; Ismail, KA; Khalifa, AS; Saber, T; Shehab-Eldeen, SA | 1 |
| Bignon, E; Blin, P; Diquet, B; Droz-Perroteau, C; Guiard, E; Lassalle, R; Lelievre, B; Mégraud, F; Moore, N; Rouyer, M; Tison, F; Zerbib, F | 1 |
| Ahn, JY; Baik, GH; Cheung, DY; Cho, SJ; Choi, KD; Choi, YJ; Chung, JW; Jung, HK; Jung, HY; Kim, BW; Kim, JH; Kim, JJ; Kim, JM; Kim, SY; Lee, H; Lee, JH; Lee, SH; Lee, WS; Min, YW; Park, JC; Shin, CM; Sung, JK | 1 |
| Castro Fernández, M; Grande Santamaría, L; Keco Huerga, A; Lamas Rojas, E; Llorca Fernández, R; Pabón Jaén, M; Rojas Feria, M; Romero García, T | 1 |
| Acosta-Gonzales, G; Alsamman, MA; Moss, SF; Resnick, MB; Shawwa, K; Vecchio, EC | 1 |
| de Andrés, E; Gómez Hernando, C; Gómez Rodríguez, R; Muñoz Gómez, P; Sierra Bernal, C; Valle Muñoz, J | 1 |
| Bibbò, S; Dore, MP; Graham, DY; Loria, M; Manca, A; Pes, GM; Salis, R | 1 |
| Bair, MJ; Chang, CM; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chen, YN; Chuang, EY; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Lee, JY; Lin, JT; Liou, JM; Lu, TP; Luo, JC; Wu, JY; Wu, MS; Yang, TH | 1 |
| Pellicano, R | 1 |
| Clark, CM; Mergenhagen, KA; Russo, TA; Skelly, MK; Wattengel, BA | 1 |
| Kim, JH; Kim, JY; Lee, SY; Park, HS; Sung, IK | 1 |
| Kim, N; Lee, DH; Lee, JW; Park, YS; Shin, CM; Yoon, H; Yoon, K | 1 |
| Cogdill, AG; Guevara, B | 1 |
| Alcaide, N; Areia, M; Ariño, I; Axon, T; Barrio, J; Bordin, D; Boyanova, L; Brglez Jurecic, N; Bujanda, L; Buzas, G; Bytzer, P; Caldas, M; Capelle, L; Castro-Fernández, M; Dominguez-Cajal, M; Garre, A; Gasbarrini, A; Gisbert, JP; Goldis, A; Huguet, JM; Jonaitis, L; Kunovský, L; Kupcinskas, L; Lamy, V; Leja, M; Lerang, F; Lucendo, A; Marcos Pinto, R; María Botargues Bote, J; Mégraud, F; Milosavljevic, T; Modolell, I; Niv, Y; Nyssen, OP; O'Morain, C; Ortuño, J; Pérez Lasala, J; Pérez-Aisa, Á; Perona, M; Phull, P; Przytulski, K; Rodrigo-Sáez, L; Rokkas, T; Romero, PM; Shvets, O; Simsek, I; Tepes, B; Tonkic, A; Venerito, M; Voynovan, I | 1 |
| Baik, GH; Bang, CS; Choi, JH; Hong, JT; Jeong, HM; Kang, HS; Kim, DJ; Lee, JJ; Lim, H; Shin, SP; Shin, WG; Soh, JS; Suk, KT; Yang, YJ | 1 |
| Alshareef, A; Bach Dat, B; Duc, NT; Nam, NH; Ngoc, NM; Nguyen, JG; Reda, A; Thieu, H; Tien Huy, N | 1 |
| Aumpan, N; Mahachai, V; Ratanachu-Ek, T; Tshering, L; Uchida, T; Vilaichone, RK; Yamaoka, Y | 1 |
| Alcaide, N; Barrio, J; Bujanda, L; Burgos, D; Caldas, M; Calvet, X; Castro, M; de la Coba, C; Di Maira, T; Dominguez-Cajal, M; Fernandez, N; Fernández-Salazar, L; Ferrer, L; Figuerola, A; Garre, A; Gisbert, JP; Gomez Rodriguez, BJ; Gomez, B; Gomez-Camarero, J; Hinojosa, J; Huguet, JM; Jimenez-Moreno, M; Lucendo, A; Mata Romero, P; Megraud, F; Modollel, I; Molina-Infante, J; Nyssen, OP; O'Morain, C; Ortuño, J; Perez-Aisa, A; Perona, M; Pozzati, L; Puig, I; Resina, E; Rodrigo, L; Tito, L; Varela, P | 1 |
| Chang, YL; Hsu, PI; Kim, SE; Liou, WS; Shiu, SI; Tu, YK; Tung, YC; Wu, MF; Yang, JC; Yeh, HZ | 1 |
| Cho, SJ; Choi, J; Chung, H; Chung, SJ; Kim, JL; Kim, SG; Lee, A | 1 |
| Areia, M; Castro-Fernandez, M; Fernanadez-Salazar, L; Fernandez-Bermejo, M; Gasbarrini, A; Gisbert, JP; Gomez-Rodriguez, BJ; Gravina, AG; Huguet, JM; Malfertheiner, P; Megraud, F; Nuñez, O; Nyssen, OP; O'Morain, C; Ortuñ, J; Pellicano, R; Perez-Aisa, A; Perona, M; Pinto, RM; Pozzati, L; Puig, I; Rodrigo, L; Romano, M; Vaira, D; Venerito, M | 1 |
| Bryant, RV; Costello, S; Gehlert, J; Mangoni, AA; Rayner, CK; Roberts-Thomson, IC; Schubert, JP | 1 |
| Coşkun Sökmen, F; Demirci, S; Kasapoğlu, B; Yozgat, A | 1 |
| Barcenilla Laguna, J; Bonoso Criado, R; Cabezudo Molleda, L; García Castro, MA; González de Castro, E; Maestro Antolín, S; Montero Moretón, Á; Moreira Da Silva, BA; Pérez Citores, L; Pérez Millán, AG; Santos Santamarta, F | 1 |
| Graham, DY; Howden, CW | 1 |
| Alsamman, MA; Argueta, EA; D'Agata, EMC; Moss, SF | 1 |
| Jeon, JY; Kim, B; Kim, MG; Kim, SY; Lee, J; Moon, SJ; Oh, K; Song, GS | 1 |
| De Francesco, V; Fiorini, G; Gatta, L; Manta, R; Saracino, IM; Vaira, D; Zullo, A | 1 |
| Al-Charrakh, AH; Al-Shukri, MSM; Hmood, AM | 1 |
| Ahmadinejad, Z; Emaneini, M; Fazeli, MS; Feizabadi, MM; Jasemi, S; Sadeghpour Heravi, F; Sechi, LA | 1 |
| Bang, MTL; Duc, NM; Khoi, HH; Nghi, BTD; Ngoc, TLC; Tien, VNT; Van Bach, N; Van Thieu, H | 1 |
| Chen, YH; Chuah, SK; Hsu, PI; Kao, JY; Kao, SS; Kuo, CH; Peng, NJ; Shie, CB; Tang, SY; Tsay, FW; Wang, HM; Wu, DC; Wu, IT | 1 |
| Bottino, MC; Chan, HL; Daghrery, A; Dubey, N; Fenno, JC; Ferreira, JA; Kantorski, KZ; Mendonça, G; Mishina, Y | 1 |
| Abdollahi, A; Goodarzi, V; Hosseini, H; Jafari, A; Jafari, M; Shojaei, S; Su, CH; Tirgar, M; Uzun, L | 1 |
| Akpan, RM; Akpan, SE; Ozuluoha, CC; Udoh, EI | 1 |
| Bryant, RV; Costello, S; Mangoni, AA; Rayner, CK; Roberts-Thomson, IC; Schubert, JP; Warner, MS | 1 |
| Liu, Y; Pang, D; Song, H; Wang, L; Zhang, S | 1 |
| Continisio, A; D'Abramo, FS; Di Leo, A; Ierardi, E; Losurdo, G; Piazzolla, M; Pricci, M; Rima, R | 1 |
| Florholmen, JR; Goll, R; Halvorsen, FA; Johnsen, KM; Melby, KK; Moayeri, B; Nestegard, O; Paulssen, E; Sørbye, SW; Tønnesen, T | 1 |
| An, Z; Kang, L; Li, J; Ru, C; Tian, L; Wang, L; Yao, Y; Yin, L | 1 |
| Elfanagely, Y; Ho, JJC; Moss, SF; Navarro, M; Sawyer, K | 1 |
| Abbondio, M; Bibbò, S; Dore, MP; Loria, M; Niolu, C; Pes, GM; Sau, R; Tanca, A; Uzzau, S | 1 |
| Benghezal, M; Li, H; Marshall, BJ; Shen, Y; Song, X; Tang, H; Tang, X; Wang, Z | 1 |
| Chan, MTV; Chen, H; Liu, X; Wu, WKK; Xie, C; Zeng, J; Zhang, L | 1 |
| Li, CL; Lu, HP; Ren, XL; Song, ZQ; Suo, BJ; Tian, XL; Yao, XY; Zhang, H; Zhang, YX; Zhou, LY | 1 |
| Hoang, VT; Tran, TNQ; Tran, TQA; Vu, DL; Vu, TB | 1 |
| Chehter, EZ; de Moraes Andrade, PV; Monteiro, YM | 1 |
| Ayaş, M; Gürol, Y | 1 |
| Li, C; Lu, H; Ren, X; Song, Z; Suo, B; Tian, X; Yao, X; Zhang, H; Zhang, Y; Zhou, L | 2 |
| Akyön, Y; Örsten, S; Yılmaz, E | 1 |
| Bo, Y; Cao, Y; Cao, Z; Chen, X; Cui, T; Deng, Y; Fu, L; Gao, H; Gao, R; Guo, J; Hao, Q; Hou, Z; Hu, J; Hu, S; Jin, L; Li, F; Li, H; Li, X; Li, Y; Liu, J; Ma, B; Ma, L; Ma, S; Ma, Z; Mu, R; Niu, M; Qi, H; Shi, R; Su, X; Tang, N; Tang, Y; Wang, P; Wang, X; Xin, R; Yang, B; Yang, W; Yao, L; Yong, H; You, Y; Yu, X; Yu, Y; Zhang, X; Zhao, W; Zhou, Y | 1 |
| Chen, J; Chen, X; Ding, Z; Han, Y; Huang, Y; Liang, X; Lu, H; Xu, F; Zeng, X | 1 |
| Ai, Q; Chen, Y; Hu, L; Li, GQ; Liu, C; Liu, L; Zeng, X; Zhang, X | 1 |
| Chen, M; Dong, Y; Gong, Y; Li, Y; Sun, J; Wang, Y | 1 |
| Babic, I; Gisbert, J; Kekic, D; Krstic, M; Mégraud, F; Milivojevic, V; Milosavljevic, T; Moreira, L; Nyssen, OP; O' Morain, C; Panic, N; Rankovic, I; Sagdati, S; Spasic, IS | 1 |
| Bontems, P; Iliadis, E; Kotilea, K; Mahler, T; Miendje Deyi, VY; Nguyen, J; Salame, A | 1 |
| Chen, Q; Chen, Y; Huang, X; Ji, X; Lin, Z; Suo, B; Wu, B; Zheng, X; Zhou, X | 1 |
| Bontems, P; Che, TH; Le, GKN; Nguyen, HT; Nguyen, LTH; Nguyen, PNV; Nguyen, TC; Pham, BV; Pham, DTH; Robert, A; Truong, DQ | 1 |
| Atherton, J; Bakshi, N; Garvey, E; Letley, D; Mahmood, F; Rhead, J; Robinson, K; Suffian, S; Whiley, D; White, J; Winter, JA | 1 |
99 review(s) available for metronidazole and tetracycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Treatment of intestinal parasitosis].
Topics: Amphotericin B; Anthelmintics; Bithionol; Cestode Infections; Chloroquine; Humans; Intestinal Diseases, Parasitic; Leishmaniasis; Malaria; Metronidazole; Nematode Infections; Quinacrine; Tetracycline; Thiabendazole | 1975 |
The gynecologist's approach to sexually transmitted infections.
Topics: Ampicillin; Culture Techniques; Female; Gonorrhea; Humans; Metronidazole; Neisseria gonorrhoeae; Penicillin G Procaine; Sexually Transmitted Diseases; Sulfisoxazole; Syphilis; Syphilis Serodiagnosis; Tetracycline; Treponema pallidum | 1975 |
Juvenile periodontitis: a review of pathogenesis, diagnosis and treatment.
Topics: Adolescent; Aggressive Periodontitis; Bone Transplantation; Child; Humans; Metronidazole; Penicillins; Surgical Flaps; Tetracycline | 1992 |
[Antibiotics in pregnancy].
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Cephalosporins; Chloramphenicol; Female; Fetus; Humans; Macrolides; Metronidazole; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Sulfonamides; Tetracycline | 1990 |
Chemotherapy. A viable periodontal treatment modality?
Topics: Dental Plaque; Humans; Metronidazole; Periodontal Diseases; Tetracycline | 1990 |
Antibacterial therapy.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Cephalosporins; Clindamycin; Drug Combinations; Erythromycin; Humans; Methicillin; Metronidazole; Nalidixic Acid; Penicillin Resistance; Penicillins; Rifampin; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Current concepts in periodontal diseases.
Topics: Acute Disease; Adult; Child; Chronic Disease; Dental Plaque; Gingivitis; Gingivitis, Necrotizing Ulcerative; Humans; Metronidazole; Oral Hygiene; Periodontal Diseases; Periodontal Pocket; Periodontitis; Periodontium; Stomatitis, Herpetic; Tetracycline | 1985 |
[Classification, diagnosis and therapy of pneumonia].
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antibody Specificity; Biopsy; Cefoxitin; Cephalosporins; Clindamycin; Cross Infection; Erythromycin; Humans; Legionnaires' Disease; Lung; Metronidazole; Penicillin G; Pneumonia; Radiography, Thoracic; Serologic Tests; Sputum; Tetracycline | 1985 |
Antimicrobial agents in the treatment of obstetric and gynecologic infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Chloramphenicol; Erythromycin; Female; Genital Diseases, Female; Genitalia, Female; Humans; Idoxuridine; Infections; Lactobacillus; Metronidazole; Penicillins; Placenta; Pregnancy; Pregnancy Complications, Infectious; Puerperal Infection; Pyrimethamine; Spectinomycin; Streptococcus; Sulfonamides; Tetracycline; Vagina; Vancomycin | 1974 |
Infectious vaginopathies in pregnancy.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Glucocorticoids; Gonorrhea; Haemophilus Infections; Herpes Simplex; Humans; Infant, Newborn; Infant, Newborn, Diseases; Metronidazole; Mycoplasma Infections; Ophthalmia Neonatorum; Penicillin G Procaine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy in Diabetics; Syphilis; Syphilis Serodiagnosis; Syphilis, Congenital; Tetracycline; Trichomonas Vaginitis; Vaginal Diseases | 1970 |
The treatment of intestinal protozoan infections.
Topics: Amebicides; Antimalarials; Antiprotozoal Agents; Balantidiasis; Chloroquine; Coccidiosis; Dientamoebiasis; Drug Combinations; Dysentery, Amebic; Emetine; Furans; Furazolidone; Giardiasis; Humans; Intestinal Diseases, Parasitic; Iodoquinol; Liver Abscess, Amebic; Metronidazole; Paromomycin; Quinacrine; Sulfamethoxazole; Tetracycline; Tinidazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
Necrotising enteritis--a review.
Topics: Ampicillin; Ascariasis; Clostridium perfringens; Enterocolitis, Pseudomembranous; Germany; Humans; Immunoglobulins; India; Intestines; Laparoscopy; Metronidazole; New Guinea; Tetracycline | 1980 |
Mechanism of antimicrobial resistance and resistance transfer in anaerobic bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Chloramphenicol; Clindamycin; Clostridium; Clostridium perfringens; Conjugation, Genetic; Drug Resistance, Microbial; Lactams; Metronidazole; R Factors; Sulfamethoxazole; Tetracycline; Trimethoprim | 1982 |
Perioral dermatitis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Child; Dermatitis; Diagnosis, Differential; Facial Dermatoses; Female; Humans; Male; Metronidazole; Middle Aged; Mouth; Prognosis; Risk Factors; Rosacea; Sex Distribution; Tetracycline | 1995 |
The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Randomized Controlled Trials as Topic; Tetracycline | 1995 |
Treating peptic ulcer: an ongoing challenge.
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline | 1995 |
[Subgingival application of antibiotics: literature review].
Topics: Administration, Topical; Anti-Bacterial Agents; Dental Scaling; Gingiva; Gingivitis; Humans; Metronidazole; Root Planing; Tetracycline | 1994 |
[Topical application of antimicrobial agents in periodontics. Current status of the problem].
Topics: Administration, Topical; Adolescent; Adult; Anti-Infective Agents, Local; Child; Gels; Humans; Metronidazole; Mouthwashes; Periodontitis; Tetracycline | 1994 |
Amoebic recto-vaginal fistula--a case report and review of literature.
Topics: Adult; Biopsy; Colostomy; Combined Modality Therapy; Dysentery, Amebic; Female; Humans; Metronidazole; Prognosis; Radiography; Rectovaginal Fistula; Tetracycline | 1993 |
Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
Topics: Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; United States | 1994 |
Duodenal ulcer treatment: progress from pH to HP.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Tetracycline | 1994 |
Helicobacter pylori infection.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Stomach Neoplasms; Stomach Ulcer; Tetracycline | 1993 |
The role of antibiotics in the treatment of periodontitis (Part 2--Controlled drug delivery).
Topics: Anti-Bacterial Agents; Delayed-Action Preparations; Drug Delivery Systems; Gels; Humans; Metronidazole; Minocycline; Patient Care Planning; Patient Selection; Periodontal Pocket; Periodontitis; Polyvinyls; Root Planing; Tetracycline | 1995 |
Triple therapy and Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Stomach Neoplasms; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
[Helicobacter pylori eradication: triple therapy versus dual therapy].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline; Tinidazole; Treatment Outcome | 1996 |
Microbiological response to mechanical treatment in combination with adjunctive therapy. A review of the literature.
Topics: Administration, Oral; Administration, Topical; Adult; Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antitrichomonal Agents; Chemotherapy, Adjuvant; Chlorhexidine; Chronic Disease; Colony Count, Microbial; Dental Scaling; Gels; Humans; Metronidazole; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Root Planing; Spirochaetales; Tetracycline; Therapeutic Irrigation | 1996 |
Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Monte Carlo Method; Organometallic Compounds; Patient Compliance; Proton Pump Inhibitors; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1997 |
Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Salicylates; Tetracycline | 1997 |
Treatment strategies for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Salicylates; Tetracycline | 1997 |
Treatment of Helicobacter pylori infection: a review of the world literature.
Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Smoking; Tetracycline; Treatment Outcome | 1996 |
[Treatment of Helicobacter pylori infections].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Tetracycline; Time Factors | 1998 |
Systemic antibiotic therapy in severe periodontitis.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Metronidazole; Patient Care Planning; Periodontitis; Tetracycline | 1997 |
Chemical treatment of periodontitis: local delivery of antimicrobials.
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Chlorhexidine; Chronic Disease; Doxycycline; Drug Delivery Systems; Drug Implants; Gels; Humans; Metronidazole; Minocycline; Ointments; Periodontitis; Polymers; Tetracycline | 1998 |
Use of topical products for maintaining remission in rosacea.
Topics: Administration, Topical; Anti-Infective Agents; Humans; Metronidazole; Rosacea; Skin; Tetracycline | 1999 |
Local delivery of antimicrobial agents for the treatment of periodontitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Chlorhexidine; Delayed-Action Preparations; Doxycycline; Drug Delivery Systems; Humans; Metronidazole; Minocycline; Periodontitis; Tetracycline | 1998 |
Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Tetracycline; Treatment Outcome | 1999 |
The conservative approach in the treatment of furcation lesions.
Topics: Amputation, Surgical; Anti-Bacterial Agents; Anti-Infective Agents, Local; Dental Scaling; Furcation Defects; Humans; Metronidazole; Molar; Subgingival Curettage; Tetracycline; Tooth Root; Toothbrushing | 2000 |
Antibiotic resistance of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles; Penicillins; Peptic Ulcer; Tetracycline | 2001 |
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.
Topics: Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Ranitidine; Recurrence; Research Design; Tetracycline; Treatment Outcome | 2001 |
Treatment of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2001 |
Local antimicrobial therapies in periodontal disease.
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Biocompatible Materials; Cellulose; Delayed-Action Preparations; Dental Scaling; Disease Progression; Drug Delivery Systems; Gingival Crevicular Fluid; Glycerides; Humans; Metronidazole; Minocycline; Periodontal Diseases; Periodontal Pocket; Root Planing; Sesame Oil; Tetracycline | 2000 |
[Classic triple therapy for Helicobacter pylori infection].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Salicylates; Tetracycline | 2002 |
[Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Tetracycline | 2002 |
[Helicobacter heilmannii-associated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2002 |
Rationale for use of antibiotics in periodontics.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Chemotherapy, Adjuvant; Child; Clavulanic Acid; Dental Scaling; Drug Delivery Systems; Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Humans; Metronidazole; Periodontitis; Tetracycline | 2002 |
Periodontal therapy using local delivery of antimicrobial agents.
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Cellulose; Chlorhexidine; Cost-Benefit Analysis; Doxycycline; Drug Approval; Drug Costs; Drug Delivery Systems; Gels; Glycerides; Humans; Metronidazole; Microspheres; Minocycline; Periodontal Diseases; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Sesame Oil; Tetracycline; Treatment Outcome | 2002 |
Meta-analysis of the effect of scaling and root planing, surgical treatment and antibiotic therapies on periodontal probing depth and attachment loss.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Combined Modality Therapy; Dental Scaling; Follow-Up Studies; Humans; Metronidazole; Minocycline; Periodontal Attachment Loss; Periodontal Pocket; Randomized Controlled Trials as Topic; Root Planing; Sample Size; Statistics as Topic; Surgical Flaps; Tetracycline; Treatment Outcome | 2002 |
Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Ditiocarb; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline | 2003 |
What are the global response rates to Helicobacter pylori eradication therapy?
Topics: Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Global Health; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2003 |
Local anti-infective therapy: pharmacological agents. A systematic review.
Topics: Alkaloids; Anti-Bacterial Agents; Anti-Infective Agents, Local; Benzophenanthridines; Chlorhexidine; Delayed-Action Preparations; Dental Scaling; Doxycycline; Humans; Isoquinolines; Metronidazole; Minocycline; Periodontitis; Tetracycline | 2003 |
Systemic anti-infective periodontal therapy. A systematic review.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clindamycin; Consensus; Dental Scaling; Doxycycline; Humans; Metronidazole; Penicillins; Periodontal Attachment Loss; Periodontal Index; Periodontitis; Spiramycin; Tetracycline | 2003 |
Topical and systemic antibiotics in the management of periodontal diseases.
Topics: Actinobacillus Infections; Administration, Oral; Administration, Topical; Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacteroidaceae Infections; Chlorhexidine; Humans; Metronidazole; Periodontitis; Porphyromonas gingivalis; Tetracycline | 2004 |
Sequential therapy; a new treatment for Helicobacter pylori infection. But is it ready for general use?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Ranitidine; Tetracycline | 2004 |
Eradicate H. pylori with effective treatment regimens.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Proton Pump Inhibitors; Salicylates; Tetracycline; Treatment Outcome | 2004 |
Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.
Topics: Antacids; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Guideline Adherence; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Practice Guidelines as Topic; Tetracycline; Treatment Outcome | 2004 |
Present and future rosacea therapy.
Topics: Anti-Infective Agents; Biomedical Research; Chronic Disease; Dermatologic Agents; Dicarboxylic Acids; Forecasting; Humans; Metronidazole; Rosacea; Tetracycline | 2005 |
The rigor of trials evaluating Rosacea treatments.
Topics: Anti-Infective Agents; Dermatologic Agents; Dicarboxylic Acids; Gels; Humans; Metronidazole; Randomized Controlled Trials as Topic; Rosacea; Tetracycline | 2005 |
[Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; Metronidazole; Tetracycline | 2005 |
Critical appraisal of reports on the treatment of perioral dermatitis.
Topics: Administration, Oral; Administration, Topical; Adult; Dermatitis, Perioral; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Evaluation Studies as Topic; Evidence-Based Medicine; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Randomized Controlled Trials as Topic; Severity of Illness Index; Tetracycline; Treatment Outcome | 2005 |
Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Chemotherapy, Adjuvant; Chlorhexidine; Chronic Disease; Clinical Trials as Topic; Dental Scaling; Humans; Metronidazole; Minocycline; Periodontitis; Tetracycline | 2005 |
Face up to rosacea.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Dermatologic Agents; Diagnosis, Differential; Dicarboxylic Acids; Doxycycline; Humans; Laser Therapy; Life Style; Metronidazole; Minocycline; Patient Education as Topic; Referral and Consultation; Risk Factors; Rosacea; Tetracycline | 2005 |
[Anti-Helicobacter pylori quadruple therapy].
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2005 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline | 2006 |
Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Humans; Metronidazole; Rosacea; Tetracycline | 2007 |
Locally delivered antimicrobials in the management of periodontitis: a critical review of the evidence for their use in practice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Combined Modality Therapy; Drug Implants; Humans; Metronidazole; Periodontitis; Tetracycline | 2007 |
Pylera plus omeprazole: quadruple treatment for Helicobacter pylori.
Topics: Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Capsules; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline | 2008 |
What is new in the management of Helicobacter pylori?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Practice Guidelines as Topic; Probiotics; Proton Pump Inhibitors; Rifabutin; Tetracycline | 2008 |
Helicobacter pylori treatment: is sequential or quadruple therapy the answer?
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Tetracycline; Treatment Outcome | 2008 |
Pylera for the eradication of Helicobacter pylori infection.
Topics: Administration, Oral; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Capsules; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Randomized Controlled Trials as Topic; Tetracycline; Treatment Outcome | 2009 |
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Outcome Assessment, Health Care; Patient Compliance; Practice Guidelines as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline | 2010 |
A review of the diagnosis and treatment of rosacea.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Dermatologic Agents; Diagnosis, Differential; Dicarboxylic Acids; Humans; Laser Therapy; Metronidazole; Phytotherapy; Rosacea; Sunscreening Agents; Tetracycline | 2010 |
Helicobacter pylori eradication therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome | 2010 |
Evidence based review of perioral dermatitis therapy.
Topics: Administration, Topical; Dermatitis, Perioral; Erythromycin; Evidence-Based Medicine; Humans; Metronidazole; Tetracycline | 2010 |
Clinical inquiries. What is the most effective treatment for acne rosacea?
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Evidence-Based Medicine; Humans; Metronidazole; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Rosacea; Tetracycline; Treatment Outcome | 2011 |
Diagnosis and treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Stomach Neoplasms; Tetracycline | 2011 |
A new look at anti-Helicobacter pylori therapy.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Tetracycline | 2011 |
Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2013 |
Interventions for rosacea.
Topics: Anti-Infective Agents; Brimonidine Tartrate; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Ivermectin; Male; Metronidazole; Middle Aged; Ophthalmic Solutions; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea; Tetracycline | 2015 |
How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Hypersensitivity; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Medication Adherence; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2015 |
Doxycycline in Eradication Therapy of Helicobacter pylori--a Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Proton Pump Inhibitors; Ranitidine; Tetracycline | 2016 |
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Bismuth; Canada; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2016 |
Canadian Clinical Practice Guidelines for Rosacea.
Topics: Anti-Infective Agents; Consensus; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Eye Diseases; Humans; Intense Pulsed Light Therapy; Isotretinoin; Ivermectin; Laser Therapy; Metronidazole; Outliers, DRG; Practice Guidelines as Topic; Rosacea; Tetracycline | 2016 |
Novel and Effective Therapeutic Regimens for
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Mutation; Prevalence; Probiotics; Proton Pump Inhibitors; Pyrroles; Rifabutin; Sulfonamides; Tetracycline; Tetracycline Resistance | 2017 |
Antibiotic resistance in Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2017 |
Helicobacter pylori management in ASEAN: The Bangkok consensus report.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Consensus; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Proton Pump Inhibitors; Taiwan; Tetracycline; Thailand; Treatment Outcome; United States | 2018 |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Asia; Clarithromycin; Disease Eradication; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Pacific Islands; Prevalence; Tetracycline | 2017 |
Antibiotics exposure and risk of inflammatory bowel disease: a systematic review.
Topics: Anti-Bacterial Agents; Colitis, Ulcerative; Crohn Disease; Fluoroquinolones; Humans; Metronidazole; Penicillins; Risk; Tetracycline | 2018 |
Meta-analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2019 |
Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Canada; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Tetracycline; United States | 2019 |
Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions.
Topics: Alcohols; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cephalosporins; Doxycycline; Drug Interactions; Erythromycin; Fluoroquinolones; Metronidazole; Penicillins; Tetracycline | 2020 |
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath Tests; Clarithromycin; Culture Techniques; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Feces; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Nitro Compounds; Organometallic Compounds; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Rifabutin; Salicylates; Salvage Therapy; Serologic Tests; Stomach Neoplasms; Tetracycline; Thiazoles; Treatment Outcome; Urea | 2020 |
Efficacy of second-line regimens for
Topics: Adult; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Network Meta-Analysis; Outcome Assessment, Health Care; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Randomized Controlled Trials as Topic; Tetracycline | 2020 |
Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Resistance, Bacterial; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; New Zealand; Tetracycline | 2021 |
Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Rifabutin; Tetracycline; Treatment Failure | 2021 |
Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Rifabutin; Tetracycline; United States | 2022 |
Host Cell Antimicrobial Responses against
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Tetracycline; Virulence Factors | 2022 |
Third-line and rescue therapy for refractory
Topics: Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Macrolides; Metronidazole; Proton Pump Inhibitors; Rifabutin; Tetracycline | 2023 |
Antibiotic Resistance of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline; Turkey | 2023 |
215 trial(s) available for metronidazole and tetracycline
| Article | Year |
|---|---|
Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Single-Blind Method; Tetracycline | 1992 |
Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Prospective Studies; Recurrence; Risk Factors; Sucralfate; Tetracycline | 1992 |
Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.
Topics: Adult; Aged; Aged, 80 and over; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Tetracycline | 1992 |
[Treatment of acute salpingitis with tetracycline/metronidazole with or without additional balneotherapy, Augmentin or ciprofloxacin/metronidazole: a second-look laparoscopy study].
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Balneology; Clavulanic Acids; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Laparoscopy; Metronidazole; Pelvic Inflammatory Disease; Prospective Studies; Recurrence; Reoperation; Salpingitis; Tetracycline | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence; Risk Factors; Salicylates; Stomach Ulcer; Tetracycline | 1992 |
Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy.
Topics: Adult; Aged; Antacids; Bismuth; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Tetracycline | 1992 |
Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Salicylates; Single-Blind Method; Tetracycline | 1991 |
Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication.
Topics: Administration, Oral; Adult; Aged; Campylobacter Infections; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Recurrence; Tetracycline; Time Factors | 1989 |
Antibiotic prophylaxis in non-perforated appendicitis of childhood: tetracycline lavage compared with peroperative intravenous cefuroxime and metronidazole.
Topics: Adolescent; Anti-Bacterial Agents; Appendicitis; Cefuroxime; Child; Child, Preschool; Female; Humans; Male; Metronidazole; Surgical Wound Infection; Tetracycline; Therapeutic Irrigation | 1987 |
Comparison between the efficacy of a single dose of secnidazole with a 5-day course of tetracycline and clioquinol in the treatment of acute intestinal amoebiasis.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Clioquinol; Drug Therapy, Combination; Dysentery, Amebic; Female; Humans; Hydroxyquinolines; Male; Metronidazole; Middle Aged; Random Allocation; Tetracycline; Time Factors | 1985 |
Topical metronidazole in the treatment of rosacea.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Metronidazole; Middle Aged; Random Allocation; Rosacea; Tetracycline | 1986 |
Use of antimicrobial containing acrylic strips in the treatment of chronic periodontal disease. A three month follow-up study.
Topics: Adult; Aged; Chlorhexidine; Chronic Disease; Dental Scaling; Drug Implants; Female; Follow-Up Studies; Humans; Male; Methylmethacrylates; Metronidazole; Middle Aged; Periodontal Diseases; Periodontal Pocket; Tetracycline; Tooth Root | 1988 |
Management of nonspecific urethritis.
Topics: Clinical Trials as Topic; Female; Humans; Male; Metronidazole; Placebos; Tetracycline; Trichomonas Infections; Urethritis | 1971 |
[Clinical and experimental results in colpitis therapy using Mysteclin].
Topics: Amphotericin B; Candida; Candidiasis, Vulvovaginal; Drug Synergism; Female; Humans; Metronidazole; Tetracycline; Trichomonas Vaginitis | 1971 |
Effect of combined systemic antimicrobial therapy and mechanical plaque control in patients with recurrent periodontal disease.
Topics: Adult; Aged; Bacteria; Combined Modality Therapy; Dental Plaque; Dental Prophylaxis; Female; Humans; Male; Metronidazole; Middle Aged; Periodontitis; Recurrence; Tetracycline | 1984 |
Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.
Topics: Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline | 1995 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1995 |
[Antibacterial treatment of gastric ulcers associated with Helicobacter pylori without acid suppression].
Topics: Aluminum Hydroxide; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; Drug Therapy, Combination; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Magnesium Hydroxide; Metronidazole; Omeprazole; Simethicone; Stomach Ulcer; Tetracycline | 1995 |
Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Prospective Studies; Recurrence; Tetracycline; Time Factors | 1995 |
Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized
Topics: Adult; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Nitrates; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Tetracycline; Time Factors; Tinidazole | 1995 |
Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.
Topics: Adult; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Sucralfate; Tetracycline | 1995 |
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Stomach Ulcer; Tetracycline; Treatment Outcome | 1994 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Recurrence; Stomach Ulcer; Tetracycline | 1995 |
Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Chi-Square Distribution; Confidence Intervals; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Recurrence; Statistics as Topic; Tetracycline | 1995 |
Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection.
Topics: Adult; Aged; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Tetracycline; Time Factors | 1995 |
Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence; Tetracycline | 1993 |
Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.
Topics: Adult; Aged; Antacids; Biopsy; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pain; Stomach Diseases; Tetracycline; Wound Healing | 1994 |
Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Tetracycline; Time Factors | 1994 |
Combination of tetracycline and metronidazole in the treatment and control of refractory periodontitis.
Topics: Adult; Chronic Disease; Dental Scaling; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Periodontitis; Tetracycline | 1994 |
Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Tetracycline | 1994 |
Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori.
Topics: Abdominal Pain; Anti-Bacterial Agents; Constipation; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Organometallic Compounds; Patient Compliance; Prospective Studies; Tetracycline; Vomiting | 1994 |
Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Stomach Ulcer; Tetracycline; Treatment Outcome | 1993 |
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Topics: Adult; Aged; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline | 1993 |
One-year follow-up of duodenal ulcers after 1-wk triple therapy for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Recurrence; Tetracycline | 1994 |
Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates; Tetracycline | 1993 |
Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Stomach Ulcer; Tetracycline | 1993 |
Metronidazole in the treatment of localized juvenile periodontitis.
Topics: Adolescent; Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Alveolar Bone Loss; Dental Plaque; Female; Gingival Hemorrhage; Humans; Male; Metronidazole; Periodontal Index; Periodontal Pocket; Radiography; Tetracycline | 1993 |
Patient factors affecting Helicobacter pylori eradication with triple therapy.
Topics: Adult; Age Factors; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Marriage; Metronidazole; Middle Aged; Multivariate Analysis; Patient Compliance; Prospective Studies; Recurrence; Stomach Ulcer; Tetracycline | 1993 |
Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Healing and long-term relapse rates.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Chi-Square Distribution; Colloids; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Recurrence; Remission Induction; Single-Blind Method; Tetracycline; Time Factors | 1993 |
Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colloids; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Penicillins; Prospective Studies; Tetracycline; Time Factors | 1996 |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Remission Induction; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Single-Blind Method; Tetracycline; Time Factors | 1996 |
Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Tetracycline | 1995 |
Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline | 1996 |
4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Premedication; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Time Factors | 1996 |
Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Duodenal Ulcer; Female; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Recurrence; Tetracycline | 1996 |
One week treatment for Helicobacter pylori infection: a randomised study of quadruple therapy versus triple therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline | 1995 |
Only four days of quadruple therapy can effectively cure Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Tetracycline | 1995 |
Long-term follow-up after cure of Helicobacter pylori infection with 4 days of quadruple therapy.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Recurrence; Serologic Tests; Tetracycline | 1996 |
Comparison of 3 periodontal local antibiotic therapies in persistent periodontal pockets.
Topics: Administration, Topical; Analysis of Variance; Anti-Bacterial Agents; Chemotherapy, Adjuvant; Chi-Square Distribution; Dental Scaling; Humans; Linear Models; Metronidazole; Minocycline; Periodontal Pocket; Single-Blind Method; Statistics, Nonparametric; Tetracycline; Treatment Outcome | 1996 |
The effect of subgingival antimicrobial therapy on the levels of stromelysin and tissue inhibitor of metalloproteinases in gingival crevicular fluid.
Topics: Administration, Topical; Adult; Aged; Analysis of Variance; Anti-Bacterial Agents; Chemotherapy, Adjuvant; Dental Scaling; Female; Gingival Crevicular Fluid; Glycoproteins; Humans; Male; Matrix Metalloproteinase 3; Metalloendopeptidases; Metronidazole; Middle Aged; Minocycline; Periodontal Pocket; Protease Inhibitors; Tetracycline; Tissue Inhibitor of Metalloproteinases | 1996 |
A twelve-month follow-up after Helicobacter pylori eradication. A clinical and histological evaluation.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Tetracycline | 1996 |
One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Diarrhea; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tetracycline | 1997 |
Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Topics: Activities of Daily Living; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitalization; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer Hemorrhage; Stomach Ulcer; Tetracycline | 1997 |
The effect of smoking on mechanical and antimicrobial periodontal therapy.
Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Dental Plaque Index; Dental Scaling; Female; Humans; Linear Models; Male; Metronidazole; Middle Aged; Minocycline; Outcome Assessment, Health Care; Periodontal Index; Periodontal Pocket; Prognosis; Root Planing; Smoking; Tetracycline | 1997 |
Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia.
Topics: Adult; Anti-Bacterial Agents; Bismuth; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Prospective Studies; Tetracycline; Time Factors | 1997 |
Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Drug Administration Schedule; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Naproxen; Organometallic Compounds; Prospective Studies; Stomach Ulcer; Tetracycline | 1997 |
The management of failed dual or triple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Tetracycline; Treatment Failure | 1997 |
Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Smoking; Tetracycline; Tetracyclines | 1997 |
Quadruple therapy: the golden bullet or a drug too far?
Topics: Antacids; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Patient Dropouts; Peptic Ulcer; Proton Pump Inhibitors; Research Design; Tetracycline; Time Factors; Treatment Outcome | 1996 |
Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Bacterial Proteins; Breath Tests; Carbon Isotopes; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Treatment Outcome; Urea; Urease | 1996 |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Combinations; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Salicylates; Tetracycline; Urea | 1997 |
Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and The Johns Hopkins University.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peru; Recurrence; Salicylates; Tetracycline; Tinidazole | 1997 |
Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Sucralfate; Tetracycline | 1997 |
One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer Hemorrhage; Ranitidine; Recurrence; Tetracycline | 1997 |
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Ranitidine; Tetracycline | 1998 |
Eradicate the bug before you start the drug?
Topics: Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Naproxen; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Tetracycline | 1998 |
Short duration therapy for Helicobacter pylori in Western Australia: the impact of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Tetracycline; Western Australia | 1998 |
Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Netherlands; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 1998 |
Evaluation of antimicrobial efficacy and release pattern of tetracycline and metronidazole using a local delivery system.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antitrichomonal Agents; Cellulose; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Hardness; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Periodontal Pocket; Tetracycline; Time Factors | 1998 |
Topical metronidazole maintains remissions of rosacea.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Bacterial Agents; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Recurrence; Rosacea; Tetracycline; Treatment Outcome | 1998 |
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Stomach Ulcer; Tetracycline; Treatment Outcome | 1998 |
Helicobacter pylori eradication: kill the bug and save the pill?
Topics: Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Naproxen; Peptic Ulcer; Prospective Studies; Risk Factors; Single-Blind Method; Tetracycline | 1998 |
Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Combinations; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Tetracycline; Time Factors; Urease | 1998 |
Two-day 'weekend' lansoprazole-quadruple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Biopsy; Clinical Protocols; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline | 1998 |
Effects of topical metronidazole and tetracycline in treatment of adult periodontitis.
Topics: Administration, Topical; Adult; Aged; Aggregatibacter actinomycetemcomitans; Analysis of Variance; Anti-Bacterial Agents; Antitrichomonal Agents; Chemotherapy, Adjuvant; Dental Scaling; Double-Blind Method; Gels; Humans; Metronidazole; Middle Aged; Ointments; Outcome Assessment, Health Care; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Root Planing; Statistics, Nonparametric; Tetracycline | 1998 |
Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Tetracycline; Treatment Outcome | 1998 |
Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Female; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Tetracycline; Treatment Outcome | 1998 |
Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline | 1998 |
Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Tetracycline | 1998 |
[Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 1999 |
A six-month comparison of three periodontal local antimicrobial therapies in persistent periodontal pockets.
Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents, Local; Chronic Disease; Dental Scaling; Drug Delivery Systems; Female; Follow-Up Studies; Gels; Humans; Linear Models; Male; Metronidazole; Middle Aged; Minocycline; Periodontal Index; Periodontal Pocket; Statistics, Nonparametric; Tetracycline; Treatment Outcome | 1999 |
One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Tetracycline | 1999 |
Eradication of Helicobacter pylori infection after ranitidine bismuth citrate, metronidazole and tetracycline for 7 or 10 days.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Patient Compliance; Ranitidine; Tetracycline; Urea | 1999 |
Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Doxycycline; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline; Treatment Failure | 1999 |
Role of anti-Helicobacter pylori treatment in H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer dyspepsia: results of a randomized, double-blind, controlled trial in Asian Indians.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; India; Male; Metronidazole; Organometallic Compounds; Prospective Studies; Ranitidine; Sucralfate; Tetracycline; Treatment Outcome | 1999 |
Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains.
Topics: Adult; Antacids; Anti-Bacterial Agents; Bismuth; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Tetracycline; Treatment Outcome | 1999 |
Helicobacter treatment with quadruple therapy in primary health care for patients with a history of ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tetracycline; Time Factors; Treatment Outcome | 1999 |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 1999 |
A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Health Maintenance Organizations; Helicobacter Infections; Helicobacter pylori; Humans; Male; Massachusetts; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Program Evaluation; Salicylates; Tetracycline; Treatment Outcome | 1999 |
Bismuth-based quadruple therapy for Helicobacter pylori - a single triple capsule plus lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; Enzyme Inhibitors; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Tetracycline | 2000 |
Furazolidone combination therapies for Helicobacter pylori infection in the United States.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline; Time Factors; United States | 2000 |
Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Outlet Obstruction; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinidazole and omeprazole to cure Helicobacter pylori infection: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Organometallic Compounds; Patient Compliance; Pilot Projects; Tetracycline; Time Factors; Tinidazole; Treatment Outcome | 2000 |
Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Regression Analysis; Tetracycline; Treatment Outcome | 2000 |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Female; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Ranitidine; Tetracycline; Treatment Outcome | 2000 |
Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Patient Compliance; Prospective Studies; Salicylates; Tetracycline; Treatment Outcome | 2000 |
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Primary Health Care; Prospective Studies; Stomach Ulcer; Tetracycline; Time Factors | 2000 |
Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Biopsy, Needle; Confidence Intervals; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pantoprazole; Probability; Prospective Studies; Rifabutin; Sulfoxides; Tetracycline; Treatment Failure | 2001 |
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Naproxen; Omeprazole; Organometallic Compounds; Secondary Prevention; Tetracycline | 2001 |
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome; Urea | 2001 |
Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Calcium Carbonate; Drug Therapy, Combination; Epithelium; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Male; Metronidazole; Middle Aged; Organometallic Compounds; Penicillins; Placebos; Risk Factors; Salicylates; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2001 |
Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Tetracycline; Treatment Outcome | 2001 |
Quadruple therapy for symptomatic spontaneous duodenal ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Tetracycline | 2001 |
Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer Perforation; Prospective Studies; Ranitidine; Recurrence; Retrospective Studies; Tetracycline | 2001 |
Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Probability; Tetracycline; Treatment Outcome | 2001 |
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Interactions; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Omeprazole; Tetracycline; Treatment Failure | 2002 |
Eradication of Helicobacter pylori in duodenal ulcer disease tetracycline & furazolidone vs. metronidazole & amoxicillin in omeprazole based triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; Duodenal Ulcer; Furazolidone; Helicobacter pylori; Humans; Metronidazole; Tetracycline | 2002 |
Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salvage Therapy; Tetracycline | 2002 |
One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Tetracycline; Treatment Outcome | 2002 |
Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Tetracycline | 2002 |
Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pantoprazole; Peptic Ulcer; Prospective Studies; Sulfoxides; Tetracycline; Treatment Failure; Treatment Outcome | 2002 |
Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Randomized Controlled Trials as Topic; Recurrence; Tetracycline; Treatment Outcome | 2002 |
Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline; Wound Healing | 2002 |
Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Ranitidine; Tetracycline | 2002 |
Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Bismuth; Capsules; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Tetracycline; Treatment Outcome | 2003 |
Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Capsules; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; North America; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2003 |
Increased reflux symptoms after calcium carbonate supplementation and successful anti-Helicobacter pylori treatment.
Topics: Adult; Amoxicillin; Antacids; Bismuth; Calcium Carbonate; Drug Therapy, Combination; Dyspepsia; Female; Gastric Acidity Determination; Gastritis, Atrophic; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors; Salicylates; Tetracycline | 2003 |
A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Tetracycline; Urea | 2003 |
Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Tetracycline | 2003 |
[Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Internet; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer; Tetracycline | 2003 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Stomach Ulcer; Tetracycline; Treatment Outcome; Turkey | 2004 |
Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost Savings; Cost-Benefit Analysis; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prevalence; Proton Pump Inhibitors; Proton Pumps; Statistics as Topic; Tetracycline; Treatment Outcome | 2003 |
Influence of omeprazole on bioavailability of bismuth following administration of a triple capsule of bismuth biskalcitrate, metronidazole, and tetracycline.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Area Under Curve; Biological Availability; Drug Interactions; Drug Synergism; Half-Life; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline | 2004 |
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Pilot Projects; Prospective Studies; Proton-Translocating ATPases; Rabeprazole; Salicylates; Tetracycline; Treatment Outcome | 2004 |
Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Azithromycin; Bismuth; Drug Resistance, Bacterial; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Ranitidine; Tetracycline; Treatment Outcome | 2004 |
The influence of pretreatment on cure rates of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Tetracycline | 2004 |
Periodontal treatment of patients with Papillon-Lefèvre syndrome: a 3-year follow-up.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Dental Care for Chronically Ill; Dental Scaling; Humans; Male; Metronidazole; Papillon-Lefevre Disease; Patient Compliance; Periodontitis; Tetracycline; Treatment Outcome | 2004 |
Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Protocols; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2005 |
Eradication rate of Helicobacter pylori in dyspeptic patients.
Topics: Analysis of Variance; Anti-Bacterial Agents; Breath Tests; Ciprofloxacin; Drug Therapy, Combination; Dyspepsia; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Single-Blind Method; Tetracycline; Treatment Outcome; Urea | 2005 |
Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy.
Topics: Amoxicillin; Colitis, Ulcerative; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Humans; Intestinal Mucosa; Metronidazole; Tetracycline | 2005 |
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tetracycline; Treatment Outcome; Turkey | 2005 |
High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Hypersensitivity; Drug Therapy, Combination; Duodenal Ulcer; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Tetracycline; Treatment Outcome | 2005 |
7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 2005 |
Effects of food and formulation on the relative bioavailability of bismuth biskalcitrate, metronidazole, and tetracycline given for Helicobacter pylori eradication.
Topics: Administration, Oral; Adolescent; Adult; Antacids; Anti-Bacterial Agents; Biological Availability; Bismuth; Cross-Over Studies; Drug Combinations; Food-Drug Interactions; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Tetracycline | 2005 |
Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Fusobacterium; Fusobacterium Infections; Humans; Male; Metronidazole; Middle Aged; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Tetracycline; Treatment Outcome | 2005 |
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2006 |
Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Patient Compliance; Quinolines; Tetracycline; Treatment Outcome | 2006 |
Twice-a-day quadruple therapy for eradication of Helicobacter pylori in the elderly.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Male; Metronidazole; Nausea; Organometallic Compounds; Patient Compliance; Prospective Studies; Tetracycline | 2006 |
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
[Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Russia; Tetracycline; Treatment Outcome | 2005 |
Bismuth-based therapies for the first step eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Ranitidine; Tetracycline; Treatment Outcome; Urease; Young Adult | 2006 |
Combinations containing amoxicillin-clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Contraindications; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pantoprazole; Pyloric Antrum; Stomach Ulcer; Tetracycline; Treatment Failure | 2006 |
Randomized comparison of two rescue therapies for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Tetracycline | 2006 |
Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial.
Topics: Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Dopamine Agents; Double-Blind Method; Dyspepsia; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Levodopa; Metronidazole; Omeprazole; Peptic Ulcer; Sucrose; Tetracycline; Treatment Outcome | 2006 |
Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors; Tetracycline; Treatment Failure; Treatment Outcome; Turkey | 2008 |
H pylori infection in patients with Behcet's disease.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Behcet Syndrome; Biopsy; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Pyloric Antrum; Tetracycline | 2007 |
Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Rifabutin; Tetracycline; Treatment Outcome | 2007 |
The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Middle Aged; Single-Blind Method; Statistics, Nonparametric; Tetracycline; Treatment Outcome | 2007 |
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Rifabutin; Tetracycline; Treatment Failure | 2008 |
Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Patient Compliance; Quinolines; Tetracycline | 2007 |
A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Patient Compliance; Pilot Projects; Tetracycline; Turkey | 2007 |
Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2008 |
Effects of albendazole/metronidazole or tetracycline/folate treatments on persisting symptoms after Giardia infection: a randomized open clinical trial.
Topics: Adult; Albendazole; Animals; Antiprotozoal Agents; Feces; Female; Folic Acid; Giardia; Giardiasis; Humans; Male; Metronidazole; Prospective Studies; Severity of Illness Index; Tetracycline; Treatment Outcome | 2008 |
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitals, General; Hospitals, Rural; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Prospective Studies; Tetracycline; Treatment Outcome | 2008 |
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Organometallic Compounds; Prospective Studies; Salvage Therapy; Tetracycline; Treatment Outcome; Young Adult | 2009 |
Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Quinolines; Recurrence; Retreatment; Single-Blind Method; Tetracycline; Young Adult | 2009 |
Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Tetracycline; Treatment Outcome; Young Adult | 2009 |
A placebo-controlled trial of 10-day bismuth-based quadruple therapy to eradicate Helicobacter pylori infection; a pilot study for the large Linqu County trial.
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; China; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Pilot Projects; Placebos; Rural Population; Tetracycline; Urea | 2010 |
Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Amoxicillin; Colitis, Ulcerative; Double-Blind Method; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme-Linked Immunosorbent Assay; Female; Fusobacterium Infections; Humans; Male; Metronidazole; Placebos; Statistics, Nonparametric; Tetracycline; Treatment Outcome | 2010 |
Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Republic of Korea; Tetracycline; Time Factors; Treatment Outcome | 2010 |
Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5 days versus 14 days amoxicillin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Animals; Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Tetracycline; Time Factors; Treatment Outcome; Turkey | 2010 |
Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Case-Control Studies; Chi-Square Distribution; Clarithromycin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Statistics, Nonparametric; Surveys and Questionnaires; Tetracycline; Treatment Outcome | 2010 |
Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid-dependent cases.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biomarkers; Colitis, Ulcerative; Colon; Colonoscopy; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Recurrence; Remission Induction; Severity of Illness Index; Steroids; Tetracycline; Time Factors; Treatment Outcome; Young Adult | 2010 |
Effect of sequential treatment as a first-line therapy for Helicobacter pylori eradication in patients with diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Pilot Projects; Prospective Studies; Tetracycline | 2010 |
Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline | 2010 |
Comparison of two different treatment protocols in Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Tetracycline; Turkey | 2011 |
Antibiotic combination therapy for steroid withdrawal in steroid-dependent ulcerative colitis.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Metronidazole; Middle Aged; Remission Induction; Tetracycline; Young Adult | 2011 |
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tablets; Tetracycline; Young Adult | 2011 |
The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Hypothyroidism; Male; Metronidazole; Middle Aged; Tetracycline; Thyrotropin; Thyroxine; Triiodothyronine | 2011 |
Helicobacter pylori infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Polymorphism, Genetic; Tetracycline; Treatment Outcome | 2011 |
Second-line Helicobacter pylori eradication: a randomized comparison of 1-week or 2-week bismuth-containing quadruple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Medication Adherence; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Tetracycline; Time Factors; Treatment Outcome; Urea | 2011 |
Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histocytochemistry; Humans; Italy; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Tetracycline; Time Factors; Treatment Outcome; Urea; Young Adult | 2011 |
Low efficacy of clarithromycin including sequential regimens for Helicobacter pylori infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Tetracycline; Young Adult | 2012 |
Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antidiarrheals; Bismuth; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Salicylates; Tetracycline; Young Adult | 2012 |
Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Doxycycline; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Tetracycline; Treatment Outcome; Young Adult | 2012 |
Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites.
Topics: Amoxicillin; Analysis of Variance; Anti-Infective Agents; Cellulose; Chemotherapy, Adjuvant; Chlorhexidine; Dental Scaling; Drug Combinations; Drug Delivery Systems; Female; Humans; Male; Metronidazole; Middle Aged; Oral Surgical Procedures; Periodontal Attachment Loss; Periodontal Diseases; Periodontal Index; Periodontal Pocket; Smoking; Tetracycline; Treatment Outcome | 2012 |
Effect of periodontal therapy on the subgingival microbiota over a 2-year monitoring period. I. Overall effect and kinetics of change.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Bacteroides; Biofilms; Capnocytophaga; Chronic Periodontitis; Dental Scaling; Drug Combinations; Eubacterium; Female; Follow-Up Studies; Fusobacterium; Humans; Male; Metronidazole; Middle Aged; Periodontal Pocket; Prevotella; Prospective Studies; Root Planing; Single-Blind Method; Streptococcus; Tetracycline; Treponema denticola | 2013 |
Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Disease-Free Survival; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Peptic Ulcer; Quinolines; Recurrence; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2013 |
Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salvage Therapy; Spain; Surveys and Questionnaires; Tetracycline; Time Factors; Treatment Failure | 2014 |
Comparison of Helicobacter pylori eradication rates of standard 14-day quadruple treatment and novel modified 10-day, 12-day and 14-day sequential treatments.
Topics: Adult; Anti-Infective Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Remission Induction; Tetracycline; Time Factors; Turkey | 2014 |
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Asian People; Breath Tests; China; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Tetracycline; Treatment Outcome | 2014 |
Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy.
Topics: Actins; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colitis, Ulcerative; Double-Blind Method; Drug Therapy, Combination; Female; Fusobacterium; Fusobacterium Infections; Humans; Intestinal Mucosa; Male; Metronidazole; Microbiota; Middle Aged; Tetracycline | 2014 |
Adjunct antibiotic combination therapy for steroid-refractory or -dependent ulcerative colitis: an open-label multicentre study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colectomy; Colitis, Ulcerative; Colonoscopy; Combined Modality Therapy; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Metronidazole; Middle Aged; Severity of Illness Index; Tetracycline; Time Factors; Treatment Outcome; Young Adult | 2014 |
Pharmacokinetics of metronidazole, tetracycline and bismuth in healthy volunteers after oral administration of compound tablets containing a combination of metronidazole, tetracycline hydrochloride and bismuth oxide.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Biological Availability; Bismuth; Drug Combinations; Fasting; Female; Healthy Volunteers; Humans; Male; Metronidazole; Tablets; Tetracycline; Young Adult | 2015 |
Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome; Urea; Young Adult | 2014 |
Helicobacter pylori eradication in renal recipient: triple or quadruple therapy?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunocompromised Host; Iran; Kidney Transplantation; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2014 |
Coenzyme Q10 in combination with triple therapy regimens ameliorates oxidative stress and lipid peroxidation in chronic gastritis associated with H. pylori infection.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Glutathione Peroxidase; Helicobacter Infections; Helicobacter pylori; Humans; Lipid Peroxidation; Male; Malondialdehyde; Metronidazole; Middle Aged; Organometallic Compounds; Oxidative Stress; Tetracycline; Ubiquinone | 2015 |
The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Dental Amalgam; Dental Restoration, Permanent; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Male; Metronidazole; Middle Aged; Outpatients; Prospective Studies; Rabeprazole; Tetracycline; Treatment Outcome; Turkey; Urea | 2015 |
A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; China; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2016 |
Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection.
Topics: Adult; Aged; Amoxicillin; Bismuth; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Rabeprazole; Tetracycline | 2015 |
Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Tertiary Care Centers; Tetracycline; Young Adult | 2016 |
Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Clarithromycin; Cross-Over Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Potassium Citrate; Prospective Studies; Rabeprazole; Tetracycline; Time Factors; Young Adult | 2016 |
Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline; Treatment Failure; Treatment Outcome; Young Adult | 2016 |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors; Taiwan; Tetracycline; Urea | 2016 |
Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diabetes Mellitus, Type 2; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tetracycline; Treatment Outcome | 2017 |
Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Smoking; Tetracycline; Treatment Outcome; Young Adult | 2017 |
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pantoprazole; Prospective Studies; Tetracycline | 2017 |
Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Tetracycline; Young Adult | 2017 |
New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese pro
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Capsules; China; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline; Young Adult | 2018 |
Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline | 2018 |
The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Middle Aged; Probiotics; Proton Pump Inhibitors; Retrospective Studies; Tetracycline | 2018 |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Breath Tests; Clarithromycin; Clinical Decision-Making; Doxycycline; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Predictive Value of Tests; Proton Pump Inhibitors; Taiwan; Tetracycline; Time Factors; Treatment Outcome | 2018 |
Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or Lactobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori. Two randomized pilot studies.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Limosilactobacillus reuteri; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pilot Projects; Probiotics; Prospective Studies; Proton Pump Inhibitors; Tetracycline | 2019 |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Female; Follow-Up Studies; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metabolic Syndrome; Metronidazole; Middle Aged; Organometallic Compounds; Prevalence; Tetracycline | 2019 |
Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Patient Compliance; Penicillin Resistance; Rabeprazole; Tetracycline; Tetracycline Resistance | 2020 |
Empiric Versus Clarithromycin Resistance-Guided Therapy for Helicobacter pylori Based on Polymerase Chain Reaction Results in Patients With Gastric Neoplasms or Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Randomized Controlled Trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Republic of Korea; RNA, Ribosomal, 23S; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2020 |
Tetracycline-levofloxacin versus amoxicillin-levofloxacin quadruple therapies in the second-line treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2021 |
Metagenomic Changes of Gut Microbiota following Treatment of
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Limosilactobacillus reuteri; Metronidazole; Proton Pump Inhibitors; Rabeprazole; RNA, Ribosomal, 16S; Tetracycline; Treatment Outcome | 2022 |
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Tetracycline | 2023 |
New regimens as first-line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Cefuroxime; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Hypersensitivity; Medication Adherence; Metronidazole; Minocycline; Penicillins; Tetracycline; Treatment Outcome | 2023 |
Bismuth, esomeprazole, metronidazole, and minocycline or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Minocycline; Potassium Citrate; Tetracycline | 2023 |
Minocycline vs. tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Minocycline; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2023 |
415 other study(ies) available for metronidazole and tetracycline
| Article | Year |
|---|---|
Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 2.
Topics: Animals; Anti-Bacterial Agents; Benzimidazoles; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Helicobacter pylori; Kinetics; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Structure-Activity Relationship | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
In vitro inhibitory activity of boropinic acid against Helicobacter pylori.
Topics: Carboxylic Acids; Helicobacter pylori; Rutaceae | 2006 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Design; Drug Resistance, Multiple, Bacterial; Duodenal Ulcer; Enzyme Inhibitors; Gastritis; Glycosyltransferases; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Molecular Conformation; Stomach Neoplasms; Stomach Ulcer | 2014 |
The effect of systemic antimicrobial therapy on plaque and gingivitis in dogs.
Topics: Administration, Oral; Animals; Dental Plaque; Dogs; Gingivitis; Metronidazole; Tetracycline | 1979 |
Amebic liver abscess in childhood.
Topics: Aortography; Chloroquine; Emetine; Entamoeba histolytica; Humans; Infant; Iodoquinol; Liver Abscess, Amebic; Male; Metronidazole; Niridazole; Radionuclide Imaging; Tetracycline | 1975 |
Antibiotic susceptibility testing of anaerobic bacteria by the standardized disc diffusion method with special reference to bacteroides fragilis.
Topics: Agar; Bacteroides; Chloramphenicol; Clindamycin; Clostridium perfringens; Diffusion; Erythromycin; Lactams; Lincomycin; Metronidazole; Microbial Sensitivity Tests; Peptostreptococcus; Propionibacterium; Regression Analysis; Sulfamethoxazole; Tetracycline; Trimethoprim | 1975 |
Antibiotic susceptibility of Clostridium species isolated from human infections.
Topics: Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Clindamycin; Clostridium; Clostridium perfringens; Doxycycline; Erythromycin; Lincomycin; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Tetracycline; Tinidazole | 1975 |
Invasive amebiasis. I. Amebic dysentery and its complications.
Topics: Adult; Amebiasis; Amebicides; Child, Preschool; Colonic Diseases; Entamoeba histolytica; Granuloma; Humans; Infant; Intestinal Perforation; Intussusception; Male; Metronidazole; Peritonitis; Skin Diseases, Infectious; Tetracycline | 1977 |
[Preventive drug therapy against anaerobic bacteria].
Topics: Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Clindamycin; Digestive System; Female; Genitalia, Female; Humans; Male; Metronidazole; Penicillin Resistance; Penicillins; Respiratory System; Surgical Wound Infection; Tetracycline; Vancomycin | 1978 |
Development of germfree animal characteristics in conventional rats in antibiotics.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aspirin; Bacitracin; Bile Pigments; Cholestanol; Clofibrate; Colistin; Erythromycin; Feces; Ferrous Compounds; Germ-Free Life; Intestines; Kanamycin; Male; Metronidazole; Neomycin; Oxytetracycline; Penicillin G; Rats; Sorbitol; Sulfathiazoles; Tetracycline | 1977 |
Failure of chloroquine in human babesiosis (Babesia microti): case report and chemotherapeutic trials in hamsters.
Topics: Animals; Babesiosis; Benzamidines; Chloroquine; Cricetinae; Drug Resistance; Humans; Male; Metronidazole; Middle Aged; Minocycline; Pentamidine; Pyrimethamine; Recurrence; Sulfadiazine; Tetracycline; Time Factors | 1978 |
Antimicrobial in vitro susceptibility of actinomyces israelii and arachnia propionica.
Topics: Actinomyces; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Lincomycin; Metronidazole; Microbial Sensitivity Tests; Sulfanilamides; Tetracycline; Tinidazole | 1977 |
Giardiasis: clinical and therapeutic aspects.
Topics: Adult; Female; Giardiasis; Humans; Intestinal Absorption; Jejunum; Male; Metronidazole; Quinacrine; Tetracycline; Travel; United Kingdom; Vitamin B 12; Xylose | 1977 |
[Urethritis syndrome and atypical germ flora of the exterior female genitalia (author's transl)].
Topics: Candidiasis, Vulvovaginal; Cervix Uteri; Chronic Disease; Female; Humans; Male; Metronidazole; Mycoplasma Infections; Nystatin; Psychophysiologic Disorders; Tetracycline; Trichomonas Vaginitis; Urethra; Urethritis; Vagina; Vaginal Diseases | 1976 |
Antimicrobial therapy of anaerobic infections.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium; Erythromycin; Fusobacterium; Gram-Negative Anaerobic Bacteria; Humans; Lincomycin; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Tetracycline; Thiamphenicol; Vancomycin | 1975 |
Three serious parasitic infections often missed in clinical practice.
Topics: Amebiasis; Diagnosis, Differential; Emetine; Entamoebiasis; Giardiasis; Humans; Iodoquinol; Liver Abscess, Amebic; Metronidazole; Quinacrine; Strongyloidiasis; Tetracycline; Thiabendazole | 1975 |
[Treatment of unspecific urethritis].
Topics: Antigens, Viral; Antiviral Agents; Female; Herpes Simplex; Humans; Male; Metronidazole; Mycoplasma Infections; Nystatin; Oxytetracycline; Tetracycline; Urethritis | 1975 |
[Dysplasia and carcinoma in situ of the uterine cervix. Outcome of several cases].
Topics: Adult; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Metronidazole; Nystatin; Precancerous Conditions; Rifampin; Tetracycline; Uterine Cervical Neoplasms | 1975 |
Epizootic of fatal amebiasis among exhibited snakes: epidemiologic, pathologic, and chemotherapeutic considerations.
Topics: Amebiasis; Animals; Animals, Zoo; Emetine; Entamoebiasis; Enteritis; Gastroenteritis; Inflammation; Intestines; Kidney; Liver; Metronidazole; Necrosis; Snakes; Tetracycline | 1975 |
Activity of combinations of antimicrobial agents against Bacteroides fragilis.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Carbenicillin; Cefoxitin; Chloramphenicol; Clindamycin; Drug Combinations; Drug Interactions; Drug Synergism; Erythromycin; Metronidazole; Penicillins; Tetracycline | 1976 |
In vitro activity of meropenem and other agents against oral bacteria.
Topics: Anti-Bacterial Agents; Bacteria; Meropenem; Metronidazole; Microbial Sensitivity Tests; Mouth; Penicillin Resistance; Penicillin V; Tetracycline; Thienamycins | 1992 |
E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms.
Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Ampicillin; Anti-Bacterial Agents; Bacteria; Bacteroides; Bacteroides fragilis; Campylobacter; Capnocytophaga; Cefoxitin; Ciprofloxacin; Clindamycin; Clostridium perfringens; Dental Plaque; Eikenella corrodens; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptostreptococcus; Periodontal Diseases; Periodontitis; Porphyromonas gingivalis; Tetracycline | 1992 |
A preliminary study on the use of a combination of tetracycline and metronidazole in the treatment of refractory periodontitis.
Topics: Aggressive Periodontitis; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Periodontal Pocket; Tetracycline | 1992 |
Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication.
Topics: Anti-Ulcer Agents; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Recurrence; Risk Factors; Smoking; Tetracycline; Time Factors | 1992 |
Eradication of Helicobacter pylori reduces gastric and duodenal ulcer recurrence.
Topics: Bismuth; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Ranitidine; Recurrence; Salicylates; Tetracycline | 1992 |
Short report: short-term triple therapy for H. pylori-associated duodenal ulcer disease.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Tetracycline | 1992 |
The effects of antimicrobial acrylic strips on the subgingival microflora in chronic periodontitis.
Topics: Acrylic Resins; Adult; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Chlorhexidine; Chronic Disease; Colony Count, Microbial; Combined Modality Therapy; Delayed-Action Preparations; Drug Implants; Drug Resistance, Microbial; Humans; Metronidazole; Periodontal Pocket; Periodontitis; Root Planing; Tetracycline | 1992 |
[Helicobacter pylori: from harmless commensal to clinically significant disease factor].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Recurrence; Stomach Ulcer; Tetracycline | 1992 |
Factors influencing the eradication of Helicobacter pylori with triple therapy.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Regression Analysis; Salicylates; Stomach Ulcer; Tetracycline | 1992 |
The effect of subinhibitory concentrations of metronidazole and tetracycline on the ultrastructure of periodontopathic bacteria.
Topics: Actinobacillus; Bacteroides; Humans; Metronidazole; Microbial Sensitivity Tests; Periodontal Diseases; Tetracycline | 1991 |
The role of laparoscopy in acute pelvic infections.
Topics: Acute Disease; Adult; Ampicillin; Chlamydia Infections; Drug Therapy, Combination; Female; Gonorrhea; Humans; Laparoscopy; Metronidazole; Mycoplasma Infections; Netilmicin; Pelvic Inflammatory Disease; Penicillin G Procaine; Tetracycline; Tobramycin | 1991 |
Antimicrobials in periodontitis: a clinical approach.
Topics: Amoxicillin; Drug Combinations; Humans; Metronidazole; Periodontitis; Spiramycin; Tetracycline | 1991 |
Cure of duodenal ulcer after eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Ulcer Agents; Campylobacter Infections; Duodenal Ulcer; Duodenitis; Duodenum; Female; Follow-Up Studies; Gastroscopy; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Recurrence; Tetracycline | 1990 |
Therapy in Helicobacter pylori infection.
Topics: Amoxicillin; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Tetracycline | 1990 |
Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline.
Topics: Animals; Bacteria; Bacterial Infections; Colony Count, Microbial; Female; Gentamicins; Hepatomegaly; Intestine, Small; Jejunum; Liver; Liver Diseases; Liver Function Tests; Male; Metronidazole; Polymyxin B; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Tetracycline | 1991 |
Management of intraperitoneal rupture of amoebic liver abscess: a 6-year experience with 11 cases in Port Harcourt, Nigeria.
Topics: Abdomen, Acute; Humans; Liver Abscess, Amebic; Metronidazole; Peritoneal Cavity; Rupture, Spontaneous; Tetracycline | 1991 |
Broth-disk elution determination of antimicrobial susceptibility of selected anaerobes isolated from animals.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Chloramphenicol; Clindamycin; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Tetracycline | 1991 |
Conservative approach to the management of pelvic inflammatory disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Metronidazole; Oxytetracycline; Pelvic Inflammatory Disease; Penicillin G; Prospective Studies; Tetracycline; Tobramycin | 1990 |
Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection.
Topics: Bismuth; Campylobacter Infections; Drug Therapy, Combination; Duodenal Ulcer; Female; Food; Gastrins; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Tetracycline | 1990 |
In-vitro activity of ciprofloxacin and other agents against oral bacteria.
Topics: Bacteria; Ciprofloxacin; Humans; Metronidazole; Microbial Sensitivity Tests; Mouth; Penicillin V; Tetracycline | 1989 |
Use of strips containing tetracycline hydrochloride or metronidazole for the treatment of advanced periodontal disease.
Topics: Administration, Topical; Calorimetry, Differential Scanning; Dental Plaque; Gingiva; Humans; Metronidazole; Periodontal Diseases; Periodontitis; Solubility; Tetracycline | 1989 |
The effect of subminimal inhibitory concentrations of antimicrobial agents on three bacterial mixtures.
Topics: Bacteria; Bacteroides; Capnocytophaga; Eubacterium; Fusobacterium; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 1989 |
Comparison of the in vitro activities of fenticonazole, other imidazoles, metronidazole, and tetracycline against organisms associated with bacterial vaginosis and skin infections.
Topics: Antifungal Agents; Bacteria; Female; Humans; Imidazoles; Metronidazole; Microbial Sensitivity Tests; Skin Diseases, Infectious; Tetracycline; Vaginal Diseases | 1989 |
Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridium perfringens; Female; Gas Gangrene; Male; Metronidazole; Mice; Penicillin G; Rifampin; Tetracycline | 1987 |
Effect of antibiotics on toxin production and viability of Clostridium perfringens.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Calcium-Binding Proteins; Cefoxitin; Chloramphenicol; Clindamycin; Clostridium perfringens; Kinetics; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Rifampin; Tetracycline; Type C Phospholipases | 1987 |
Evaluation of anaerobic microdilution MIC results with the Prompt Inoculation System.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Carbenicillin; Cefoxitin; Chloramphenicol; Clindamycin; Clostridium perfringens; Metronidazole; Microbial Sensitivity Tests; Penicillins; Peptococcus; Tetracycline | 1987 |
A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity.
Topics: Animals; Arthritis, Rheumatoid; Cartilage, Articular; Diabetes Mellitus, Experimental; Humans; Male; Metronidazole; Microbial Collagenase; Minocycline; Rats; Rats, Inbred Strains; Rickets; Skin; Streptozocin; Tetracycline; Tetracyclines | 1987 |
Susceptibility testing of 7 antibiotics against anaerobic bacteria: comparison of 2 different media and carbon dioxide concentrations.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbon Dioxide; Chloramphenicol; Clindamycin; Culture Media; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins; Regression Analysis; Rifamycins; Tetracycline | 1987 |
Treatment of rosacea with tetracycline and metronidazole--a comparative study.
Topics: Adult; Female; Humans; Male; Metronidazole; Prospective Studies; Rosacea; Tetracycline; Time Factors | 1985 |
Emergence of antibiotic resistant strains of Bacteroides fragilis.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; Chloramphenicol; Clindamycin; Drug Resistance, Microbial; Evaluation Studies as Topic; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Tetracycline | 1988 |
Comparison of in vitro activity of niridazole, metronidazole and tetracycline against subgingival bacteria in chronic periodontitis.
Topics: Bacteria, Anaerobic; Dental Plaque; Humans; Metronidazole; Niridazole; Periodontal Pocket; Periodontitis; Tetracycline | 1987 |
Efficacy of different antibiotics in the treatment of pelvic inflammatory disease.
Topics: Ampicillin; Anti-Bacterial Agents; Doxycycline; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Metronidazole; Oxytetracycline; Pelvic Inflammatory Disease; Random Allocation; Tetracycline | 1987 |
Use of an intravenous steroid regimen in the treatment of acute Crohn's disease.
Topics: Adolescent; Adult; Aged; Crohn Disease; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Infusions, Parenteral; Male; Metronidazole; Middle Aged; Prednisolone; Recurrence; Retrospective Studies; Tetracycline; Time Factors | 1986 |
Choosing antimicrobials. Factors to consider, available agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Clindamycin; Drug Interactions; Drug Therapy, Combination; Erythromycin; Humans; Kidney Failure, Chronic; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Tetracycline; Tissue Distribution; Vancomycin | 1985 |
The development and clinical use of acrylic strips containing anti-microbial agents in the management of chronic periodontitis.
Topics: Acrylic Resins; Anti-Bacterial Agents; Bacteria; Bacterial Physiological Phenomena; Bacteroides; Chlorhexidine; Delayed-Action Preparations; Drug Implants; Humans; In Vitro Techniques; Metronidazole; Periodontal Pocket; Periodontitis; Random Allocation; Tetracycline | 1985 |
Antibiotics for periodontal disease. When, why and what.
Topics: Adult; Anti-Bacterial Agents; Humans; Leucomycins; Metronidazole; Penicillins; Periodontal Diseases; Tetracycline | 1985 |
Effects of acute and short-time antibiotic treatment on renal lithium elimination and serum lithium levels in the rat.
Topics: Ampicillin; Animals; Diuresis; Kidney; Lithium; Male; Metabolic Clearance Rate; Metronidazole; Rats; Rats, Inbred Strains; Tetracycline | 1985 |
Letter: Bacteroides infections.
Topics: Bacteroides; Bacteroides Infections; Clindamycin; Culture Media; Drug Evaluation; Drug Resistance, Microbial; Drug Synergism; Humans; Intestinal Diseases; Lincomycin; Metronidazole; Rifampin; Surgical Wound Infection; Tetracycline | 1973 |
Letter: Amoebic infection treated with metronidazole.
Topics: Chronic Disease; Colonic Diseases; Drug Synergism; Drug Therapy, Combination; Dysentery, Amebic; Humans; Metronidazole; Tetracycline | 1974 |
A clinical study on 29 cases of debatable STS and TPI seroreactions in Greenland.
Topics: Adolescent; Adult; Age Factors; Female; Gonorrhea; Greenland; Humans; Male; Metronidazole; Middle Aged; Penicillins; Sex Factors; Syphilis; Syphilis Serodiagnosis; Tetracycline; Treponema Immobilization Test | 1974 |
The amoebicidal, trichomonicidal, and antibacterial effects of niridazole in laboratory animals.
Topics: Amebiasis; Amebicides; Amoeba; Animals; Anthelmintics; Antimony; Antiprotozoal Agents; Chloroquine; Clioquinol; Cricetinae; Dysentery, Bacillary; Emetine; Enterobacteriaceae Infections; Furazolidone; Imidazoles; Intestinal Diseases, Parasitic; Liver Abscess, Amebic; Metronidazole; Mice; Quinacrine; Salmonella Infections; Sulfonamides; Sulfones; Tartrates; Tetracycline; Thiazoles; Trichomonas Infections | 1969 |
Activity of metronidazole against experimental tetanus and gas gangrene.
Topics: Animals; Clostridium; Clostridium perfringens; Clostridium tetani; Gas Gangrene; Metronidazole; Mice; Penicillin G; Tetanus; Tetracycline | 1968 |
Amoebiasis in Cape Town children.
Topics: Child; Child, Preschool; Chloroquine; Dysentery, Amebic; Entamoeba histolytica; Humans; Infant; Iodoquinol; Metronidazole; Tetracycline | 1970 |
Treatment of children with acute amoebic dysentery. Comparative trial of metronidazole against a combination of dehydroemetine, tetracycline, and diloxanide furoate.
Topics: Amebicides; Child; Child, Preschool; Dysentery, Amebic; Emetine; Entamoeba histolytica; Feces; Female; Humans; Infant; Injections, Intravenous; Male; Metronidazole; Tetracycline | 1970 |
Letter: Malabsorption in overland travellers to India.
Topics: Amebiasis; Diarrhea; Entamoeba histolytica; Humans; India; Intestinal Absorption; Metronidazole; Tetracycline; Travel | 1974 |
[Amebal abscess of the liver].
Topics: Adult; Amoeba; Antibodies; Fluorescent Antibody Technique; Humans; Hydroxychloroquine; Liver Abscess, Amebic; Male; Metronidazole; Middle Aged; Punctures; Tetracycline | 1972 |
Treatment of liver abscesses. A conservative surgical approach.
Topics: Adult; Autopsy; Chloroquine; Drainage; Emetine; Humans; Iodoquinol; Liver Abscess; Liver Abscess, Amebic; Male; Metronidazole; Radionuclide Imaging; Tetracycline | 1973 |
Imported infections. Unexplained fever.
Topics: Africa; Asia; Brucellosis; Chloramphenicol; Chloroquine; Fever; Humans; Leishmaniasis, Visceral; Liver Abscess, Amebic; Malaria; Metronidazole; Plasmodium falciparum; Tetracycline; Travel; Trypanosomiasis, African; Tuberculosis; Typhoid Fever; United Kingdom | 1974 |
Venereal disease among Nigerian women attending intra-uterine contraceptive device clinics.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Intrauterine Devices; Metronidazole; Neisseria gonorrhoeae; Nigeria; Nystatin; Penicillin Resistance; Sexually Transmitted Diseases; Tetracycline; Trichomonas Vaginitis | 1972 |
Two-day treatment with metronidazole in vaginal trichomoniasis.
Topics: Adult; Contraceptives, Oral; Female; Gonorrhea; Humans; Marriage; Metronidazole; Tetracycline; Time Factors; Trichomonas Vaginitis; Urethritis | 1972 |
Treatment of amoebiasis.
Topics: Acetanilides; Amebicides; Dysentery, Amebic; Emetine; Furans; Humans; Liver Abscess, Amebic; Metronidazole; Tetracycline | 1973 |
Treatment of venereal diseases.
Topics: Chancroid; Drug Combinations; Erythromycin; Female; Gonorrhea; Granuloma Inguinale; Humans; Injections, Intramuscular; Kanamycin; Lymphogranuloma Venereum; Male; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Sexually Transmitted Diseases; Streptomycin; Sulfamethoxazole; Sulfonamides; Syphilis; Tetracycline; Trimethoprim; Urethritis | 1973 |
Amoebic perforation of the colon.
Topics: Adult; Colon; Colonic Diseases; Dysentery, Amebic; Female; Humans; Intestinal Perforation; Metronidazole; Tetracycline | 1974 |
Antimicrobial considerations in anaerobic infections.
Topics: Actinomycetales Infections; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides Infections; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium Infections; Erythromycin; Fusobacterium; Humans; Lincomycin; Metronidazole; Microbial Sensitivity Tests; Oxygen; Penicillins; Rifampin; Streptococcal Infections; Tetracycline; Treponemal Infections; Vancomycin; Veillonella | 1974 |
Chronic intestinal coccidiosis in man: intestinal morphology and response to treatment.
Topics: Antiprotozoal Agents; Biopsy; Chloroquine; Chronic Disease; Coccidiosis; Diagnosis, Differential; Diarrhea; Diet Therapy; Drug Therapy, Combination; Duodenum; Follow-Up Studies; Humans; Intestinal Diseases, Parasitic; Intestine, Small; Isospora; Jejunum; Malabsorption Syndromes; Male; Metronidazole; Microscopy, Electron; Middle Aged; Nitrofurantoin; Primaquine; Pyrimethamine; Quinacrine; Sulfadiazine; Tetracycline; Time Factors | 1974 |
Bactericidal activity of five antimicrobial agents against Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteroides; Clindamycin; Metronidazole; Microbial Sensitivity Tests; Rifampin; Tetracycline; Vancomycin | 1972 |
Pharmacology for the dental practitioner. Drug interactions, drug-induced diseases and drugs in pregnancy (continued).
Topics: Adrenal Cortex Hormones; Anticoagulants; Female; General Practice, Dental; Humans; Metronidazole; Pregnancy; Tetracycline; Tooth Extraction | 1969 |
Drugs for dysentery.
Topics: Adult; Amebicides; Child; Chloroquine; Drug Resistance, Microbial; Dysentery, Amebic; Dysentery, Bacillary; Emetine; Humans; Liver Abscess, Amebic; Metronidazole; Nalidixic Acid; Streptomycin; Sulfonamides; Tetracycline | 1970 |
[1st results on the drugs active in vitro on soil amoebas which cause human meningoencephalitis].
Topics: Amoeba; Anti-Infective Agents; Arsenicals; Culture Media; Erythromycin; Humans; Meningoencephalitis; Metronidazole; Quinolines; Sulfadiazine; Tetracycline | 1970 |
[Treatment of vaginal fluor].
Topics: Amphotericin B; Female; Humans; Metronidazole; Tetracycline; Trichomonas Infections; Trichomonas Vaginitis | 1971 |
[Syphilis diagnosis in the age of antibiotics].
Topics: Adult; Aged; Alopecia; Anti-Bacterial Agents; Balanitis; Biopsy; Child; Child, Preschool; Chloramphenicol; Deoxyuridine; Diagnosis, Differential; Diagnostic Errors; Erythromycin; Exanthema; Female; Hemorrhoids; Hernia, Inguinal; Herpes Simplex; Humans; Lymphadenitis; Male; Metronidazole; Middle Aged; Mycoses; Oxytetracycline; Penicillins; Sarcoidosis; Sclerosis; Skin Tests; Stomatitis; Syphilis; Syphilis Serodiagnosis; Syphilis, Latent; Tetracycline | 1971 |
Concurrent Whipple's disease and Giardia lamblia infection.
Topics: Aged; Giardiasis; Humans; Male; Metronidazole; Tetracycline; Whipple Disease | 1980 |
The relapse rate for rosacea after treatment with either oral tetracycline or metronidazole cream.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Recurrence; Rosacea; Tetracycline | 1983 |
Effects of some antimicrobial agents on neuromuscular blocking activity of chandonium iodide.
Topics: Ampicillin; Androstenes; Animals; Anti-Bacterial Agents; Cats; Female; Male; Metronidazole; Neuromuscular Junction; Streptomycin; Tetracycline | 1984 |
[Susceptibility of potential periodontopathic bacteria to metronidazole, spiramycin and their combination].
Topics: Bacteria; Bacteroides; Dental Plaque; Drug Combinations; Erythromycin; Humans; Leucomycins; Metronidazole; Microbial Sensitivity Tests; Ornidazole; Periodontal Diseases; Tetracycline | 1984 |
Comparison of the immediate effects on the sub-gingival microflora of acrylic strips containing 40% chlorhexidine, metronidazole or tetracycline.
Topics: Acrylic Resins; Administration, Topical; Bacteria; Chlorhexidine; Dental Plaque; Humans; Metronidazole; Periodontal Pocket; Periodontitis; Tetracycline | 1984 |
In vitro activity of rodogyl against putative periodontopathic bacteria.
Topics: Bacteria; Drug Combinations; Humans; Leucomycins; Metronidazole; Microbial Sensitivity Tests; Periodontitis; Spiramycin; Tetracycline | 1983 |
1981 schedules for the treatment of the sexually transmitted diseases as recommended by the New York City Health Department Bureau of Venereal Disease Control Part II.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Metronidazole; New York City; Penicillins; Sexually Transmitted Diseases; Sulfisoxazole; Tetracycline | 1981 |
The development and in vitro evaluation of acrylic strips and dialysis tubing for local drug delivery.
Topics: Chlorhexidine; Delayed-Action Preparations; Dialysis; Dosage Forms; Humans; Intubation; Methylmethacrylates; Metronidazole; Periodontal Pocket; Spectrophotometry; Tetracycline | 1982 |
Use of antibiotics to prevent hepatitis and typhlitis in male scid mice spontaneously infected with Helicobacter hepaticus.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bismuth; Cecal Diseases; Cecum; Chronic Disease; Helicobacter; Helicobacter Infections; Hepatitis, Animal; Inflammation; Liver; Male; Metronidazole; Mice; Mice, SCID; Neomycin; Rodent Diseases; Tetracycline | 1995 |
Mitsuokella dentalis in human periodontitis.
Topics: Adolescent; Adult; Age Distribution; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteroides; Ciprofloxacin; Cross-Sectional Studies; DNA Probes; Drug Resistance, Microbial; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Periodontal Pocket; Periodontitis; Sex Factors; Tetracycline; Tetracycline Resistance | 1994 |
[Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pepsinogens; Prospective Studies; Radioimmunoassay; ROC Curve; Sensitivity and Specificity; Stomach; Tetracycline; Time Factors | 1995 |
[The importance of obtaining biopsies of the gastric body in the follow-up after eradicating treatment of Helicobacter pylori].
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Biopsy; Bismuth; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Prospective Studies; Pyloric Antrum; Stomach; Tetracycline; Time Factors | 1995 |
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Ulcer; Tetracycline | 1995 |
Eczema responsive to treatment for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Eczema; Gastroenteritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Recurrence; Salicylates; Tetracycline | 1995 |
In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.
Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Clindamycin; Erythromycin; Fluoroquinolones; Metronidazole; Microbial Sensitivity Tests; Minocycline; Miocamycin; Naphthyridines; Ofloxacin; Porphyromonas gingivalis; Prevotella intermedia; Quinolones; Tetracycline | 1995 |
Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Base Sequence; Bismuth; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Helicobacter Infections; Male; Metronidazole; Mice; Mice, Inbred Strains; Molecular Sequence Data; Random Allocation; Stomach Diseases; Tetracycline | 1995 |
"Cure" of Helicobacter pylori and "cure" of peptic ulcer: do they mean the same thing?
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Recurrence; Tetracycline; Time Factors | 1995 |
90% cure: which anti-Helicobacter therapy can achieve this treatment goal?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Tetracycline | 1995 |
Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting.
Topics: Adult; Anti-Ulcer Agents; Base Sequence; DNA Fingerprinting; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Agar Gel; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Molecular Sequence Data; Polymerase Chain Reaction; Random Allocation; Recurrence; Tetracycline | 1995 |
Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy.
Topics: Adult; Cell Division; Chronic Disease; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Metronidazole; Organometallic Compounds; Tetracycline | 1995 |
Murine yeast gut flora affected by tetracycline, metronidazole and norfloxacin.
Topics: Administration, Oral; Animals; Candida albicans; Digestive System; Feces; Male; Metronidazole; Mice; Mice, Inbred ICR; Norfloxacin; Tetracycline | 1994 |
Effect of Helicobacter pylori eradication on peptic ulcer healing.
Topics: Adult; Aged; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Smoking; Stomach Ulcer; Tetracycline | 1995 |
[The effect of "triple therapy" on the eradicating of H. pylori and the healing of a duodenal ulcer. The initial study and 6 months later].
Topics: Adult; Aged; Anti-Ulcer Agents; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Recurrence; Remission Induction; Tetracycline; Time Factors | 1995 |
Susceptibility of Helicobacter pylori to antimicrobial agents: effect of sulglycotide.
Topics: Amoxicillin; Erythromycin; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Sialoglycoproteins; Tetracycline | 1995 |
Helicobacter pylori eradication and reinfection.
Topics: Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline | 1995 |
Treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline | 1995 |
Topical antibiotics and gastric flora.
Topics: Administration, Topical; Drug Resistance, Microbial; Helicobacter pylori; Humans; Metronidazole; Periodontal Diseases; Tetracycline; Tetracycline Resistance | 1995 |
Hitting H pylori for four.
Topics: Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Tetracycline | 1995 |
Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Tetracycline; Treatment Outcome | 1994 |
Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation.
Topics: Adult; Aged; Bismuth; Cell Division; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Longitudinal Studies; Male; Metaplasia; Metronidazole; Middle Aged; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Pyloric Antrum; Tetracycline | 1994 |
Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Failure; Treatment Outcome | 1994 |
Long-term follow-up and serological study after triple therapy of Helicobacter pylori-associated duodenal ulcer.
Topics: Anti-Ulcer Agents; Antibodies, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Metronidazole; Organometallic Compounds; Recurrence; Serologic Tests; Tetracycline | 1994 |
Preservation of gastric antral mucus is associated with failure of eradication of Helicobacter pylori by bismuth, metronidazole and tetracycline.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Administration Schedule; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Neutrophils; Pyloric Antrum; Tetracycline | 1994 |
Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole.
Topics: Animals; Antiprotozoal Agents; Bacteroides; Culture Media; Dientamoeba; Iodoquinol; Klebsiella pneumoniae; Metronidazole; Paromomycin; Tetracycline | 1994 |
[Antimicrobial sensitivity and treatment of Helicobacter pylori infections].
Topics: Amoxicillin; Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 1994 |
Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Tetracycline | 1994 |
Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing.
Topics: Adult; Bismuth; Female; Food; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Peptic Ulcer; Protein Precursors; Protein Processing, Post-Translational; Salicylates; Tetracycline | 1993 |
Short report: treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibiotics.
Topics: Adult; Aged; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline | 1993 |
Campylobacter rectus in human periodontitis.
Topics: Adolescent; Adult; Age Distribution; Aged; Campylobacter; Chi-Square Distribution; Ciprofloxacin; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Penicillin G; Periodontal Pocket; Periodontitis; Sensitivity and Specificity; Sex Distribution; Subgingival Curettage; Tetracycline; Time Factors | 1993 |
In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans.
Topics: Aggregatibacter actinomycetemcomitans; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Metronidazole; Penicillin G; Penicillin Resistance; Serotyping; Tetracycline; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
[Helicobacter pylori infection and peptic ulcer].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Tetracycline | 1993 |
Beta-hemolytic streptococci in advanced periodontitis.
Topics: Adolescent; Adult; Age Factors; Aged; Ciprofloxacin; Colony Count, Microbial; Cross-Sectional Studies; Female; Hemolysis; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillin G; Periodontitis; Prevalence; Serotyping; Streptococcus; Tetracycline | 1993 |
[Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
Topics: Administration, Oral; Adult; Aged; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Ranitidine; Salicylates; Tetracycline | 1993 |
Apparent reversal of early gastric mucosal atrophy after triple therapy for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline | 1993 |
Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori.
Topics: Acute Disease; Adult; Aged; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acid; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Parietal Cells, Gastric; Tetracycline | 1993 |
Long-term Helicobacter pylori recurrence after successful eradication with triple therapy.
Topics: Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Recurrence; Salicylates; Tetracycline | 1993 |
Eradication of Helicobacter pylori normalizes serum gastrin concentration and antral gastrin cell number in a patient with primary gastrin cell hyperplasia.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Enterochromaffin Cells; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Male; Metronidazole; Middle Aged; Pyloric Antrum; Tetracycline | 1993 |
Local cellular and immune response by antral mucosa in patients undergoing treatment for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulins; Male; Metronidazole; Middle Aged; Omeprazole; Pyloric Antrum; T-Lymphocytes; Tetracycline | 1993 |
Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Interactions; Helicobacter pylori; Humans; Hydroxamic Acids; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Organometallic Compounds; Tetracycline | 1993 |
In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 1993 |
[Eradication of Helicobacter pylori and hemorrhagic recurrence of duodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer Hemorrhage; Tetracycline; Time Factors | 1995 |
Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Interactions; Erythromycin; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Sucralfate; Tetracycline | 1995 |
Resolution of gastric outlet obstruction after eradication of Helicobacter pylori.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Pyloric Stenosis; Tetracycline | 1995 |
Pulsed oral irrigation in the management of inflammatory periodontal diseases.
Topics: Chlorhexidine; Dental Devices, Home Care; Gingivitis; Humans; Metronidazole; Mouthwashes; Oral Hygiene; Periodontitis; Tetracycline; Therapeutic Irrigation | 1993 |
Distribution of biotypes and antimicrobial susceptibility of Actinobacillus actinomycetemcomitans.
Topics: Adolescent; Adult; Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Antitrichomonal Agents; Bacterial Typing Techniques; Cefoxitin; Cephamycins; Clindamycin; Dental Plaque; Drug Resistance, Microbial; Erythromycin; Female; Humans; Imipenem; Lincomycin; Male; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Penicillins; Periodontitis; Tetracycline; Thienamycins | 1995 |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Omeprazole; Patient Compliance; Penicillins; Recurrence; Tetracycline; Time Factors | 1996 |
[What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
Topics: Adult; Age Factors; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Evaluation Studies as Topic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Penicillins; Sex Factors; Smoking; Tetracycline; Time Factors; Wound Healing | 1996 |
[New guidelines from the Medical Products Agency: the triple regime against Helicobacter pylori is necessary. Treat only if the ulcer is verified].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Stomach Ulcer; Tetracycline | 1996 |
Verification of decreased basal and stimulated serum pepsinogen-I levels is a useful non-invasive method for determining the success of eradication therapy for Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Duodenum; Female; Follow-Up Studies; Helicobacter Infections; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pentagastrin; Pepsinogens; Tetracycline; Treatment Outcome | 1996 |
Evaluation of various oral antimicrobial formulations for eradication of Helicobacter hepaticus.
Topics: Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Base Sequence; Bismuth; Diet; Drinking; Female; Helicobacter; Helicobacter Infections; Male; Metronidazole; Mice; Mice, Inbred A; Mice, Inbred DBA; Molecular Sequence Data; Polymerase Chain Reaction; Rodent Diseases; Tetracycline | 1996 |
[Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Pyloric Antrum; Stomach; Tetracycline | 1996 |
Isolation and antimicrobial susceptibility of obligate anaerobic bacteria recovered from the uteri of dairy cows with retained fetal membranes and postparturient endometritis.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Cattle; Cattle Diseases; Ciprofloxacin; Clindamycin; Endometritis; Female; Metronidazole; Placenta, Retained; Pregnancy; Puerperal Infection; Tetracycline; Uterus | 1996 |
An audit of low dose triple therapy for eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitrichomonal Agents; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medical Audit; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Tetracycline; Treatment Outcome | 1996 |
Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids.
Topics: Anti-Bacterial Agents; Caprylates; Decanoic Acids; Drug Resistance, Microbial; Fatty Acids, Nonesterified; Glycerides; Helicobacter pylori; Laurates; Lauric Acids; Metronidazole; Microbial Sensitivity Tests; Monoglycerides; Tetracycline | 1996 |
Novel in vitro small intestinal graft model for study of bacterial translocation in the rat.
Topics: Animals; Antibiotic Prophylaxis; Bacterial Translocation; Chi-Square Distribution; Escherichia coli; Gram-Negative Bacteria; Intestinal Mucosa; Intestine, Small; Lymph Nodes; Metronidazole; Peyer's Patches; Rats; Rats, Wistar; Tetracycline | 1996 |
Eradication of helicobacter pylori among patients from a primary care practice.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Drug Therapy, Combination; Endoscopy; Evaluation Studies as Topic; Family Practice; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Tetracycline; Treatment Outcome | 1996 |
Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic.
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Cost of Illness; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Pilot Projects; Salicylates; Tetracycline | 1996 |
Drugs for treatment of peptic ulcers.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Drug Interactions; Drug Resistance, Microbial; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Misoprostol; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Salicylic Acid; Sucralfate; Tetracycline | 1997 |
[Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Tetracycline | 1996 |
"Mediterranean lymphoma" treated with antibiotics.
Topics: Aged; Amoxicillin; Drug Therapy, Combination; Duodenoscopy; Duodenum; Female; Humans; Immunoproliferative Small Intestinal Disease; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Tetracycline | 1996 |
Treating Helicobacter pylori--the best is yet to come?
Topics: Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Practice Guidelines as Topic; Tetracycline | 1996 |
A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Tetracycline | 1997 |
Triple-drug therapy of Helicobacter pylori infection in duodenal ulcer disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Recurrence; Tetracycline; Time Factors | 1997 |
Chronic abdominal pain and Helicobacter pylori.
Topics: Abdominal Pain; Adolescent; Anti-Bacterial Agents; Chronic Disease; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Tetracycline | 1997 |
[Helicobacter pylori: pretherapeutic resistance status in Germany (Ruhr area)].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple; Female; Gastritis; Germany; Helicobacter Infections; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 1997 |
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection.
Topics: Adult; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline | 1997 |
In vitro anti-Helicobacter pylori activity of ebrotidine.
Topics: Amoxicillin; Benzenesulfonates; Clarithromycin; Drug Synergism; Erythromycin; Helicobacter pylori; Histamine H2 Antagonists; Metronidazole; Microbial Sensitivity Tests; Ranitidine; Tetracycline; Thiazoles | 1997 |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment.
Topics: Amoxicillin; Bicarbonates; Bismuth; Carbon Isotopes; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Spectrometry; Metronidazole; Middle Aged; Omeprazole; Sensitivity and Specificity; Tetracycline | 1997 |
Identification and eradication of Helicobacter pylori in an isolated patient population.
Topics: Amoxicillin; Bismuth; Cost Savings; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Military Personnel; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; United States; Utah | 1997 |
Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter pylori; Humans; Male; Metronidazole; Spain; Tetracycline | 1997 |
Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular?
Topics: Adult; Antacids; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antitrichomonal Agents; Bismuth; Chaperonin 60; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epithelium; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; HLA-DR Antigens; Humans; Immunohistochemistry; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Tetracycline; Time Factors | 1997 |
Treatment of gastritis in cheetahs (Acinonyx jubatus).
Topics: Acinonyx; Animals; Anti-Bacterial Agents; Antitrichomonal Agents; Biopsy; Bismuth; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Gram-Negative Bacterial Infections; Helicobacter; Helicobacter Infections; Lymphocytes; Male; Metronidazole; Organometallic Compounds; Prospective Studies; Salicylates; Sensitivity and Specificity; Tetracycline; Time Factors | 1997 |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline; Tinidazole | 1996 |
An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Imipenem; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Tetracycline | 1996 |
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Helicobacter pylori; Humans; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Microbiological Techniques; Middle Aged; Nitroimidazoles; Tetracycline | 1997 |
Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Patient Selection; Tetracycline; Treatment Outcome | 1998 |
Rosacea.
Topics: Aged; Anti-Bacterial Agents; Diagnosis, Differential; Humans; Male; Metronidazole; Rosacea; Tetracycline | 1996 |
The ideal therapy must be defined in each geographical area: experience with a quadruple therapy in Spain.
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Spain; Tetracycline | 1998 |
Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycillin, clarithromycin, metronidazole and tetracycline.
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Biopsy; Clarithromycin; Gastritis; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Predictive Value of Tests; Sensitivity and Specificity; Stomach; Tetracycline; Urease | 1998 |
Four-day quadruple therapy as a routine treatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Tetracycline | 1997 |
Clinical quiz. Gastrospirillum hominis.
Topics: Bacterial Infections; Bismuth; Child; Gastric Mucosa; Gastritis; Helicobacter heilmannii; Humans; Male; Metronidazole; Organometallic Compounds; Salicylates; Tetracycline | 1998 |
Antimicrobial susceptibility of Helicobacter pylori determined by the E test using tetrazolium egg yolk agar.
Topics: Agar; Culture Media; Egg Yolk; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline; Tetrazolium Salts | 1998 |
In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitrofurantoin; Tetracycline | 1998 |
The pharmacoeconomic impact of antimicrobial therapy for peptic ulcer disease in a large urban jail.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; New York City; Organometallic Compounds; Peptic Ulcer; Prisons; Ranitidine; Retrospective Studies; Salicylates; Tetracycline; Urban Health | 1998 |
[A biocompatibility study and the effects of slow-release antibiotic materials in the treatment of periodontal disease. II. The biocompatibility and behavior of polyhydroxyethyl methacrylate (pHEMA) as a slow-release material for tetracycline of metronida
Topics: Anti-Bacterial Agents; Biocompatible Materials; Delayed-Action Preparations; Drug Combinations; Drug Delivery Systems; Drug Evaluation; Humans; Metronidazole; Microscopy, Electron, Scanning; Periodontal Pocket; Polyhydroxyethyl Methacrylate; Tetracycline | 1998 |
A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation.
Topics: Algorithms; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; Drug Delivery Systems; Helicobacter Infections; Metronidazole; Solubility; Stomach Ulcer; Tablets, Enteric-Coated; Tetracycline | 1999 |
Isolation of Fusobacterium necrophorum from cancrum oris (noma).
Topics: Adolescent; Anti-Bacterial Agents; Bacteroidaceae Infections; Child; Child, Preschool; Clindamycin; Culture Media; Drug Resistance, Microbial; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Metronidazole; Microbial Sensitivity Tests; Nigeria; Noma; Nutrition Disorders; Penicillins; Prevotella intermedia; Tetracycline | 1999 |
Optimal treatment for duodenal ulcer disease: a cost-decision analysis in Malaysian patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Duodenal Ulcer; Humans; Malaysia; Metronidazole; Models, Economic; Omeprazole; Tetracycline | 1999 |
Duodenal ulcer disease: to treat H. pylori infection or not?
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ranitidine; Tetracycline; United States | 1992 |
The use of antimicrobial acrylic strips in the nonsurgical management of chronic periodontitis.
Topics: Acrylic Resins; Adult; Bacterial Infections; Chlorhexidine; Chronic Disease; Drug Delivery Systems; Female; Humans; Male; Metronidazole; Middle Aged; Periodontal Pocket; Root Planing; Tetracycline | 1990 |
Effect of Helicobacter pylori eradication on the natural history of duodenal ulcer disease.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 1998 |
beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Child, Preschool; Female; Fluoroquinolones; Fusobacterium nucleatum; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Penicillin G; Tetracycline | 1999 |
Prospective evaluation of ranitidine bismuth citrate-based triple therapy for the treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Ranitidine; Tetracycline | 1999 |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Utilization; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Netherlands; Tetracycline | 1999 |
Antibiotic susceptibility of putative periodontal pathogens in advanced periodontitis patients.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Biofilms; Dental Plaque; Drug Resistance, Microbial; Female; Fusobacterium nucleatum; Gingival Crevicular Fluid; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptostreptococcus; Periodontal Index; Periodontitis; Porphyromonas gingivalis; Prevotella; Tetracycline; Tetracycline Resistance | 1999 |
Microbiotica associated with refractory periodontis. Prevalence and antibiotic susceptibility.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Erythromycin; Gingiva; Humans; Metronidazole; Mouth Mucosa; Periodontitis; Prevalence; Tetracycline | 1999 |
Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Ornidazole; Periodontal Pocket; Periodontitis; Species Specificity; Spiramycin; Tetracycline; Virginiamycin | 1999 |
[Symptomatic improvement of patients with nonulcer dyspepsia after Helicobacter pylori eradication].
Topics: Amoxicillin; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline; Treatment Outcome | 1999 |
What can be learnt from the new data about antibiotic resistance? Are there any practical clinical consequences of Helicobacter pylori antibiotic resistance?
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline; Tetracycline Resistance; Treatment Outcome | 1999 |
[Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Bismuth; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; L-Lactate Dehydrogenase; Metronidazole; Omeprazole; Organometallic Compounds; Purpura, Thrombocytopenic, Idiopathic; Salicylates; Tetracycline | 1999 |
A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule.
Topics: Adult; Aged; Anti-Ulcer Agents; Capsules; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Pilot Projects; Tetracycline; Treatment Outcome | 2000 |
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bulgaria; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Stomach; Tetracycline | 2000 |
Cost-effectiveness analysis of periodontal disease control.
Topics: Alveoloplasty; Anti-Bacterial Agents; Anti-Infective Agents; Cost-Benefit Analysis; Decision Support Techniques; Dental Prophylaxis; Dental Scaling; Health Care Costs; Humans; Metronidazole; Middle Aged; Outcome Assessment, Health Care; Periodontal Diseases; Periodontal Pocket; Quality-Adjusted Life Years; Relative Value Scales; Root Planing; Sensitivity and Specificity; Subgingival Curettage; Surgical Flaps; Tetracycline | 1987 |
Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Helicobacter pylori; Humans; Metronidazole; Tetracycline | 2000 |
Blastocystis hominis: neutral red supravital staining and its application to in vitro drug sensitivity testing.
Topics: Amebicides; Animals; Blastocystis hominis; Chloroquine; Coloring Agents; Humans; Metronidazole; Neutral Red; Nitro Compounds; Parasitic Sensitivity Tests; Paromomycin; Quinacrine; Staining and Labeling; Sulfamethoxazole; Tetracycline; Thiazoles; Trimethoprim | 2000 |
In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Interactions; Drug Therapy, Combination; Erythromycin; Helicobacter pylori; Humans; Ketolides; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2000 |
[Helicobacter pylori eradication in gastroduodenal ulcer: good, fine and not expensive].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Primary Health Care; Tetracycline | 2000 |
Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori.
Topics: Drug Resistance, Multiple; Helicobacter pylori; Humans; Japan; Korea; Metronidazole; Microbial Sensitivity Tests; Tetracycline; Tetracycline Resistance | 2000 |
Single drug therapy for Helicobacter pylori infection.
Topics: Bismuth; Capsules; Drug Combinations; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Tetracycline | 2000 |
Pooled analysis of Helicobacter pylori eradication regimes in Asia.
Topics: Asia; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2000 |
Strategies to treat patients with antibiotic resistant Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Resistance, Microbial; Drug Therapy; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2000 |
[Efficacy of a multistep strategy for Helicobacter pylori eradication: quadruple therapy with omeprazole, metronidazole, tetracycline and bismuth after failure of a combination of omeprazole, clarithromycin and amoxycillin].
Topics: Anti-Ulcer Agents; Bismuth; Combined Modality Therapy; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline; Treatment Failure | 2000 |
Identification and antimicrobial susceptibility of enterococci isolated from the root canal.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Calcium Hydroxide; Clindamycin; Dental Pulp Cavity; Dental Pulp Diseases; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillin G; Penicillin Resistance; Penicillins; Root Canal Filling Materials; Tetracycline; Tetracycline Resistance; Treatment Failure; Vancomycin | 2000 |
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Sex Characteristics; Tetracycline; Tetracycline Resistance | 2001 |
Evolution of metronidazole and tetracycline susceptibility pattern in Helicobacter pylori at a hospital in Saudi Arabia.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Saudi Arabia; Tetracycline | 2001 |
Acne rosacea occurring after carbon dioxide laser treatment.
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Infective Agents; Carbon Dioxide; Female; Forehead; Humans; Keratosis; Laser Therapy; Male; Metronidazole; Middle Aged; Rosacea; Surgery, Plastic; Tetracycline | 2001 |
Resistance of Helicobacter pylori to antimicrobial treatment in a Seville hospital catchment area.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Catchment Area, Health; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter pylori; Hospitals; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Prospective Studies; Spain; Tetracycline | 2000 |
The clinical relevance of microbiologic testing: a comparative analysis of microbiologic samples secured from the same sites and cultured in two independent laboratories.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Bacteroides; Campylobacter; Cost-Benefit Analysis; Drug Combinations; Drug Resistance, Microbial; Humans; Laboratories, Dental; Metronidazole; Middle Aged; Penicillin Resistance; Penicillins; Peptostreptococcus; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Reproducibility of Results; Tetracycline; Tetracycline Resistance | 2001 |
[Current principles of the use of laparoscopic surgery in gastroduodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Laparoscopy; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Postoperative Complications; Ranitidine; Recurrence; Stomach Ulcer; Tetracycline; Time Factors | 2001 |
Women commonly seek care for rosacea: dermatologists frequently provide the care.
Topics: Administration, Oral; Administration, Topical; Adult; Age Distribution; Aged; Dermatology; Drug Therapy, Combination; Female; Health Care Surveys; Humans; Incidence; Metronidazole; Middle Aged; Office Visits; Patient Acceptance of Health Care; Prognosis; Registries; Rosacea; Severity of Illness Index; Tetracycline; Treatment Outcome; United States | 2001 |
Treatment of rosacea.
Topics: Administration, Oral; Administration, Topical; Benzoyl Peroxide; Humans; Metronidazole; Rosacea; Tetracycline | 2001 |
Antibiotic susceptibility of Helicobacter pylori in the Chinese population.
Topics: China; Clarithromycin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Reproducibility of Results; Tetracycline | 2001 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cross Infection; Drug Resistance; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyloric Antrum; Spain; Tetracycline | 2001 |
Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease.
Topics: Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Quality of Life; Recurrence; Retrospective Studies; Tetracycline; Treatment Outcome | 2001 |
Pectin-based microspheres: a preformulatory study.
Topics: Chemistry, Pharmaceutical; Drug Carriers; Metronidazole; Microscopy, Electron, Scanning; Microspheres; Pectins; Surface-Active Agents; Tetracycline | 2001 |
[A comparative study of various evaluation methods of the antibiotic sensitivity of strict anaerobic bacteria of the subgingival flora].
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Campylobacter; Chronic Disease; Diffusion; Drug Resistance, Bacterial; Erythromycin; Fusobacterium nucleatum; Gingiva; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins; Peptostreptococcus; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Recurrence; Tetracycline; Time Factors | 2001 |
Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; Enzyme Inhibitors; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Medical Records; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Retrospective Studies; Tetracycline; Treatment Failure; Treatment Outcome | 2001 |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter pylori; Lebanon; Metronidazole; Microbial Sensitivity Tests; Penicillins; Prevalence; Tetracycline | 2002 |
Increasing resistance of Helicobacter pylori to clarithromycin: is the horse bolting?
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Biopsy; Clarithromycin; Drug Resistance, Microbial; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Stomach; Tetracycline | 2002 |
Rosacea now successfully controlled with therapy and lifestyle changes.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Humans; Low-Level Light Therapy; Metronidazole; Rosacea; Tetracycline | 2000 |
Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model.
Topics: Animals; Bismuth; Disease Models, Animal; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mice; Mice, Inbred C57BL; Organometallic Compounds; Salicylates; Tetracycline | 2002 |
[Evolution of the sensitivity of 235 strains of Helicobacter pylori from 1995 to 1998 and impact of antibiotic treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Spain; Tetracycline | 2002 |
Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime.
Topics: Amoxicillin; Cefixime; Chi-Square Distribution; Clarithromycin; Confidence Intervals; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline | 2002 |
[Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Ciprofloxacin; Clarithromycin; Confidence Intervals; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Random Amplified Polymorphic DNA Technique; Reunion; Stomach Ulcer; Tetracycline; Treatment Failure | 2002 |
Local antibiotic therapy guided by microbiological diagnosis.
Topics: Administration, Topical; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Cellulose; Colony Count, Microbial; Humans; Logistic Models; Metronidazole; Periodontitis; Porphyromonas gingivalis; Tetracycline | 2002 |
Antibiotic susceptibility patterns of Helicobacter pylori strains isolated from northeastern Mexico.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Mexico; Microbial Sensitivity Tests; Middle Aged; Tetracycline | 2002 |
Bismuth subcitrate/metronidazole/ tetracycline--Axcan Pharma. Bismuth triple therapy--Axcan Pharma, Helicide.
Topics: Anti-Bacterial Agents; Bismuth; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Tetracycline | 2002 |
Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Diseases; Metronidazole; Poland; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Tetracycline | 2002 |
Change of antibiotic susceptibility following periodontal therapy. A pilot study in aggressive periodontal disease.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Combined Modality Therapy; Dental Plaque; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Gram-Negative Bacteria; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Periodontal Diseases; Periodontitis; Pilot Projects; Statistics, Nonparametric; Tetracycline | 2003 |
Antimicrobial susceptibilities of canine Clostridium difficile and Clostridium perfringens isolates to commonly utilized antimicrobial drugs.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Diarrhea; Dog Diseases; Dogs; Erythromycin; Metronidazole; Microbial Sensitivity Tests; Tetracycline; Tylosin | 2003 |
In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Chloramphenicol; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Meropenem; Metronidazole; Moxifloxacin; Quinolines; Spirochaetales; Swine; Tetracycline; Thienamycins | 2003 |
Antimicrobial resistance in Helicobacter pylori isolates from children.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Child; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Hospitals, Pediatric; Humans; Male; Metronidazole; Tetracycline; Victoria | 2003 |
The QUADRATE study: a proposal for a change in the reporting of pharmaceutical supported trials.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Tetracycline | 2003 |
CURRENT THERAPY OF INFECTIONS OF THE RENAL EXCRETORY SYSTEM.
Topics: Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Azo Compounds; Bacitracin; Chlormerodrin; Diuretics; Drug Therapy; Erythromycin; Humans; Kanamycin; Mandelic Acids; Methenamine; Metronidazole; Nalidixic Acid; Naphthyridines; Neomycin; Nitrofurans; Nitrofurantoin; Nystatin; Organomercury Compounds; Penicillins; Polymyxins; Sulfonamides; Tetracycline; Toxicology; Urinary Tract Infections | 1964 |
[MEGALOBLASTIC ANEMIA AND INTESTINAL DIVERTICULOSIS].
Topics: Anemia, Macrocytic; Anemia, Megaloblastic; Diverticulum; Drug Therapy; Duodenal Diseases; Humans; Intestines; Metronidazole; Tetracycline; Vitamin B 12 | 1965 |
Modulation of Porphyromonas gingivalis proteinase activity by suboptimal doses of antimicrobial agents.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Bacterial Outer Membrane Proteins; Chlorhexidine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Doxycycline; Endopeptidases; Gelatin; Gingipain Cysteine Endopeptidases; Hemagglutinins; Humans; Metronidazole; Minocycline; Penicillin G; Periodontitis; Porphyromonas gingivalis; Protease Inhibitors; Tetracycline | 2003 |
Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study.
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; India; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Tetracycline | 2003 |
Selection for high-level resistance by chronic triclosan exposure is not universal.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Chlorhexidine; Dental Plaque; Drug Resistance, Bacterial; Escherichia coli; Humans; Metronidazole; Microbial Sensitivity Tests; Mouth; Mouthwashes; Tetracycline; Triclosan | 2004 |
Helicobacter pylori: a historical perspective 1983-2003.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Comorbidity; Drug Therapy, Combination; Esophagitis, Peptic; Helicobacter Infections; Helicobacter pylori; History, 20th Century; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Prevalence; Stomach Neoplasms; Tetracycline | 2004 |
Effectiveness of antimicrobial adjuncts to scaling and root-planing therapy for periodontitis.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Chlorhexidine; Chronic Disease; Combined Modality Therapy; Dental Scaling; Evidence-Based Medicine; Humans; Metronidazole; Minocycline; Periodontal Index; Periodontitis; Research Design; Root Planing; Tetracycline; Treatment Outcome | 2004 |
[Efficacy of 14 day OBMT therapy as a second-line treatment for Helicobacter pylori infection].
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Retreatment; Tetracycline | 2004 |
Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori.
Topics: Amoxicillin; Anaerobiosis; Anti-Infective Agents; Bacterial Proteins; Chloramphenicol; Clarithromycin; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; FMN Reductase; Gene Deletion; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nitroreductases; Sequence Analysis, DNA; Tetracycline | 2004 |
Comparison of E-test and disk diffusion assay to evaluate resistance of Helicobacter pylori isolates to amoxicillin, clarithromycin, metronidazole and tetracycline in Costa Rica.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2004 |
Stability of metronidazole, tetracycline HCl and famotidine alone and in combination.
Topics: Drug Combinations; Drug Stability; Famotidine; Metronidazole; Solubility; Tetracycline | 2005 |
Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Pilot Projects; Ranitidine; Tablets; Tetracycline; Treatment Outcome | 2005 |
Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tetracycline | 2005 |
Adjunctive periodontal therapies.
Topics: Anti-Bacterial Agents; Biofilms; Chlorhexidine; Humans; Metronidazole; Penicillins; Periodontal Diseases; Tetracycline | 2005 |
[The trend of eradication rates of second-line quadruple therapy containing metronidazole for Helicobacter pylori infection: an analysis of recent eight years].
Topics: Adult; Antacids; Anti-Infective Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Tetracycline | 2005 |
Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Poland; Tetracycline | 2005 |
How effective are quadruple therapies as first-line H. pylori eradication therapies?
Topics: Adult; Anti-Infective Agents; Australia; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Metronidazole; Netherlands; Omeprazole; Tetracycline; Treatment Outcome | 2005 |
Antibiotic susceptibility of the bacteria causing odontogenic infections.
Topics: Acetamides; Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Clindamycin; Drug Resistance, Bacterial; Female; Focal Infection, Dental; Humans; Linezolid; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Molar, Third; Oxazolidinones; Periapical Periodontitis; Pericoronitis; Tetracycline | 2006 |
Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline | 2006 |
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.
Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Recurrence; Risk Factors; Tetracycline | 2006 |
Drug susceptibility pattern of Helicobacter pylori in patients with dyspepsia at the Kenyatta National Hospital, Nairobi.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Hospitals, Teaching; Humans; Kenya; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline | 2005 |
[What is recommended in rosacea?].
Topics: Administration, Oral; Administration, Topical; Humans; Male; Metronidazole; Middle Aged; Minocycline; Rosacea; Tetracycline | 2006 |
[Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Child; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Species Specificity; Tetracycline; Virulence | 2006 |
[Long term results of treatment by simple surgical closure of perforated gastroduodenal ulcer followed by eradication of Helicobacter pylori].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer Perforation; Randomized Controlled Trials as Topic; Recurrence; Tetracycline; Time Factors | 2006 |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Helicobacter pylori: prevalence of antimicrobial resistance in clinical isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Helicobacter pylori; Metronidazole; Mutation; Tetracycline | 2006 |
Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Tetracycline | 2006 |
Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003.
Topics: Adult; Aged; Alaska; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Population Groups; Sentinel Surveillance; Stomach; Tetracycline | 2006 |
Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Chromosomes, Bacterial; Clindamycin; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genes, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Phenylalanine; Plasmids; Sequence Analysis, DNA; Tetracycline | 2007 |
Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Patient Selection; Taiwan; Tetracycline | 2007 |
What is the best first choice treatment option for Helicobacter pylori?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Humans; Medication Adherence; Metronidazole; Pantoprazole; Tetracycline | 2007 |
[Prevalence of metronidazole, clarithromycin and tetracycline resistance in Helicobacter pylori isolated from Chilean patients].
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Chile; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Tetracycline Resistance | 2007 |
14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Ranitidine; Tetracycline; Treatment Failure | 2006 |
Antibiotic resistance in an in vitro subgingival biofilm model.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Clindamycin; Dental Pellicle; Dental Plaque; Dose-Response Relationship, Drug; Doxycycline; Drug Resistance, Bacterial; Durapatite; Erythromycin; Gingiva; Gram-Negative Bacteria; Humans; Metronidazole; Middle Aged; Minocycline; Periodontitis; Tetracycline; Time Factors | 2007 |
[Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Child; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2007 |
Levofloxacin-resistant Helicobacter pylori in Hong Kong.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Ketolides; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Point Mutation; Tetracycline | 2008 |
Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Cameroon; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Pyloric Antrum; Sex Factors; Stomach; Tetracycline | 2008 |
Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance.
Topics: Animals; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple; Erythromycin; Genes, Bacterial; Genes, MDR; Helicobacter pylori; Metronidazole; Mutation; Penicillin G; RNA, Messenger; Tetracycline | 2008 |
Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Case-Control Studies; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Polymorphism, Restriction Fragment Length; Severity of Illness Index; Tetracycline | 2009 |
Contact sensitization to metronidazole from possible occupational exposure.
Topics: Administration, Topical; Adult; Aged; Carcinoma, Basal Cell; Dermatitis, Allergic Contact; Dermatitis, Occupational; Diagnosis, Differential; Facial Dermatoses; Female; Humans; Metronidazole; Nursing; Occupational Exposure; Patch Tests; Rosacea; Skin Neoplasms; Tetracycline | 2009 |
Aspirin increases susceptibility of Helicobacter pylori to metronidazole by augmenting endocellular concentrations of antimicrobials.
Topics: Anti-Infective Agents; Aspirin; Bacterial Outer Membrane Proteins; Bacterial Proteins; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Gene Amplification; Gene Expression Regulation, Bacterial; Helicobacter pylori; Metronidazole; Nitroreductases; Polymerase Chain Reaction; RNA, Bacterial; RNA, Messenger; Tetracycline | 2009 |
Antibiotic susceptibility patterns in Helicobacter pylori strains from patients with upper gastrointestinal pathology in western Nigeria.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Clarithromycin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Nigeria; Peptic Ulcer; Polymerase Chain Reaction; Stomach; Tetracycline | 2009 |
Clinical peri-implant sounding accuracy in the presence of chronic inflammation of peri-implant tissues. Clinical observation study.
Topics: Alveolar Bone Loss; Anti-Bacterial Agents; Chronic Periodontitis; Combined Modality Therapy; Debridement; Dental Implants; Device Removal; Gels; Gingival Hemorrhage; Humans; Metronidazole; Periodontal Pocket; Periodontics; Tetracycline | 2009 |
[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children].
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Spain; Tetracycline | 2009 |
Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colombia; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Tetracycline | 2009 |
Drug resistance pattern and clonality in H. pylori strains.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents, Local; beta-Lactamases; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Tetracycline | 2009 |
Effects of the macrolide drug tylosin on chronic diarrhea in rhesus macaques (Macaca mulatta).
Topics: Animals; Anti-Bacterial Agents; C-Reactive Protein; Chronic Disease; Colonoscopy; Cytokines; Diarrhea; Disease Models, Animal; Dog Diseases; Dogs; Feces; Gene Expression Regulation; Macaca mulatta; Metronidazole; Prednisone; Primate Diseases; RNA, Messenger; Tetracycline; Tumor Necrosis Factor-alpha; Tylosin | 2008 |
[Symptomatic perioral, perinasal, and periocular papules].
Topics: Child; Dermatitis, Perioral; Diagnosis, Differential; Facial Dermatoses; Female; Granuloma; Humans; Isotretinoin; Metronidazole; Skin Diseases, Papulosquamous; Tetracycline | 2009 |
[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Enzyme-Linked Immunosorbent Assay; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms; Tetracycline | 2009 |
Antibiotic resistance of Helicobacter pylori in Israeli children.
Topics: Adolescent; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Biopsy; Chi-Square Distribution; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Prospective Studies; Surveys and Questionnaires; Tetracycline; Treatment Failure | 2010 |
Phenotypic and genetic characterization of antimicrobial profiles of Helicobacter pylori strains in Cuba.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Cuba; Drug Resistance, Bacterial; Female; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Sex Factors; Species Specificity; Tetracycline; Young Adult | 2010 |
Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Gentamicins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; South Africa; Tetracycline | 2010 |
Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Chi-Square Distribution; Clarithromycin; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Probability; Retrospective Studies; Sex Factors; Tetracycline; Young Adult | 2010 |
Sequential therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Young Adult | 2010 |
Antibiotic resistance of Helicobacter pylori in Mazandaran, North of Iran.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2010 |
Case of the month. MALT lymphoma.
Topics: Anemia; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Cyclophosphamide; Drug Therapy, Combination; Helicobacter Infections; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Melena; Metronidazole; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Tetracycline | 2010 |
Quadruple or triple therapy to eradicate H pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tablets; Tetracycline | 2011 |
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline | 2011 |
Helicobacter pylori eradication: A new, single-capsule bismuth-containing quadruple therapy.
Topics: Anti-Bacterial Agents; Bismuth; Capsules; Drug Combinations; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline; Treatment Outcome | 2011 |
Primary antibiotic resistance of Helicobacter pylori strains isolated from Portuguese children: a prospective multicentre study over a 10 year period.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Portugal; Prospective Studies; Tetracycline | 2011 |
Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance.
Topics: Adult; Aged; Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Republic of Korea; Tetracycline | 2012 |
[Treatment of rosacea].
Topics: Adapalene; Anti-Infective Agents; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Humans; Immunosuppressive Agents; Isotretinoin; Keratolytic Agents; Metronidazole; Mite Infestations; Naphthalenes; Rosacea; Sulfacetamide; Tacrolimus; Tetracycline; Toluidines; Tretinoin | 2011 |
Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy.
Topics: Adult; Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Metronidazole; Middle Aged; Patient Compliance; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2011 |
Treatment of rosacea.
Topics: Anti-Infective Agents; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Humans; Immunosuppressive Agents; Isotretinoin; Keratolytic Agents; Lasers, Dye; Metronidazole; Mite Infestations; Naphthalenes; Phototherapy; Rosacea; Sulfacetamide; Tacrolimus; Tetracycline; Toluidines; Tretinoin | 2011 |
Is quadruple therapy the new triple therapy for H pylori?
Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2012 |
High prevalence and resistance rates to antibiotics in anaerobic bacteria in specimens from patients with chronic balanitis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Balanitis; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Humans; Inhibitory Concentration 50; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2012 |
Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hispanic or Latino; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Tetracycline; Texas; Time Factors; Treatment Outcome; Urea | 2012 |
Antibiotic exposure and IBD development among children: a population-based cohort study.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Cefoxitin; Child; Child, Preschool; Clindamycin; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Inflammatory Bowel Diseases; Logistic Models; Male; Metronidazole; Penicillins; Proportional Hazards Models; Retrospective Studies; Risk; Tetracycline; United Kingdom; Vancomycin | 2012 |
[Simultaneous determination of 6 antibiotics and metronidazole in acne removal products bt high performance liquid chromatography].
Topics: Acne Vulgaris; Anti-Bacterial Agents; Anti-Infective Agents; Chromatography, High Pressure Liquid; Cosmetics; Humans; Metronidazole; Minocycline; Oxytetracycline; Tetracycline | 2012 |
Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lithuania; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Tetracycline | 2013 |
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; DNA Mutational Analysis; Drug Resistance, Bacterial; Erythromycin; Female; Gambia; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Nitroreductases; RNA, Ribosomal, 16S; Tetracycline | 2013 |
Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Ofloxacin; RNA, Ribosomal, 23S; Senegal; Tetracycline; Young Adult | 2013 |
High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Brazil; Child; Child, Preschool; Clarithromycin; Developing Countries; Disease Eradication; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline; Young Adult | 2013 |
Anti-Helicobacter pylori and urease inhibition activities of some traditional medicinal plants.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Pakistan; Plant Extracts; Plants, Medicinal; Tetracycline; Urease | 2013 |
Living in Sofia is associated with a risk for antibiotic resistance in Helicobacter pylori: a Bulgarian study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bulgaria; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Assessment; Surveys and Questionnaires; Tetracycline; Topography, Medical; Young Adult | 2013 |
Bismuth + metronidazole + tetracycline. Why risk adding bismuth?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2013 |
What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Breath Tests; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Stomach; Tetracycline; Treatment Outcome; Urea; Young Adult | 2013 |
Antibiotic resistance of Helicobacter pylori in Mashhad, Iran.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Chi-Square Distribution; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Sensitivity and Specificity; Tetracycline; Urease | 2013 |
[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition].
Topics: Amoxicillin; Anti-Bacterial Agents; Aspirin; Bismuth; Breath Tests; Clarithromycin; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metaplasia; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms; Tetracycline | 2013 |
Patterns of ambulatory care usage and leading treatments for rosacea.
Topics: Administration, Oral; Administration, Topical; Ambulatory Care; Anti-Infective Agents; Dermatology; Doxycycline; Female; Health Care Surveys; Humans; Metronidazole; Minocycline; Rosacea; Tetracycline; United States | 2014 |
Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2014 |
Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Retrospective Studies; Tetracycline; Treatment Outcome | 2015 |
Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Metronidazole; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Rifabutin; Salvage Therapy; Spain; Tetracycline; Time Factors; Treatment Outcome | 2015 |
The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Cohort Studies; Drug Therapy, Combination; Female; Fluoroquinolones; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Peptic Ulcer; Rabeprazole; Republic of Korea; Retrospective Studies; Salvage Therapy; Stomach; Tetracycline; Treatment Failure; Treatment Outcome; Urea | 2014 |
Genotypic and clinical differences of seropositive Helicobacter pylori children and adults in the Polish population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; Cross-Sectional Studies; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Infant; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Poland; Prospective Studies; Tetracycline; Young Adult | 2014 |
Occurrence of porphyromonas gingivalis and its antibacterial susceptibility to metronidazole and tetracycline in patients with chronic periodontitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Load; Bacteriological Techniques; Chronic Periodontitis; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Porphyromonas gingivalis; Tetracycline; Young Adult | 2014 |
In vitro effects of N-acetyl cysteine alone and in combination with antibiotics on Prevotella intermedia.
Topics: Acetylcysteine; Ampicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Metronidazole; Microbial Sensitivity Tests; Prevotella intermedia; Tetracycline | 2015 |
The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Taiwan; Tetracycline; Virulence Factors | 2015 |
Antibiotics prescription in Nigerian dental healthcare services.
Topics: Acquired Immunodeficiency Syndrome; Amoxicillin; Anaphylaxis; Anti-Bacterial Agents; Antibiotic Prophylaxis; Attitude of Health Personnel; Dental Care; Dentists; Diabetes Mellitus; Drug Combinations; Drug Prescriptions; Drug Resistance, Bacterial; Education, Dental; Female; Heart Diseases; Hip Prosthesis; HIV Infections; Humans; Male; Metronidazole; Nigeria; Practice Patterns, Dentists'; Rheumatic Fever; Tetracycline; Tooth Discoloration | 2014 |
Efficiency of Moxifloxacin in the Treatment of Helicobacter pylori Infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Female; Fluoroquinolones; Helicobacter Infections; Humans; Male; Metronidazole; Organometallic Compounds; Rabeprazole; Tetracycline | 2015 |
Lower plasma pantoprazole level predicts Helicobacter pylori treatment failure in patients with type 2 diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pantoprazole; Predictive Value of Tests; Proton Pump Inhibitors; ROC Curve; Tetracycline; Treatment Failure | 2015 |
Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medical Records; Medication Adherence; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors; Rabeprazole; Remission Induction; Retrospective Studies; Tetracycline; Time Factors; Treatment Outcome | 2015 |
Linezolid susceptibility in Helicobacter pylori, including strains with multidrug resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Linezolid; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2015 |
Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Taiwan; Tetracycline; Time Factors | 2015 |
Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Longitudinal Studies; Metronidazole; Omeprazole; Prospective Studies; Rifabutin; Tetracycline; Treatment Failure | 2015 |
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Fluoroquinolones; Gastric Fundus; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pyloric Antrum; Rifabutin; Tetracycline; Young Adult | 2016 |
Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains.
Topics: Anti-Infective Agents; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salvage Therapy; Tetracycline | 2016 |
Inclusion of Lactobacillus Reuteri in the Treatment of Helicobacter pylori in Sardinian Patients: A Case Report Series.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Limosilactobacillus reuteri; Male; Metronidazole; Middle Aged; Pantoprazole; Probiotics; Proton Pump Inhibitors; Tetracycline | 2016 |
Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bismuth; Canada; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Salvage Therapy; Tetracycline; Treatment Failure; Treatment Outcome; Young Adult | 2016 |
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Endoscopy; Female; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Nepal; Nitroreductases; Point Mutation; Prevalence; Prokaryotic Initiation Factor-2; RNA, Ribosomal, 23S; Tetracycline; Young Adult | 2016 |
Increasing role for modified bismuth-containing quadruple therapies for Helicobacter pylori eradication.
Topics: Anti-Infective Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Proton Pump Inhibitors; Tetracycline | 2017 |
New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice.
Topics: Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Treatment Outcome; Urea | 2017 |
Second-line bismuth-containing quadruple therapy for
Topics: Adult; Aged; Antacids; Anti-Infective Agents; Bismuth; Breath Tests; Diabetes Mellitus, Type 2; Disease Eradication; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Republic of Korea; Retrospective Studies; Risk Factors; Tetracycline; Treatment Failure; Treatment Outcome | 2017 |
Effect of biofilm formation by clinical isolates of
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biofilms; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S; Tetracycline | 2017 |
In vitro pharmacological interaction of caffeine and first-line antibiotics is antagonistic against clinically important bacterial pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Caffeine; Chloramphenicol; Drug Synergism; Erythromycin; Humans; Kanamycin; Metronidazole; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline | 2017 |
A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2017 |
Clinical Pearls in Infectious Diseases 2017.
Topics: Administration, Intravaginal; Adult; Aged; Anti-Bacterial Agents; Body Piercing; Campylobacter Infections; Campylobacter jejuni; Cellulitis; Ciprofloxacin; Communicable Diseases; Cyanosis; Diarrhea; Dietary Fiber; Drug Therapy, Combination; Estrogens; Female; Helicobacter Infections; Humans; Lyme Disease; Male; Metronidazole; Middle Aged; Otitis; Penicillin V; Phenazopyridine; Proton Pump Inhibitors; Tetracycline; Tick Bites; Travel-Related Illness; Urinary Tract Infections; Young Adult | 2017 |
Secondary antibiotic resistance of Helicobacter pylori isolates in Israeli children and adults.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Tetracycline; Young Adult | 2017 |
Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Tetracycline | 2017 |
Bismuth-based quadruple therapy following H. pylori eradication failures: a multicenter study in clinical practice.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bismuth; Capsules; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Italy; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Tablets; Tetracycline; Time Factors; Treatment Failure | 2017 |
Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2018 |
Eradication of Helicobacter pylori infection with a new bismuth-based quadruple therapy in clinical practice.
Topics: Anti-Infective Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Tetracycline; Treatment Outcome | 2018 |
Helicobacter pylori resistance in the Netherlands: a growing problem?
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Netherlands; Tetracycline | 2017 |
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Time Factors; Tinidazole; Treatment Outcome | 2018 |
Effect of pH on the microstructure of β-Ga
Topics: Anti-Bacterial Agents; Catalysis; Environmental Pollutants; Gallium; Hydrogen-Ion Concentration; Light; Metronidazole; Microspheres; Oxidation-Reduction; Particle Size; Photochemical Processes; Surface Properties; Tetracycline | 2018 |
Effectiveness and Safety of Pylera® in Patients Infected by Helicobacter Pylori: A Multicenter, Retrospective, Real Life Study.
Topics: Anti-Bacterial Agents; Bismuth; Demography; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Retrospective Studies; Tetracycline; Treatment Outcome | 2018 |
The emergence of Clostridium difficile PCR ribotype 078 in piglets in the Czech Republic clusters with Clostridium difficile PCR ribotype 078 isolates from Germany, Japan and Taiwan.
Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; Germany; Japan; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Swine; Taiwan; Tetracycline; Vancomycin | 2018 |
[Phylogenetic study of drug resistance genes from clinical isolates of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Phylogeny; Tetracycline; Tibet | 2018 |
Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Actinobacteria; Adult; Anti-Bacterial Agents; Bacteroidetes; Bismuth; Drug Therapy, Combination; Dysbiosis; Feces; Female; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Proteobacteria; Proton Pump Inhibitors; Tetracycline; Young Adult | 2018 |
Retrospective analysis of the use of quadruple therapy with bismuth (Pylera
Topics: Adult; Aged; Breath Tests; Cross-Sectional Studies; Drug Evaluation; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Recurrence; Retrospective Studies; Tetracycline; Treatment Outcome; Young Adult | 2018 |
Effective antimicrobial activity of rifabutin against multidrug-resistant Helicobacter pylori.
Topics: Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Furazolidone; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Rifabutin; Tetracycline | 2018 |
Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2018 |
Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Clinical Protocols; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Multicenter Studies as Topic; Organometallic Compounds; Phenotype; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Republic of Korea; Tetracycline; Treatment Outcome | 2018 |
Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Bismuth; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Risk Factors; Tetracycline; Treatment Failure | 2019 |
The first isolation of Clostridium difficile RT078/ST11 from pigs in China.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Chickens; China; Ciprofloxacin; Clostridioides difficile; Ducks; Imipenem; Metronidazole; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Swine; Tetracycline; Vancomycin | 2019 |
A novel hybrid first-line therapy for H. pylori eradication: results of a pilot study.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Time Factors; Treatment Outcome | 2019 |
Molecular diagnosis of Helicobacter pylori antibiotic resistance in the Taif region, Saudi Arabia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Cohort Studies; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Nitroreductases; Pathology, Molecular; Prevalence; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Saudi Arabia; Tetracycline; Young Adult | 2019 |
Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study.
Topics: Aged; Bismuth; Cohort Studies; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Neurotoxicity Syndromes; Organometallic Compounds; Tetracycline; Treatment Failure | 2019 |
Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Republic of Korea; Tetracycline; Young Adult | 2019 |
Compliance, adverse effects and effectiveness of first line bismuth-containing quadruple treatment (Pylera®) to eradicate Helicobacter pylori infection in 200 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Capsules; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Tetracycline; Treatment Outcome; Young Adult | 2019 |
Retrospective Analysis Confirms Tetracycline Quadruple as Best Helicobacter pylori Regimen in the USA.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Electronic Health Records; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Outcome and Process Assessment, Health Care; Proton Pump Inhibitors; Retrospective Studies; Tetracycline; United States | 2019 |
Tailored Helicobacter pylori eradication based on prior intake of macrolide antibiotics allows the use of triple therapy with optimal results in an area with high clarithromycin resistance.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Electronic Health Records; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Quinolones; Tetracycline; Young Adult | 2019 |
Which should be the first-line treatment for Helicobacter pylori in Colombia? A lesson from a recent study.
Topics: Anti-Bacterial Agents; Clarithromycin; Colombia; Drug Combinations; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Point Mutation; Tetracycline | 2019 |
Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Organometallic Compounds; Pantoprazole; Proton Pump Inhibitors; Tetracycline | 2020 |
Annual eradication rate of bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: A 15-year prospective study at a tertiary hospital in Korea.
Topics: Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Disease Eradication; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Republic of Korea; Tertiary Care Centers; Tetracycline; Tetracycline Resistance | 2020 |
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg).
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Hypersensitivity; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Registries; Tetracycline | 2020 |
Antibiotic resistance of Helicobacter pylori infection in a children's hospital in Vietnam: prevalence and associated factors.
Topics: Amoxicillin; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Peptic Ulcer; Tetracycline; Vietnam | 2020 |
Population-based study of Helicobacter pylori infection and antibiotic resistance in Bhutan.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bhutan; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Prevalence; Tetracycline | 2020 |
Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bismuth; Doxycycline; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Spain; Tetracycline; Treatment Outcome; Young Adult | 2020 |
European Registry on Helicobacter pylori management: Single-capsule bismuth quadruple therapy is effective in real-world clinical practice.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bismuth; Capsules; Drug Combinations; Drug Resistance, Bacterial; Europe; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Proton Pump Inhibitors; Registries; Tetracycline; Young Adult | 2021 |
Modified quadruple therapy or bismuth-containing quadruple therapy in the first-line treatment of Helicobacter pylori in Turkey.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Retrospective Studies; Tetracycline; Treatment Outcome; Turkey | 2021 |
Prospective comparative study of the treatment of Helicobacter pylori with antibiotic susceptibility testing-guided triple therapy compared to quadruple therapy with bismuth-metronidazole-tetracycline subcitrate.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2021 |
Recent Developments Pertaining to H. pylori Infection.
Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Pyrroles; Rifabutin; Stomach Neoplasms; Sulfonamides; Tetracycline; Treatment Outcome | 2021 |
Impact of Antimicrobial Resistance Rates on Eradication of Helicobacter pylori in a US Population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bismuth; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Rhode Island; Rifabutin; Tetracycline; Young Adult | 2021 |
Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects.
Topics: Anti-Bacterial Agents; Benzene Derivatives; Bismuth; Cross-Over Studies; Drug Therapy, Combination; Healthy Volunteers; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Male; Metronidazole; Republic of Korea; Tetracycline | 2021 |
Sequencing of Clostridium perfringens toxin genes (cpa, etx, iap) from Iraqi hospitals and detection by PCR of the genes encoding resistance to metronidazole, tetracycline, and clindamycin.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridium Infections; Clostridium perfringens; Cross-Sectional Studies; Drug Resistance, Bacterial; Genes, Bacterial; Hospitals; Humans; Iraq; Metronidazole; Polymerase Chain Reaction; Sequence Analysis, DNA; Tetracycline | 2021 |
Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Bacterial; Gastrointestinal Tract; Genes, Bacterial; Humans; Imipenem; Inpatients; Metalloendopeptidases; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Polymerase Chain Reaction; RNA, Ribosomal, 16S; Tetracycline | 2021 |
Antimicrobial Resistance and the Successful Eradication of
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Child, Preschool; Clarithromycin; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Tetracycline | 2021 |
Personalized and Defect-Specific Antibiotic-Laden Scaffolds for Periodontal Infection Ablation.
Topics: Anti-Bacterial Agents; Bone Regeneration; Fusobacterium nucleatum; Materials Testing; Metronidazole; Microbial Sensitivity Tests; Particle Size; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Tetracycline; Tissue Scaffolds | 2021 |
Introducing a flexible drug delivery system based on poly(glycerol sebacate)-urethane and its nanocomposite: potential application in the prevention and treatment of oral diseases.
Topics: Clay; Decanoates; Drug Delivery Systems; Glycerol; Metronidazole; Nanocomposites; Polymers; Tetracycline; Urethane | 2022 |
Community pharmacists' management of self-limiting infections: a simulation study in Akwa Ibom State, South-South Nigeria.
Topics: Amoxicillin; Anti-Bacterial Agents; Common Cold; Community Pharmacy Services; Diarrhea; Humans; Inappropriate Prescribing; Metronidazole; Nigeria; Patient Simulation; Pharmacists; Tetracycline | 2021 |
Increasing Helicobacter pylori clarithromycin resistance in Australia over 20 years.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2022 |
Simultaneous electrochemical degradation of tetracycline and metronidazole through a high-efficiency and low-energy-consumption advanced oxidation process.
Topics: Anti-Bacterial Agents; Electrodes; Metronidazole; Oxidation-Reduction; Tetracycline; Titanium; Water Pollutants, Chemical | 2022 |
Second-line Therapy for Helicobacter Pylori Eradication: State of the Art.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2022 |
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Protein Synthesis Inhibitors; Tetracycline | 2022 |
Direct Detection of Antibiotic Resistance in Chinese
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2022 |
Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Tetracycline; Tibet | 2022 |
Antibiotic Resistance of
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Microbial; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Tetracycline; Ulcer | 2022 |
Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Tetracycline | 2023 |
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Tetracycline | 2023 |
Long-Read- and Short-Read-Based Whole-Genome Sequencing Reveals the Antibiotic Resistance Pattern of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Nucleotides; RNA, Ribosomal, 23S; Tetracycline | 2023 |
Antibiotic resistance characteristics and risk factors analysis of
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Risk Factors; Tetracycline | 2023 |
Current Trends in the Management of Helicobacter pylori Infection in Serbia: Preliminary Results from the European Registry on H. pylori Management.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Quinolones; Registries; Serbia; Tetracycline; Treatment Outcome | 2023 |
Antibiotic resistance, heteroresistance, and eradication success of Helicobacter pylori infection in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Tetracycline | 2023 |
Antibiotic resistance profile of
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2023 |
Antibiotic resistance and heteroresistance in Helicobacter pylori isolates from symptomatic Vietnamese children: A prospective multicenter study.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Prospective Studies; Southeast Asian People; Tetracycline | 2023 |
High incidence of antibiotic resistance amongst isolates of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline; United Kingdom | 2023 |